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 To the chemist, the epipolythiodiketopiperazine (ETP) fungal metabolites represent a 
fascinating family of natural products, not only for their unique structural elements, but 
also for the unusual modes by which they are hypothesized to exert their biological 
activities. Though efforts at the total synthesis of these molecules have led to an 
evolution of innovative synthetic methodologies and strategies, challenges remain—
particularly with respect to acid-sensitive and highly oxygenated ETP structures, such as 
those containing one or more dihydrooxepine ring. As part of a broad research program 
targeting ETP natural products, we have developed a synthetic strategy towards 
dihydrooxepine-containing ETPs. 
 Herein, the enantioselective total synthesis of (–)-acetylaranotin is described. This 
represents the first total synthesis of any dihydrooxepine-containing ETP natural product. 
The key steps of the synthesis include an enantioselective azomethine ylide (1,3)-dipolar 
cycloaddition reaction to set the absolute and relative stereochemistry, a rhodium-
catalyzed cycloisomerization/chloride elimination sequence to generate the 
dihydrooxepine moiety, and a stereoretentive diketopiperazine sulfenylation to install the 
epidisulfide. 
 Our strategy was extended to the synthesis of a small panel of 
epitetrathiodiketopiperazines, including the natural products SCH64877 and emethallicin 
C as well as analogs, which are currently being evaluated for biological activity. 
Furthermore, preliminary investigations into the synthesis of dihydrooxepine-containing 
macrocycles have been conducted, with a particular focus on the preparation of bis(ortho-
methoxyaryl) ethers. 
 viii 
 Finally, as part of our efforts to further explore interesting side reactions observed 
during synthetic studies toward acetylaranotin, a catalytic asymmetric double (1,3)-
dipolar cycloaddition reaction was developed. This reaction provides access to highly 
substituted, enantioenriched pyrrolidizines from inexpensive, commercially available 
starting materials. Furthermore, the reactivity of diketopiperazine intermediates prepared 
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Epipolythiodiketopiperazine Natural Products 
 
1.1 INTRODUCTION 
To the chemist, the epipolythiodiketopiperazine (ETP) fungal metabolites 
represent a fascinating family of natural products, not only for their unique structural 
elements, but also for the unusual modes by which they are hypothesized to exert their 
biological activities.1 Gliotoxin (1, see Figure 1.1) was the first of these molecules to be 
isolated,2 and has been the most extensively studied: numerous manuscripts document 
gliotoxin’s biological activities, and efforts to elucidate the details of its biosynthesis are 
ongoing. At the time of its isolation, the structure of gliotoxin was completely 
unprecedented; efforts to determine its connectivity via degradation studies and 
spectroscopy required collaboration between multiple research groups, and were 
presented over the course of thirteen separate reports.3,4 With the subsequent discovery of 
a multitude of ETP subfamilies, each possessing unique structural elements peripheral to 
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the ETP core, the story of ETP chemistry and biology has come to beautifully exemplify 
the interplay between molecular structure and function. 
Figure 1.1. Gliotoxin (1) and previously proposed structures (2 and 3) 
 
1.2 OVERVIEW OF EPIPOLYTHIODIKETOPIPERAZINE NATURAL 
PRODUCTS 
 
The structural element at the core of each ETP natural product is the namesake 
epipolythiodiketopiperazine bicycle (Figure 1.2), comprising a diketopiperazine ring and 
a polysulfide linkage that bridges the two C(α)-centers. As shown in Figure 1.2, this core 
is found among the ETPs in combination with a variety of peripheral structures. These 
appendages can be as simple as the unmodified phenylalanine and serine residues of 
hyalodendrin (4)5 to the highly oxygenated polycyclic ring system of sirodesmin (6).6 As 
in the case of acetylaranotin (11),7 some structures are C2-symmetric about the ETP core, 
whereas others represent dimerization of two ETP-containing fragments adjoined at their 
periphery (as in 7–10).8,9 Though sub-families can roughly be designated based on 
structure, they are not mutually exclusive; for example, apoaranotin (12)7f possesses the 
cyclohexadienol monomer unit found in gliotoxin (1) as well as the dihydrooxepine unit 
found in acetylaranotin (11), whereas MPC1001B (13)10 contains the acetylaranotin 
monomer unit embedded within a macrocyclic framework. Finally, the characteristic 
polysulfide bridge can exist as the di-, tri-, or tetrasulfide (as with 7–9). Though the 
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together, and the tri- and tetrasulfides are hypothesized to exert their biological activities 
following reduction to the disulfide (or alternatively, the dithiol) to generate the active 
pharmacophore.11 
Figure 1.2. Epipolythiodiketopiperazine natural products 
 
 As suggested by the isolation sources listed in Figure 1.2, ETP natural products 
are found exclusively as secondary metabolites in fungal species. In many cases, they are 
hypothesized to serve as virulence and/or defense factors,12 and generally exhibit various 
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1.2.1 Biosynthesis 
Though feeding studies have suggested that all ETP natural products derive from 
cyclic dipeptides,13 and that the sulfur atoms generally derive from cysteine residues,14 
efforts to elucidate the details of biosynthetic pathway, including the associated gene 
clusters, have only been carried out for a few species: Aspergillus fumigatus (a producer 
of gliotoxin, 1),15 Leptosphaeria maculans (a producer of sirodesmin PL, not shown),16 
and Aspergillus terreus (a producer of acetylaranotin, 11).17 Of these investigations, the 
best-understood pathway to date is that for gliotoxin (1). 
Based on a combination of feeding experiments, directed mutagenesis, and 
BLAST primary sequence analyses, it is proposed that gliotoxin biosynthesis begins with 
the synthesis of diketopiperazine 16 from phenylalanine (14) and serine (15), catalyzed 
by GliP, a non-ribosomal peptide synthetase (NRPS) (See Scheme 1.1).15,18  Subsequent 
C–H oxidation by cytochrome P450 monooxygenase GliC then furnishes the 
dihydroxylated diketopiperazine 17. The nascent hydroxyl groups are next displaced by 
two equivalents of glutathione (GSH), a reaction catalyzed by glutathione S-transferase 
GliG and presumed to involve the intermediacy of an iminium electrophile 18, to afford 
the bis-GSH adduct 19. 19  Hydrolytic degradation by peptidase GliJ renders the 
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Scheme 1.1. C–S bond formation during gliotoxin (1) biosynthesis 
 
 C–S bond cleavage to deliver the free dithiol 23 is mediated by GliI, a 
homodimeric pyridoxal phosphate (PLP)-dependent carbon–sulfur lyase that is 
homologous to 1-aminocyclopropane-1-carboxylic acid synthases (ACCS) (Scheme 
1.2).20  Significantly, this is the first confirmed example of C–S lyase activity in the 
biosynthesis of a secondary metabolite. Furthermore, the absence of detectable amounts 
of the mono-Cys adduct during the process suggests that GliI cleaves the two C–S bonds 
simultaneously. Next, N-methylation is accomplished by N-methyltransferase GliN to 
afford 24, and subsequent cytochrome P450-mediated oxidative cyclization furnishes the 
polycyclic cyclohexadienol ring system of the natural product, via the intermediacy of 
epoxide 25.21 Finally, the oxidase GliT promotes oxidation of the penultimate dithiol (26) 
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Scheme 1.2. Completion of the biosynthesis of gliotoxin (1) 
 
 Classically, the biosynthesis of acetylaranotin has been hypothesized to occur via 
a benzene oxide intermediate (27) similar to that for the biosynthesis of gliotoxin (see 
Scheme 1.3, part A). Whereas the diketopiperazine attacks the epoxide 25 directly to give 
the gliotoxin ring system, it was envisioned that epoxide 27 might instead undergo 
electrocyclic ring opening to afford oxepine 28. It was proposed that subsequent 
oxidation to sym-oxepine oxide 29 followed by cyclization would furnish dihydrooxepine 
30.7a Recent genome-based deletion analyses reported by Wang and coworkers affirm the 
biogenetic relationship between gliotoxin (1) and acetylaranotin (11).17 They propose a 
biosynthetic pathway similar to that outlined for 1 above (see Scheme 1.3, part B), in 
which cyclic dipeptide 32 undergoes cytochrome P450 AtaF-promoted oxidative 
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acetyltransferase AtaH to furnish diacetate 35, which undergoes sequential AtaY-
mediated oxidative ring expansion to afford acetylaranotin (11). Feeding experiments 
confirmed that cyclization to provide the cyclohexadienol moiety occurs prior to 
dihydrooxepine formation, in contrast to the traditional mechanistic hypothesis. 
Scheme 1.3. Proposed biosynthetic transformations en route to acetylaranotin (11) 
 
1.2.2 Biological Activity 
In addition to the general antimicrobial activity mentioned above, ETPs 
demonstrate cytotoxicity and/or antiproliferative effects against a variety of human 
cancer cell lines.10,11,23,24 Observed differences in efficacy from one agent to the next 
suggest a correlation between structure and specificity. Though it is generally agreed that 
the ETP core represents the primary pharmacophore of ETP natural products, the 
mechanism by which this moiety exerts its biological effects, as well as the role of 
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hypotheses can be termed the redox cycling mechanism and the covalent modification 
mechanism, though recently strong evidence has been provided for a metal chelation 
mechanism as well. 
The redox cycling hypothesis states that ETP cytotoxicity is mediated by the 
redox activity of the highly strained disulfide moiety. Once inside the cell, the toxin (36) 
is reduced by various cellular reductants (e.g., glutathione) to the corresponding dithiol 
(37, see Figure 1.3). The increased polarity of the dithiol relative to the disulfide causes 
sequestration and accumulation within the cell. The dithiol’s low redox potential, on the 
other hand, allows for reoxidation to the disulfide by molecular oxygen, resulting in the 
formation of reactive oxygen species (ROS) such as superoxide and hydrogen peroxide. 
The resulting cycle of cellular reductant depletion and ROS generation ultimately causes 
cell death.1a It is notable that this mechanism should be minimally affected by the 
peripheral structure of ETP agents, aside from effects on solubility and the ability to 
permeate the cell membrane. In support of this mechanism is the toxicity of sporidesmin 
(5) toward erythrocytes, and that of chaetocin (7) toward myeloma cells, both of which 
have been correlated with increased cellular levels of superoxide radical.25,26 On the other 
hand, the observed ability of gliotoxin (1) to modulate cellular calcium flux suggests that 
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Figure 1.3. The redox cycling mechanism for ETP bioactivity 
 
Perhaps more in line with the typical mode of action for bioactive small 
molecules is the covalent modification hypothesis, which states that ETPs deactivate 
specific molecular targets by reacting with susceptible cysteine residues to form mixed 
disulfides (see Figure 1.4, part A). This proposal is supported by a number of in vitro 
biochemical studies; for example, gliotoxin (1) has been identified to form covalent 
adducts with alcohol dehydrogenase.28 As a part of their investigation of the inhibition of 
glutaredoxin (GRx) by sporidesmin A (5), Mieyal and coworkers found that the synthetic 
ETPs 38 and 39 exhibited similar inhibitory action, whereas 40 demonstrated negligible 
activity (see Figure 1.4, part B).29 Epidermal Growth Factor Receptor (EGFR), a known 
molecular target of fungal metabolites 42–44,30 contains an active site cysteine residue in 
its kinase domain that has been targeted by covalent inhibitors (such as 41)31 providing 
indirect evidence for mixed disulfide formation with the aforementioned ETPs. Though 
in the case of this mechanism, peripheral ETP structure would strongly influence 
bioactivity by contributing various secondary binding interactions between small 
molecule and protein target, there remains a lack of evidence for covalent adduct 
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Figure 1.4. Deactivation of molecular targets by mixed disulfide formation 
 
 The dimeric ETPs chaetocin (7) and chaetomin (10) are known to inhibit the 
interaction between hypoxia inducible factor 1 (HIF-1) and the transcriptional coactivator 
p300, an activity with potential therapeutic potential in cancer biology.32 In an effort to 
elucidate the mechanism of this inhibition and identify structure-activity relationships, 
Figg and coworkers investigated a small panel of ETPs, including several natural 
products and synthetic compounds, and found that they were all effective at blocking the 
binding interaction between HIF-1α and p300. 33  Using a non-denaturing ESI-MS 
technique, they found that in the presence of each ETP agent, structurally crucial Zn(II) 
ions appeared to have been removed from the HIF-1-binding domain of p300, 
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ejection” mechanism, and although it is unclear what role peripheral ETP structure might 
have in determining target specificity,34 it certainly represents a novel mode of action for 
small molecule inhibitors. 
Figure 1.5. Deactivation of transcriptional regulators via Zn(II) ejection 
 
 Though evidence for each of the above mechanisms remains limited (particularly 
with respect to in vivo experiments), they represent reasonable hypotheses, and it is 
unlikely that they are mutually exclusive. Indeed, each ETP may exhibit some 
combination of these three modes of activity, and modulation of the scaffold surrounding 
the ETP core may ultimately allow for the tuning of this combination. As an increasing 
number of synthetic routes towards ETP natural products are developed, the ability to 
produce structural analogs and chemical probes for target pull-down will likely shed light 
on the mechanistic questions that remain. 
1.3 PREVIOUS/CONCURRENT SYNTHETIC EFFORTS 
As evidenced by the abundance of degradation product literature for gliotoxin (1) 
alone, the epidithiodiketopiperazine core is quite labile. In their full account of the total 
synthesis of 1 and other ETP natural products, Kishi and coworkers note the particular 
sensitivity of the compounds to oxidative, reductive, and basic conditions.35 Additionally, 
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evolution of a variety of strategies for the protection of thiols, selective late-stage 
oxidation, and direct enolate sulfenylation. 
1.3.1 Early Strategies for Installing the ETP Core 
In 1968, Trown reported the first synthetic procedure for constructing the ETP 
core (see Scheme 1.4).36 The sequence involved bromination of sarcosine dimer 45 with 
molecular bromine, followed by bromide displacement with thioacetate anion and 
subsequent acidic hydrolysis to afford dithiol 48. Final oxidation with Ellman’s reagent 
(5,5’-dithiobis(2-nitrobenzoic acid), DTNB) revealed the simple ETP bicycle 49. Several 
years later, Schmidt and coworkers disclosed a strategy involving direct enolate 
sulfenylation; they found that they could readily sulfenylate proline dimer 50 with S8 in 
the presence of NaNH2, with sequential reductive and oxidative workups affording ETP 
51.37 Notably, this process exhibits some degree of stereoretention, as 51 was shown to be 
optically active. The same authors later reported a procedure for converting 50 to trans-
diacetate 52 by oxidation with Pb(OAc)4.38 This product was hydrolyzed to afford 
dihydroxydiketopiperazine 53, which could be converted to ETP 51 by direct 
displacement by H2S under Lewis acidic conditions, followed by oxidation with KI3. 
These basic strategies continue to be used for the construction of ETPs, though their 
application to the synthesis of complex structures has been greatly facilitated by the 
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Scheme 1.4. “Classical” procedures for ETP synthesis 
 
 
 In 1975, Ottenheijm and coworkers reported the development of a rapid, redox 
manipulation-free sequence for the synthesis of ETP 59 (see Scheme 1.5).39 Imino amide 
54 was first condensed with an equivalent of pyruvoyl chloride to yield α-chloro-α’-
hydroxydiketopiperazine 56. Displacement by H2S in the presence of ZnCl2 and 
subsequent aerobic oxidation furnished the final ETP product (59). 
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1.3.2 The Thioacetal Protecting Group Strategy 
 In order to gain synthetic access to more complex ETP structures, Kishi and 
coworkers developed a thioacetal protecting group strategy that allowed them to install 
the required C–S bonds at an early stage of a synthetic route, but reserve completion of 
the ETP disulfide linkage for the end of the sequence.35,40 In their synthesis of gliotoxin 
(see Scheme 1.6), MOM-protected diketopiperazine 61 was advanced to p-anisaldehyde-
derived thioacetal 64 in four steps and 30% overall yield. Following separation of 
diastereomers, nucleophilic addition of fragment 65 into oxepine electrophile 66 provided 
cyclohexadienol adduct 67 as a 3:1 mixture of diastereomers. This material was advanced 
to tetracycle 69, at which point oxidation with m-CPBA and subsequent acidic workup 
revealed the ETP core of 1.  
Scheme 1.6. Total synthesis of gliotoxin (1) 
 
1.3.3 Recent Advances: Late Stage Oxidation/Displacement 
 For nearly three decades, Kishi’s thioacetal protecting group strategy represented 
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reported the total synthesis of (+)-11,11’-dideoxyverticillin A (75).41 This seminal effort 
involved the mild, stereoretentive, and late-stage oxidation of bis-diketopiperazine 70 by 
[Ag(pyr)2][MnO4] to afford tetraol 71. Following protecting group manipulation (it was 
noted that the free tetraol was unstable to a variety of acidic and basic conditions), 
nucleophilic displacement by trithiocarbonate under acidic conditions furnished bis-
trithiocarbonate 74. The natural product (75) was then obtained by ethanolaminolysis of 
the trithiocarbonate rings and KI3-mediated oxidation of the resulting dithiol. 
Scheme 1.7. Total synthesis of (+)-11,11’-dideoxyverticillin A (75) 
 
 In a follow-up communication, Movassaghi and Kim reported that a modification 
to the strategy used for the synthesis of 75 allowed for the selective preparation of related 
molecules as the di-, tri-, or tetrasulfide congener (see Scheme 1.8). 42  Using the 
conditions developed during their previous efforts, bis(diketopiperazine) 76 was oxidized 
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installation via SN1-type displacement at only the C(11) and C(11’) positions, and 
subsequent exhaustive acylation afforded tetra-iso-butyryl intermediate 78. Treatment 
with hydrazine selectively liberated the thiol groups to give intermediate 79, which could 
be trapped with Ph3CSCl, Ph3CSSCl, or Ph3CSSSCl to afford protected disulfide 80, 
trisulfide 81, or tetrasulfide 82, respectively. Subjection of these intermediates to 
BF3•OEt2 (following N-protection in the cases of 81 and 82) resulted in cyclization of the 
polysulfide with concomitant loss of trityl cation to reveal the epidisulfide 83, 
epitrisulfide 84, or epitetrasulfide 85, respectively. 
Scheme 1.8. Selective access to epidi-, epitri-, and epitetrathiodiketopiperazines 
 
 In 2011, Overman and coworkers reported a late-stage oxidation strategy for the 
synthesis of pyrroloindoline ETP natural products containing oxygenation at the C(12) 
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protection with TBSOTf afforded α,β-unsaturated diketopiperazine 87 as a 3:2 mixture 
of diastereomers. Dihydroxylation using AD-Mix-α resulted in the formation of the 
corresponding diol (>14:1 diastereoselectivity), which was subsequently converted to 
diacetate 88. Displacement of the C(11)-hydroxyl and C(15)-siloxyl groups by H2S was 
carried out in the presence of BF3•OEt2, and subsequent aerobic oxidation to the disulfide 
and deprotection of the C(12) acetate revealed gliocladine C (90). In a follow-up report, 
the authors demonstrated that this strategy could be generally applied to the total 
synthesis of similar ETP natural products.23 
Scheme 1.9. Total synthesis of gliocladine C (90) 
 
1.3.4 Recent Advances: Direct Diketopiperazine Sulfenylation 
 With the exception of the conditions reported by Schmidt and coworkers for the 
direct sulfenylation of proline dimer 50 under basic conditions, all of the examples of 
ETP syntheses reviewed above have involved the use of moderately to strongly acidic 
conditions for the displacement of various leaving groups by sulfur-containing 
nucleophiles. However, many natural products possess acid-labile functional groups in 
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direct enolate sulfenylation methodologies has greatly facilitated total synthesis efforts 
targeting these structures. 
 Though the peripheral appendages of hyalodendrin (4) do not appear to be 
particularly acid-sensitive, the preparation of this natural product reported by Williams 
and Rastetter in 1980 constitutes one of the first examples of an enolate sulfenylation 
strategy in the context of natural product total synthesis (see Scheme 1.10).44 In the first 
sulfenylation reaction, the lithium enolate of diketopiperazine 91 was trapped by 
monoclinic S8 (the authors point out that the use of this form of sulfur—obtained by 
briefly heating the more stable orthorhombic form under vacuum—is critical to the 
success of the reaction), generating thiol 92. The second sulfenylation event involved soft 
enolization of the more acidic α-formyl diketopiperazine 93 and subsequent trapping 
with Ph3CSSCl to afford bis(disulfide) 94. Reductive deprotection of the two disulfides 
followed by KI3-mediated oxidation completed the synthesis of 4. 
Scheme 1.10. Enolate sulfenylation in the total synthesis of hyalodendrin (4) 
 
 More recently, Nicolaou and coworkers have developed a modification to the 
conditions for direct enolate sulfenylation reported by Schmidt and coworkers that is 
better suited for complex substrates (see Scheme 1.11).45 In their initial communication of 
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authors describe having treated diketopiperazine 95 with a reagent mixture obtained by 
pre-stirring one equivalent of S8 with three equivalents of NaHMDS in THF, followed by 
another two equivalents of NaHMDS. The resulting crude mixture of polysulfides was 
then reduced to the dithiol using NaBH4, and workup with aqueous KI3 furnished the 
disulfide 96 in 55% yield as a 1.4:1 mixture of epidisulfide diastereomers. This 
intermediate was then advanced to 97. In contrast with the stereoretention observed by 
Schmidt and coworkers, a follow-up report by Nicolaou and coworkers revealed that 
sulfenylation of proline dimer ent-50 under the “NaHMDS-S8” conditions results in 
formation of racemic ETP 51.45b 
Scheme 1.11. Direct sulfenylation of diketopiperazines with S8/NaHMDS 
 
 Finally, Clive and coworkers recently reported that TsSCH2OTBS can be used to 
sulfenylate diketopiperazine-derived enolates to afford the protected thiol product.46 As 
shown in Scheme 1.12, the resulting siloxymethyl thioether (e.g., 99) can be cleaved by 
buffered TBAF solution, with oxidative workup providing the ETP core (e.g., 100). 
Though use of this reagent has yet to be reported in the context of a total synthesis, it may 
prove to be quite useful for sequences in which late stage sulfenylation is desirable, but 
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ETP natural products have a rich history, yet continue to stimulate the chemist. 
The hypothesized modes of biological activity underscore Nature’s abilities to evolve 
diverse mechanisms for the manipulation of biological systems, and will likely inspire the 
development of novel therapeutic strategies. Likewise, the complex structures and 
biosynthetic transformations described above demonstrate that the bar set by Nature for 
the synthetic chemist remains high. Though efforts at the total synthesis of these 
molecules have led to an evolution of innovative synthetic methodologies and strategies, 
challenges remain—particularly with respect to acid-sensitive and highly oxygenated 
ETP structures. Ultimately, comprehension of the molecular processes underlying ETP 
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Development of a Synthetic Strategy Towards Dihydrooxepine-
Containing Epipolythiodiketopiperazine Natural Products: 
Enantioselective Total Synthesis of (–)-Acetylaranotin† 
 
2.1 INTRODUCTION 
The dihydrooxepine-containing epidithiodiketopiperazine natural product 
acetylaranotin (11) was isolated in 1968 from the two fungal species Arachniotus aureus 
and Aspergillus terreus (see Figure 2.1).1 As a C2-symmetric homodimer it is also the 
most simple of the dihydrooxepine-containing ETPs to be isolated in the past 45 years. 
Similar C2-symmetric structures include the epitetrasulfide emethallicin C (101),2 which 
possesses the same carbocyclic core as 11 but is adorned by (R)-mandelate appendages, 
as well as the epidisulfide SCH64874 (42), epitrisulfide SCH64875 (43), and 
epitetrasulfide SCH64877 (44),3 which instead possess 2,4-dimethyl-3-hydroxyhexanoate 
appendages. Other natural products that contain the same dihydrooxepine monomer 
                                                
† Part of this chapter was published as the following communication: Codelli, J. A.; 
Puchlopek, A. L. A.; Reisman, S. E. J. Am. Chem. Soc. 2012, 134, 1930. The research 
discussed in this chapter was completed in collaboration with Angela L. A. Puchlopek, a 
postdoctoral researcher in the Reisman Lab. 
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subunit include the heterodimer acetylapoaranotin (102)1f, 4  and the macrocycle 
MPC1001B (13).5 
Figure 2.1. Dihydrooxepine-containing ETP natural products 
 
In the 40 years from the initial isolation of 11 until the initiation of our research 
program, there were no reports of any successful efforts at the total synthesis of any of 
the structures shown in Figure 2.1—despite several reported approaches6—indicating the 
challenge that this ETP sub-family poses to modern synthetic techniques. For this reason, 
as part of a broad research program targeting ETP natural products, we initially selected 
to pursue a synthetic strategy towards dihydrooxepine-containing ETPs. 
2.1.1 Biological Activity 
Though dihydrooxepine-containing ETP natural products have been found to 
possess a variety of therapeutically relevant biological properties, from antiviral 
properties to selective cytotoxicity (see Table 2.1),2,3,4,5, 7  there have been no 
comprehensive studies comparing a panel of such agents against the same cellular or 
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polymerases and epidermal growth factor receptor (EGFR) as molecular targets for 
acetylaranotin (11) and the SCH series (42–44), respectively, such experiments would be 
invaluable in the ongoing efforts to elucidate ETP mechanisms of action. For example, by 
comparing the effects of peripheral structure in cell viability assays to those in 
biochemical assays, one might gain insight into the role of these structures in the 
modulation of physical properties (e.g., solubility, membrane permeability) versus 
modulation of target-binding affinities. With this in mind, a secondary goal of our 
research program has been to produce such a panel of dihydrooxepine-containing agents 
for comprehensive biological screening. 
Table 2.1. Activities of dihydrooxepine ETPs against various cell lines and molecular 
targets 
 
 IC50 (µM) Cellular/Molecular Target 
acetylaranotin (11) 0.20 RNA polymerase (Coxsackie A-21) 
acetylaranotin (11) 23 A549 (human alveolar adenocarcinoma) 
acetylapoaranotin (102) 2 “ 
acetylaranotin (11) 21.2 HCT116 (human colon cancer) 
acetylapoaranotin (102) 13.8 “ 
SCH64874 (42) 1.4 EGFR Kinase 
SCH64877 (44) 1.6 “ 
MPC1001B (13) 0.039 DU 145 (human prostate cancer) 
emethallicin C (101) 1.0 Induced histamine release from mast cells 
 
2.1.2 Previous Synthetic Approaches 
The dihydrooxepine-containing ETP natural products have remained particularly 
challenging as the targets of modern synthetic endeavors due to their chemical lability as 
well as the relative dearth of methods for rapid construction of the dihydrooxepine ring 
itself. Indeed, at the outset of our investigations, there existed only two reported general 
methods for the synthesis of dihydrooxepine rings. 
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 In 1992, White and coworkers reported the thermal [3,3]-sigmatropic 
rearrangement of divinyl epoxides 103 to give dihydrooxepines 104.8 More recently, 
Snapper and coworkers reported the thermal rearrangement of highly strained polycyclic 
epoxides such as 105 to give dihydrooxepines such as 106 and 107.9 Unfortunately, it is 
not apparent how either of the required precursor structures could be incorporated into a 
readily accessible intermediate in the context of a total synthesis of a dihydrooxepine-
containing ETP. 
Scheme 2.1. General methods for constructing dihydrooxepine rings 
 
 Because the dihydrooxepine ring is found almost exclusively in ETP natural 
products, most of the remaining efforts towards their synthesis have been in the context 
of total synthesis endeavors. Kishi and coworkers reported the synthesis of 115, a model 
for the aranotin ring system (Scheme 2.2).6e Key to their approach was the use of the 
Criegee rearrangement to convert allylic hydroperoxide 113 to vinyl ether 114,6d with 
subsequent thermal carboxylate elimination to furnish the dihydrooxepine ring. Once 
more, however, the authors find that the required intermediate 113 can be accessed only 
in low yield as a racemate, and extension of this strategy to a total synthesis does not 

























R = H, Me
X = CO2Et, CN
CCl4
(77–89% yield)
White, 1992: Snapper, 2006:
103 104 105 106 107
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Scheme 2.2. Synthesis of model dihydrooxepine 115 
 
 In reports of progress toward the macrocyclic structure of MPC1001, Clive and 
coworkers found that they could construct the dihydrooxepine ring of model ring system 
117 by acid-promoted vinylogous lactonization of intermediate 116, followed by 
selenoxide elimination to furnish the desired unsaturation.6b,c However, preparation of 
intermediate 116 requires a 26-step synthetic sequence, and advancement to the natural 
product using this strategy has yet to be reported. 
Scheme 2.3. Construction of dihydrooxepine model system 117 
 
 With these reports in mind, we sought to pursue a novel synthetic method for 
constructing the dihydrooxepine ring that would simultaneously allow for rapid access to 
required precursors. 
2.1.3 Concurrent Synthetic Approaches 
Since our initial communication of the research described in this chapter, several  
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published. In their detailed account of the synthesis and biological evaluation of various 
perhydroindolone-containing ETP natural products, Nicolaou and coworkers reported the 
conversion of a gliotoxin-type monomer (118) to the acetylaranotin-type monomer (121) 
via a [4+2]/oxidation/retro [4+2] sequence as shown in Scheme 2.4.10 Tokuyama and 
coworkers reported the second total synthesis of acetylaranotin (11) in late 2012, using a 
Baeyer-Villiger oxidation/vinyl triflate reduction strategy to construct the dihydrooxepine 
ring (124).11 Shortly thereafter, Nicolaou and coworkers published an optimized general 
method for the synthesis of dihydrooxepines starting from cyclohexenones (e.g. 125) via 
a Baeyer-Villiger/vinyl phosphate reduction sequence. 12  Such developments greatly 
complement the work described in this chapter, and will likely provide access to an 
increased diversity of structural analogs to assist in biological studies. 
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2.1.4 Retrosynthetic Analysis 
Our initial consideration during the planning of our synthetic approach towards 
dihydrooxepine-containing ETP natural products was one of target selection. We chose to 
initially pursue a total synthesis of the natural product acetylaranotin (11), with the 
expectation that a successful strategy for synthesis of the corresponding monomer 
fragment (see Figure 2.1) would ultimately allow us to target other members of the sub-
family. In the present case, dimerization of such a monomer unit (129) would provide 
diketopiperazine 130 (see Scheme 2.5). We anticipated that C–S bond formation prior to 
dimerization might lead to opening of the pyrrolidine ring or otherwise complicate the 
coupling of monomer units. Accordingly, installation of the C–S bonds of the ETP was to 
be reserved for the final stages of the synthesis. 
Scheme 2.5. Endgame strategy for the synthesis of acetylaranotin (11) 
 
 In considering how best to accomplish late stage C–S bond formation, a major 
concern was the potential instability of the dihydrooxepine ring. Embedded within this 
structure is a divinyl ether moiety, as well as a vinylogous acetal, both of which were 
expected to be sensitive to acidic as well as oxidative reaction conditions. We therefore 
reasoned that it would be challenging to carry out a sequence involving late stage 
oxidation of diketopiperazine 130 followed by displacement with sulfur-containing 
nucleophiles under acidic conditions (Scheme 2.6, part A), and realized that direct 





































Chapter 2 – Enantioselective Total Synthesis of (–)-Acetylaranotin  35 
approach (Scheme 2.6, part B). It was unclear a priori what influence, if any, the 
stereochemistry of diketopiperazine 130 would have on the facial selectivity of this 
process. Romo and coworkers have demonstrated that for cyclo(Pro,Pro) electrophilic 
trapping of the kinetically generated monoenolate proceeds with retention of 
stereochemistry.13 Thus, we were cognizant that it might be necessary to epimerize 
diketopiperazine 130 from the syn,syn,syn configuration to the anti,syn,anti 
diketopiperazine (133) prior to sulfenylation. 
Scheme 2.6. Possible strategies for C–S bond formation 
 
 Turning our attention to construction of the acetylaranotin monomer unit 129, we 
envisioned forming the C(11)–O bond (Scheme 2.7) via transition-metal catalyzed 
cycloisomerization of alkynyl aldehyde 136. In turn, we anticipated that the densely 
functionalized pyrrolidine scaffold of this intermediate could be rapidly accessed via a 
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 The anti-Markovnikov 7-endo cyclization of an aldehyde onto a terminal alkyne, 
as described above, is relatively unprecedented. Transition metal complexes that favor 
reactions of alkynes via π-activation would likely result in the undesired Markovnikov 6-
exo cyclization. On the other hand, transition metal catalysts that promote reactions of 
alkynes via metal vinylidene intermediates, in which the carbon terminus is electrophilic 
in character,14 were expected to provide the desired dihydrooxepine, the formal product 
of 7-endo cyclization.  
 The anti-Markovnikov cyclization of primary alcohols onto terminal alkynes via 
metal vinylidene intermediates is well precedented. Complexes of transition metals 
belonging to groups 6 (Cr, Mo, W),15 8 (Ru, Os),16 and 9 (Rh, Ir)17 are commonly used for 
the catalytic synthesis of cyclic vinyl ethers (an example of 7-endo cyclization of an 
alkynyl alcohol is shown in Figure 2.8)15d as well as other vinylidene-mediated 
transformations, and we were optimistic at the outset of our investigation that the 
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Scheme 2.8. Tungsten-catalyzed 7-endo cycloisomerization of an alkynyl alcohol 
 
 Additionally, aldehyde 136 would provide rapid access to several alternative 
cyclization substrates. For example, various aldehyde 1,2-adducts (144) could be formed 
via addition of HX, which could potentially demonstrate reactivity similar to alkynyl 
alcohols (see Scheme 2.9).18 Subsequent elimination of HX would then furnish the 
desired dihydrooxepine ring (135). 
Scheme 2.9. Cyclization of alkynyl aldehyde 1,2-adducts followed by elimination to 
afford the dihydrooxepine ring 
 
 
 On the other hand, oxidation of the aldehyde would provide the corresponding 
carboxylic acid substrate (147, see Scheme 2.10). Such alkynyl acids have been shown to 
undergo cycloisomerization to give the 7-endo adducts, presumably via metal vinylidene 
intermediates.17b,19 Conceivably, subsequent conversion of the resulting enol lactone 149 
to the vinyl triflate or analogous vinyl halide surrogate would allow for palladium-
mediated reduction to furnish dihydrooxepine 135. Indeed, preliminary studies using 
model alkynyl carboxylic acid 150 revealed the anti-Markovnikov 7-endo cyclization 
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Scheme 2.10. Cyclization of alkynyl carboxylic acids followed by vinyl triflate 
reduction to afford the dihydrooxepine ring 
 
 
Scheme 2.11. Rh(I)-catalyzed cycloisomerization of a model alkynyl acid (150) 
 
2.2 FORWARD SYNTHETIC EFFORTS 
In the forward sense, our first objective was the construction of functionalized 
pyrrolidine scaffold 138. To this end, racemic styrenyl pyrrolidine 153 was synthesized 
using a silver-catalyzed (1,3)-dipolar cycloaddition between α-imino glycinate ester 152 
and tert-butyl acrylate (141, see Scheme 2.12).21 Protection of the amine as a methyl 
carbamate and subsequent cleavage of the tert-butyl ester under acidic conditions 
afforded carboxylic acid 154. Finally, ozonolytic cleavage of the styrene moiety resulted 
in formation of hydroxylactone 155, which was envisioned to serve as a masked aldehyde 
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Scheme 2.12. Construction of the functionalized pyrrolidine scaffold and synthesis 
of masked aldehyde substrate 155 
 
 
 Preliminary investigation of acetylide addition to substrate 155 revealed that 
treatment with commercially available ethynylmagnesium bromide followed by acidic 
workup resulted in formation of alkynyl lactone 158 with good diastereoselectivity 
(Scheme 2.13). Unfortunately, single crystal X-ray diffraction revealed that 158 did not 
possess the desired stereochemistry at the propargylic position for advancement to the 
natural product. This observation can be rationalized mechanistically; initial 
deprotonation of hydroxylactone 155 by the first equivalent of the Grignard reagent 
presumably results in opening of the cyclic acetal to afford aldehyde carboxylate 159, in 
which a cyclic chelation complex is formed. Approach of the nucleophile to the convex 
face of the resulting ring system affords propargylic alkoxide 157, which lactonizes upon 
workup to provide the observed product. Unfortunately, attempts at reversing the 
observed selectivity by disrupting the proposed activated chelation complex (either by 
altering the nature of the counterion, or by using strongly coordinating additives) did not 
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Scheme 2.13. Diastereoselective acetylide addition to afford alkynyl lactone 158 
 
 Based on the above mechanistic hypothesis, we envisioned that intermediate 
species 157 might be intercepted with inversion at the propargylic center via a Mitsunobu 
lactonization protocol.22 Gratifyingly, it was found that quenching of the Grignard 
reaction with phenol, followed by addition of PPh3 and DIAD afforded the desired 
epimer of the alkynyl lactone product (161) (see Scheme 2.14, part A). Though it was 
quite difficult to separate 161 from the triphenylphosphine oxide byproduct of the 
reaction, this purification challenge could be obviated by using p-nitrophenol as the 
quenching reagent and diphenyl 2-pyridylphosphine (PyrPPh2) as the phosphine (Scheme 
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Scheme 2.14. Grignard addition and subsequent Mitsunobu lactonization to 
provide alkynyl lactone 161 
 
 
 Conversion of alkynyl lactone 161 to the aldehyde 164 would formally require a 
reductive opening of the lactone ring. Unfortunately, attempts at partial reduction of 
lactone to give the aldehyde directly were largely unfruitful. On the other hand, it was 
found that lactone 161 could be reduced to diol 162 using an excess of NaBH4 in ethanol. 
Protection of the two hydroxyl groups as TBS ethers, followed by selective deprotection 
with PPTS in ethanol furnished primary alcohol 163, which was subsequently oxidized to 
aldehyde 164 on treatment with buffered Dess-Martin periodinane.24 Thus, the stage was 
set for examination of transition metal catalysts for the direct cycloisomerization of 
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Scheme 2.15. Advancement of lactone 161 to aldehyde 164 
 
 Initial attempts at cycloisomerization of substrate 164 were carried out using 
catalyst systems that are readily available and known to promote anti-Markovnikov 
cyclization of alcohols onto alkynes (as described above). In all cases, however, such 
conditions led either to complete decomposition or epimerization of aldehyde 164 (Table 
2.2). Furthermore, experiments using gold(I) salts, which were anticipated to afford the 6-
exo cyclization product, also demonstrated little reactivity other than slow decomposition 
of the starting material. Finally, cycloisomerization of several 1,2-adducts derived from 
aldehyde 164 (either isolated prior to cyclization or formed in situ) using a variety of 
transition metal catalysts could not be successfully accomplished. 
Table 2.2. Attempted cycloisomerization of alkynyl aldehyde 164 
 
entry catalyst ligand additive solvent, temp. result 
1 [Rh(cod)Cl]2 
(5 mol %) 
(p-FC6H4)3P (60 mol %) DIPEA DMF, 85 °C epimerization 
2 [Rh(cod)Cl]2 
(5 mol %) 
Ph3P (60 mol %) TMG DMF, 85 °C decomposition 
3 CpRuCl[P(p-FC6H4)3]2 
(5 mol %) 
(p-FC6H4)3P (20 mol %) NaHCO3 
n-Bu4NPF6 
DMF, 85 °C epimerization 
4 (CO)5W=C(OMe)Me 
(1 equiv) 
— Et3N PhMe, 85 °C decomposition 
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 Encouraged by our preliminary work with model system 150, we next chose to 
investigate the possibility of cycloisomerization of an alkynyl carboxylic acid substrate. 
To this end, aldehyde 164 was converted to carboxylic acid 166 under Pinnick oxidation 
conditions.25 Surprisingly, we found that the conditions identified for cycloisomerization 
of model substrate 150 to 151 could not be successfully extended to substrate 166, and in 
fact demonstrated no reactivity whatsoever (Table 2.3). On the other hand, Fisher carbene 
precatalyst (CO)5W=C(OMe)Me promoted only decomposition, whereas ruthenium 
catalysts promoted varying combinations of decomposition and Markovnikov 6-exo 
cyclization. As expected, catalysis with gold(I) salts resulted in rapid, selective formation 
of 6-exo cyclization product 168 (as confirmed by 1D and 2D 1H and 13C NMR 
spectroscopy).26 




entry catalyst ligand additive solvent, temp. result 
1 [Rh(cod)Cl]2 
(5 mol %) 
(p-FC6H4)3P (60 mol %) — DMF, 85 °C no reaction 
2 (CO)5W=C(OMe)Me 
(30 mol %) 
— Et3N THF 60 °C decomposition 
3 [(p-cumene)RuCl2]2 
(5 mol %) 
(p-FC6H4)3P (15 mol %) DMAP 
(20 mol %) 
PhMe, 85 °C 6-exo 
cyclization 
4 TpRuH(PPh3)2 
(10 mol %) 
— — PhMe, 85 °C 6-exo 
cyclization 
5 AuCl (10 mol %) — — CH2Cl2, 23 °C 6-exo 
cyclization 
 
 The difficulty encountered in trying to promote the desired anti-Markovnikov 6-
endo cyclization of either the aldehyde 164 or the carboxylic acid 166 prompted us to 
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we were delighted to find that using the previously identified conditions ([Rh(cod)Cl]2 
and (p-FC6H4)3P in DMF at 85 °C), alkynyl alcohol 163 smoothly underwent 7-endo 
cycloisomerization to provide tetrahydrooxepine 169 (Scheme 2.16). While it is unclear 
whether the facility of cycoisomerization for this particular substrate is due to steric or 
geometric parameters, it is apparent that the primary alcohol 163 represents an optimal 
structure for cycloisomerization among the substrates investigated. Accordingly, we 
hypothesized that halohydrins 170 might serve as viable aldehyde surrogates by 
providing the favorable reactivity of the primary alcohol while possessing a suitable 
functional handle for subsequent conversion to the dihydrooxepine. 
Scheme 2.16. Successful cycloisomerization of alkynyl alcohol 163 and halohydrins 
170 as potential aldehyde surrogates 
 
 
 Aldehyde 164 was readily chlorinated by NCS in the presence of pyrrolidine to 
afford chloroaldehyde 171 as a single diastereomer (relative stereochemistry as shown 
was confirmed by NOESY spectroscopy, see Scheme 2.17). Subsequent reduction with 
NaBH4 provided the desired chlorohydrin 172 in 59% overall yield from 164. 
Chlorohydrin 172 proved to be a suitable substrate for rhodium(I)-catalyzed 
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Scheme 2.17. Synthesis and cycloisomerization of chlorohydrin 172 
 
 With chlorotetrahydrooxepine 173 in hand, we were very pleased to observe that 
treatment with DBU in DMF at elevated temperatures did in fact provide the desired 
dihydrooxepine ring to complete acetylaranotin monomer 165 (Table 2.4, Entry 1). 
However, under these conditions, 165 was isolated in only 10% yield despite proceeding 
to full conversion of 173. Other strong non-ionic organic bases gave similar results, and 
reaction attempts employing less basic amine bases (e.g. DIPEA) or Ag(I) salts 
demonstrated no reactivity (Entries 2 and 3). Interestingly, we found that greatly 
improved yields for the reaction could be achieved using a mixture of LiCl and Li2CO3 in 
DMF at 100 °C, which provided the dihydrooxepine 165 in 50% isolated yield (Entry 4). 
Similar conditions have historically been used for the elimination of halides from 
relatively unfunctionalized molecules, and are not typically used in reactions involving 
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Table 2.4. Identification of reaction conditions for elimination of HCl from 
chlorotetrahydrooxepine 173 to afford dihydrooxepine 165 
 
 
entry base/additive solvent, temp. result 
1 DBU DMF, 85 °C 10% yield (no recovered SM) 
2 DIPEA DMF, 85 °C no reaction 
3 Ag(TFA), Ag2CO3 PhMe, 85 °C no reaction 
4 LiCl, Li2CO3 DMF, 100 °C 50% yield 
 
 Having accomplished a viable synthetic route towards racemic dihydrooxepine 
165, we turned our attention to the development of an enantioselective sequence. A brief 
survey of known catalyst systems for asymmetric (1,3)-dipolar cycloaddition reactions 
between alkyl acrylates and aryl glycinate imines revealed that both Ag(I)/(S)-QUINAP 
(177) and Cu(I)/Brucin-OL (174) catalyzed the reaction between 141 and 152 to give 
styrenyl pyrrolidine 153 in good ee (see Table 2.5, Entries 3 and 4).28 Because they 
provided material of greater optical activity, and because Brucin-OL is substantially less 
expensive per mole than (S)-QUINAP, we opted to use the conditions in entry 4 for the 
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entry catalyst/ligand/additive solvent temp. (°C) yield (%) ee (%) 
1 AgOAc, 175 Et2O 0 53 –63 
2 AgClO4, 176, DABCO PhMe 0 59 46 
3 AgOAc, 177, DIPEA THF –45 62 90 
4 CuI, 174, DBU CHCl3 0 50 96 
 
 
 With access to ample quantities of pyrrolidine 153,29 we next reconsidered our 
protecting group strategy, knowing that the methyl carbamate protecting group used in 
our preliminary investigations was not optimal for deprotection and advancement of 
monomer 165 to the corresponding diketopiperazine. Ultimately, we opted to employ a 
trimethylsilylethyl carbamate (Teoc) protecting group, which can be removed using 
fluoride ion under neutral or basic conditions.30 However, because of the acid sensitivity 
of this group, the order of protecting group manipulations was also modified relative to 
the preliminary sequence, so as to avoid subjection of the Teoc group to high 
concentrations of TFA. Accordingly, the tert-butyl ester of pyrrolidine 153 was first 
cleaved using TFA/Et3SiH to afford trifluoroacetate salt 178 as a crystalline solid in 77% 
yield (see Scheme 2.18). Notably, the trituration procedure used to isolate this material 
resulted in enrichment of optical activity to >98% ee. Subsequent protection of the 
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before provided hydroxylactone 179 in 77% yield over two steps. In contrast to the 
methyl carbamate-protected system (155), this substrate required an aqueous workup 
following reaction with ethynylmagnesium bromide in order for the subsequent 
Mitsunobu inversion to succeed. On the other hand, the decreased polarity of 180 versus 
161 allowed for the use of Ph3P, rather than the more expensive reagent Ph2PPyr, without 
the previously encountered challenges to purification. 
Scheme 2.18. Synthesis of enantioenriched, Teoc-protected alkynyl lactone 180 
 
 Alkynyl lactone 180 was advanced to chlorohydrin 184 using an analogous 
sequence to that developed for the methyl carbamate-protected variant, but with two 
notable exceptions (see Scheme 2.19). First, conditions employing AcOH/THF/H2O were 
used to selectively cleave the primary TBS ether following treatment of 181 with 
TBSOTf. These conditions demonstrated substantially reduced reaction times and greater 
selectivity for cleavage of the primary versus the secondary silyl ether (relative to 
PPTS/EtOH). Additionally, pyrrolidine-mediated chlorination of Teoc-protected 
aldehyde 183 was sluggish and resulted in consistently low conversion regardless of 
reaction time. By instead using pyrrolidine•TFA complex, the reaction progressed to 
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chlorination/aldehyde reduction sequence were greatly improved by performing the two 
processes in one flask, with no intermediate workup. 
Scheme 2.19. Advancement of alkynyl lactone 180 to chlorohydrin 184 
 
 As expected, Teoc-protected chlorohydrin 184 proved to be an excellent substrate 
for Rh(I)-catalyzed cycloisomerization, affording chlorotetrahydrooxepine 185 in 87% 
yield. Though the combination of LiCl and Li2CO3 remained optimal for elimination of 
HCl from 185 to afford dihydrooxepine 186, our curiosity about the role of each lithium 
salt in this reaction prompted us to perform a series of control experiments. In the 
absence of LiCl no reaction occurs (Table 2.6, Entry 2), whereas in the absence of Li2CO3 
the reaction proceeds, but is accompanied by increased formation of decomposition 
products (Entry 3). Given that LiCl is quite soluble in DMF, whereas Li2CO3 is almost 
completely insoluble, we hypothesized that perhaps the high concentration of lithium 
cations in solution was critical to activation of the chloride leaving group. However, 
employing LiClO4 rather than LiCl as the soluble source of lithium cation resulted in no 
reaction (Entry 4). These results suggest that the chloride ion itself is acting as a base 
during the elimination reaction, while the carbonate salt is simply acting as an insoluble 
buffer. Unfortunately, attempts to employ more basic lithium salts or more soluble 
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entry base/additive result 
1 LiCl, Li2CO3 53% yield 
2 Li2CO3 no reaction 
3 LiCl complex product mixture 
4 LiClO4, Li2CO3 no reaction 
5 LiOAc, Li2CO3 complex product mixture 
6 Cs2CO3 complex product mixture 
 
 Perhaps unsurprisingly, we found it difficult to selectively cleave the Teoc 
protecting group from 186 in the presence of the TBS ether. In contrast, removal of the 
carbamate protecting group from chlorotetrahydrooxepine 185 proved to be quite facile, 
providing pyrrolidine 187 in 84% yield (Scheme 2.20). Furthermore, elimination of HCl 
from this substrate occurred in even greater yield than for the Teoc-protected substrate, 
affording dihydrooxepine pyrrolidine 188 in 65% yield. Subsequent saponification 
proceeded smoothly to provide amino acid 189. Ultimately, it was determined that amino 
acid 189 could be dimerized using EDC in pyridine; however, our inability to achieve 
greater than 50% yield of diketopiperazine 190 under these conditions prompted us to 
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Scheme 2.20. Synthesis and dimerization of dihydrooxepine amino acid 189 
 
 Having previously established a sequence for the preparation of pyrrolidine 188, 
saponification of 186 to give the corresponding carboxylic acid component for amide 
coupling was required. Though the fully protected monomer unit 186 was unstable to 
standard saponification conditions using LiOH, the ethyl ester could be cleaved using an 
excess of Me3SnOH in dichloroethane at elevated temperatures to produce carboxylic 
acid 191 in 90% yield. Pyrrolidine 188 and carboxylic acid 191 could be readily coupled 
using BOP-Cl, affording protected dipeptide 192 in excellent yield. 
Scheme 2.21. Synthesis of dipeptide 192 
 
 Initial attempts to deprotect dipeptide 192 using TBAF in THF resulted in various 
mixtures of partially or fully deprotected products. Though trace amounts of 
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recovery was consistently low. Together with the apparent instability of dihydrooxepine 
186 to basic conditions, these results suggested that less basic conditions for deprotection 
of 192 were desirable. Unfortunately, no other fluoride sources appeared to promote the 
cleavage of the Teoc carbamate at all. 
Turning our attention to attenuating the basicity of TBAF itself, we became 
interested in a report from Kim and coworkers, who determined that TBAF•(t-BuOH)4 is 
not only substantially less hygroscopic than solid TBAF•(H2O)3, but also less basic than 
typical TBAF solutions.31 We were pleased to find that treatment of dipeptide 192 with 
TBAF•(t-BuOH)4 in MeCN at 70 °C effected global deprotection and cyclization to 
deliver a C2-symmetric compound as the major product. Interestingly, initial 
characterization of this compound using standard NMR techniques and high-resolution 
mass spectrometry suggested that it was a syn-diol (193), the result of a double C–H 
oxidation process (see Scheme 2.22). On the basis of the hypothesis that the oxidant was 
oxygen in the ambient atmosphere, the reaction was repeated under a nitrogen 
atmosphere using rigorously degassed solvent, which provided diketopiperazine 194 as a 
single diastereomer in 76% yield. The structures of 193 and 194 were confirmed by 
single-crystal X-ray diffraction. Notably, the (S, S)-stereochemistry of the central 
diketopiperazine of 194 is the result of epimerization at both of the diketopiperazine 
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Based on a series of control experiments,32 we hypothesize that the processes 
described above are proceeding via the sequence shown in Scheme 2.23. First, fluoride-
promoted global desilylation of 192 provides deprotected dipeptide 195, which cyclizes 
to give the expected syn,syn,syn diketopiperazine 196. Subsequent epimerization to the 
thermodynamically favored anti,syn,anti configuration affords the observed 
diketopiperazine 194. Under aerobic conditions, 194 then undergoes a stereoretentive 
radical-mediated C–H oxidation to afford the tetraol 193. 
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 Though we were unable to advance oxidized product 193 to the natural product, 
we were nevertheless encouraged by the above results, as they suggested that an 
analogous sulfenylation reaction might proceed with the correct facial selectivity for C–S 
bond formation. After several attempts at sulfenylating diketopiperazine 194 by kinetic 
deprotonation with LDA followed by trapping with sulfur electrophiles (e.g. monoclinic 
S8, p-methoxybenzyl disulfide, etc.), we found that we could obtain tetrasulfide 197 
(Scheme 2.24) as the sole isolable sulfenylated product using the conditions reported by 
Nicolaou and coworkers (see Chapter 1).10,33 By using the exact ratios of base to sulfur 
described in the literature, 197 was consistently obtained in 50% yield. However, by 
using a much larger excess of base relative to sulfur, the yield could be improved to 76%. 
Gratifyingly, single-crystal X-ray diffraction analysis revealed that oxidation had 
selectively occurred to give the C–S bonds in the desired orientation for advancement to 
the natural product.  
Scheme 2.X. Sulfenylation of diketopiperazine 194 to obtain tetrasulfide 197 
 
 Tetrasulfide 197 was found to be unstable to NaBH4 under conditions typically 
used to reduce similar cyclic epipolythiodiketopiperazines. Instead, acetylation of the two 
peripheral hydroxyl groups furnished the diacetate, and the tetrasulfide was reduced 
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resulting dithiol delivered the natural product, 11. The spectroscopic data for synthetic   
(–)-acetylaranotin were identical to the original isolation data. 
Scheme 2.25. Conversion of tetrasulfide 197 to acetylaranotin (11) 
 
2.3 CONCLUDING REMARKS 
In conclusion, we have achieved the enantioselective total synthesis of (–)-
acetylaranotin (11), the first total synthesis of any dihydrooxepine-containing ETP 
natural product, in 18 steps from inexpensive, commercially available materials. Essential 
to the development of this route was the successful execution of a rhodium-catalyzed 
cycloisomerization/chloride elimination sequence to furnish the dihydrooxepine ring and 
complete the monomer unit 186. This strategy allowed us to exploit the power of an 
azomethine ylide (1,3)-dipolar cycloaddition reaction in order to enantio- and 
diastereoselectively construct the densely functionalized pyrrolidine scaffold of the 
requisite alkynyl alcohol substrate 184. Notably, diketopiperazine 194 was obtained as a 
single diastereomer, which underwent direct sulfenylation with complete retention of 
stereochemistry to provide epitetrathiodiketopiperazine 197. Access to monomer unit 186 
has enabled the synthesis of related dihydrooxepine-containing ETP natural products and 
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2.4 EXPERIMENTAL SECTION 
2.4.1 Materials and Methods 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 
acetonitrile (MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by 
passing through activated alumina columns. Unless otherwise stated, chemicals and 
reagents were used as received. Triethylamine (Et3N) was distilled over calcium hydride 
prior to use. All reactions were monitored by thin-layer chromatography using 
EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were visualized by UV, 
p-anisaldehyde, or KMnO4 staining. Flash column chromatography was performed either 
as described by Still et al.34 using silica gel (particle size 0.032-0.063) purchased from 
Silicycle or using pre-packaged RediSep®Rf columns on a CombiFlash Rf system 
(Teledyne ISCO Inc.). Optical rotations were measured on a Jasco P-2000 polarimeter 
using a 100 mm path-length cell at 589 nm. 1H and 13C NMR spectra were recorded on a 
Varian 400 MR (at 400 MHz and 101 MHz, respectively), a Varian Inova 500 (at 500 
MHz and 126 MHz, respectively), or a Varian Inova 600 (at 600 MHz and 150 MHz, 
respectively), and are reported relative to internal CHCl3 (1H, δ = 7.26), MeCN (1H, δ = 
1.94), or DMSO (1H, δ = 2.50), and CDCl3 (13C, δ = 77.0), MeCN (13C, δ = 118.26), or 
DMSO (13C, δ = 40.0). Data for 1H NMR spectra are reported as follows: chemical shift 
(δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicity and qualifier 
abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad, app = apparent. IR spectra were recorded on a Perkin Elmer 
Paragon 1000 spectrometer and are reported in frequency of absorption (cm–1). HRMS 
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were acquired using an Agilent 6200 Series TOF with an Agilent G1978A Multimode 
source in electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), 
or mixed (MM) ionization mode. Analytical chiral HPLC was performed with an Agilent 
1100 Series HPLC utilizing Chiralpak AD or Chiralcel OD-H columns (4.6 mm x 25 cm) 
obtained from Daicel Chemical Industries, Ltd with visualization at 254 nm. Preparative 
HPLC was performed with an Agilent 1100 Series HPLC utilizing an Agilent Eclipse 
XDB-C18 5μm column (9.4 x 250 mm) or an Agilent Zorbax RX-SIL 5µm column (9.4 x 
250 mm). Melting points were determined using a Büchi B-545 capillary melting point 
apparatus and the values reported are uncorrected. 
2.4.2 Preparative Procedures and Spectroscopic Data 
Preparation of enol lactone 151 
 
 In the glove box, [Rh(cod)Cl]2 (6.3 mg, 0.0127 mmol) was weighed into an oven-
dried 1-dram vial. This was removed from the glove box, and charged with 
cycloisomerization substrate 150 (75 mg, 0.253 mmol), PPh3 (39.9 mg, 0.152 mmol), and 
a magnetic stir bar. The vial was sealed with a rubber septum, and flushed with N2. DMF 
(2.5 mL, dried over 4Å molecular sieves and degassed with Ar for 30 min) was then 
added, and the mixture was stirred until all solids had dissolved. The resulting solution 
was then heated to 85 °C. After 4 h, the reaction solution was cooled to rt, then 
transferred to a separatory funnel containing 50 mL sat. NaHCO3. The mixture was 
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NaHCO3 (15 mL), dried over Na2SO4, and concentrated to give an orange oil. The crude 
material was purified by flash chromatography (1→2% EtOAc/hexanes) to afford endo-
enol lactone 151 (46.7 mg, 62% yield) as a pale yellow oil that solidifies upon standing at 
–20 °C. 1H NMR (500 MHz, CDCl3) δ 6.31 (dd, J = 5.9, 2.0 Hz, 1H), 5.45 (t, J = 5.1 Hz, 
1H), 4.22 – 4.15 (m, 1H), 3.12 (t, J = 5.6 Hz, 1H), 2.15 – 1.99 (m, 3H), 1.87 (dd, J = 
26.3, 13.1 Hz, 1H), 1.78 (app d, J = 12.2 Hz, 1H), 1.56 (app d, J = 13.7 Hz, 1H), 1.35 (tt, 
J = 13.4, 4.9 Hz, 1H), 1.20 – 1.03 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H); 13C NMR (126 
MHz, CDCl3) δ 173.1, 137.6, 121.8, 72.9, 50.5, 37.7, 28.8, 27.4, 25.7, 24.9, 21.5, 17.9, -
4.6, -5.0; IR (NaCl/thin film): 2934, 2897, 2856, 1764, 1645 cm-1; HRMS (Multimode-
ESI/APCI) calc’d for C16H29O3Si [M+H]+ 297.1881, found 297.1881. 
Preparation of styrenyl pyrrolidine 153 
 
 Ethyl glycinate hydrochloride (30 g) was ground together with K2CO3 (60 g) and 
several drops of brine using a mortar and pestle to give a white paste. This material was 
extracted with several portions of Et2O, and the combined extracts were dried over 
Na2SO4, filtered, and concentrated to afford ethyl glycinate (~81 wt %, contains a 
significant amount of Et2O) as a nearly colorless oil (a white solid—presumably the 
cyclic glycine dimer—forms upon prolonged storage of this material at –20 °C). An 
oven-dried flask equipped with a magnetic stir bar is charged with silica gel (15.0 g) then 
sealed with a rubber septum and flushed with N2. THF (250 mL) is then added, and the 

















Chapter 2 – Enantioselective Total Synthesis of (–)-Acetylaranotin  59 
6.40 g, 50.0 mmol) was then added, followed by cinnamaldehyde (6.30 mL, 50.0 mmol), 
and the mixture was stirred at 0 °C. After 6 h, the resulting solution of imine 152 was 
filtered into an oven-dried flask to remove silica gel, and this flask was sealed with a 
rubber septum, flushed with N2, and cooled to 0 °C. 
 Prior to filtration of the imine solution, an oven-dried flask equipped with a 
magnetic stir bar was charged with AgOAc (417 mg, 2.50 mmol) and PPh3 (1.57 g, 6.00 
mmol), then sealed with a rubber septum and flushed with N2. The solids were dissolved 
in THF (250 mL) and the resulting solution was stirred for 15 min before being cooled to 
0 °C. t-Butyl acrylate (11.0 mL, 75.0 mmol) was then added, followed by DIPEA (871 
µL, 5.00 mmol). The cold imine solution was then transferred dropwise via cannula to the 
stirring solution of the catalyst system and dipolarophile over ~50 min. After 30 min of 
further stirring, the reaction solution was concentrated to an orange oil and purified by 
flash chromatography (14→50% EtOAc/hexanes) to afford pyrrolidine 153 (13.6 g, 79% 
yield) as a viscous green oil. 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.33 (m, 2H), 7.32 – 
7.27 (m, 2H), 7.24 – 7.19 (m, 1H), 6.59 (d, J = 15.8 Hz, 1H), 6.18 (dd, J = 15.8, 7.7 Hz, 
1H), 4.29 – 4.19 (m, 2H), 4.02 (dd, J = 7.6, 7.6 Hz, 1H), 3.87 (dd, J = 8.4, 8.4 Hz, 1H), 
3.11 (ddd, J = 7.6, 7.6, 7.6 Hz, 1H), 2.51 (s, 1H), 2.37 (ddd, J = 13.2, 8.4, 7.8 Hz, 1H), 
2.26 (ddd, J = 13.3, 8.2, 7.8 Hz, 1H), 1.33 (s, 9H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR 
(126 MHz, CDCl3) δ 173.8, 171.6, 136.5, 131.9, 128.5, 127.6, 127.0, 126.4, 80.9, 63.9, 
61.1, 59.7, 49.6, 33.0, 28.0, 14.2; IR (NaCl/thin film): 2978, 1737, 1732, 1729, 1495, 
1478, 1450, 1392, 1367, 1248, 1210, 1151, 1030, 966, 847, 750, 693 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C20H28NO4 [M+H]+ 346.2013, found 346.2006. 
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Preparation of methyl carbamate 198 
 
An oven-dried flask was charged with pyrrolidine 153 (667 mg, 1.93 mmol) and a 
magnetic stir bar, then was sealed with a rubber septum and flushed with N2. The material 
was dissolved in CH2Cl2 (20 mL) and Et3N (807 µL, 5.79 mmol) was added. Methyl 
chloroformate (224 µL, 2.90 mmol) was then added dropwise with stirring. After 1 h, the 
reaction was quenched with 20 mL of sat. NaHCO3. The phases were separated, and the 
aqueous layer was extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were 
washed with sat. NaHCO3 (50 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The crude material was purified by flash chromatography (20% 
EtOAc/hexanes) to afford methyl carbamate 198 (664 mg, 85% yield) as a viscous green 
oil. 1H NMR (500 MHz, CDCl3; compound exists as a 1.1:1 mixture of rotamers, the 
major rotamer is designated by *, minor rotamer denoted by §) δ 7.38 – 7.33 (m, 2H*, 
2H§), 7.32 – 7.24 (m, 2H*, 2H§), 7.24 – 7.17 (m, 1H*, 1H§), 6.80 (d, J = 15.7 Hz, 1H§), 
6.74 (d, J = 15.7 Hz, 1H*), 6.16 (dd, J = 16.1, 8.1 Hz, 1H*), 6.14 (dd, J = 16.3, 8.5 Hz, 
1H§), 4.90 (t, J = 8.0 Hz, 1H§), 4.78 (t, J = 7.9 Hz, 1H*), 4.36 – 4.19 (m, 3H*, 3H§), 3.69 
(s, 3H*), 3.67 (s, 3H§), 3.24 – 3.15 (m, 1H*, 1H§), 2.49 – 2.30 (m, 2H*, 2H§), 1.36 (s, 
9H*, 9H§), 1.30 (dd, J = 6.5 Hz, 6.5 Hz, 3H*, 3H§); 13C NMR (126 MHz, CDCl3; 
compound exists as a mixture of rotamers) δ 172.1, 172.0, 168.6, 168.6, 155.2, 154.3, 
136.5, 136.4, 133.8, 133.4, 128.5, 128.3, 127.8, 127.6, 126.7, 126.6, 124.7, 124.2, 81.6, 
61.9, 61.3, 61.3, 61.2, 59.0, 58.7, 52.8, 52.7, 48.6, 47.8, 30.6, 29.7, 29.5, 28.1, 14.2, 14.2; 
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1251, 1187, 1155, 1118, 1073, 1029, 962, 843, 752 cm–1; HRMS (Multimode-ESI/APCI) 
calc’d for C18H22NO6 [M–C4H8+H]+ 348.1442, found 348.1453 (detected fragment has 
undergone elimination of iso-butylene from the t-butyl ester). 
Preparation of carboxylic acid 154 
 
An oven-dried flask equipped with a magnetic stir bar was charged with t-butyl 
ester 198 (1.31 g, 3.25 mmol), then was sealed with a rubber septum and flushed with N2. 
CH2Cl2 (12 mL) was then added, followed by TFA (6 mL), and the resulting solution was 
stirred for 10 h at room temperature. During this time, the color of the solution changed 
from light green to bright red. The reaction solution was concentrated under reduced 
pressure to give an orange-red to brown oil, which partially solidified under high 
vacuum. The material was purified by flash chromatography (2:1 hexanes/EtOAc with 
1% AcOH) to give carboxylic acid 154 (1.00 g, 89% yield) as an orange solid. It was 
later found that the crude material could also be purified and the color removed by 
trituration with Et2O. 1H NMR (500 MHz, CD3CN; compound exists as a 1.2:1 mixture of 
rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 7.38 (d, J 
= 7.7 Hz, 2H*, 2H§), 7.33 (t, J = 7.5 Hz, 2H*, 2H§), 7.26 (t, J = 6.9 Hz, 1H*, 1H§), 6.79 
(d, J = 15.8 Hz, 1H*, 1H§), 6.18 (dd, J = 15.8, 7.5 Hz, 1H*, 1H§), 4.80 (dt, J = 14.8, 7.8 
Hz, 1H*, 1H§), 4.28 (dt, J = 10.9, 6.8 Hz, 1H*, 1H§), 4.24 – 4.15 (m, 2H*, 2H§), 3.61 (s, 
3H*), 3.59 (s, 3H§), 3.36 (dq, J = 15.3, 8.0, 7.5 Hz, 1H*, 1H§), 2.44 (apt tt, J = 13.8, 7.2 
Hz, 1H*, 1H§), 2.29 (q, J = 11.8 Hz, 1H§), 2.23 (q, J = 11.9 Hz, 1H*), 1.26 (t, J = 7.1 Hz, 
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rotamers) δ 173.2, 173.0, 171.2, 171.2, 156.0, 155.1, 137.5, 133.6, 133.5, 129.6, 128.7, 
127.3, 126.4, 126.2, 62.2, 62.0, 61.9, 61.7, 60.0, 59.6, 53.2, 53.0, 48.0, 47.3, 31.4, 30.4, 
14.5; IR (NaCl/thin film): 2987, 2596, 1743, 1711, 1452, 1384, 1287, 1242, 1190, 1122, 
1076, 1029, 966, 862, 833, 771, 739 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C18H22NO6 [M+H]+ 348.1442, found 348.1444. 
Preparation of hydroxylactone 155 
 
 An oven-dried 3-neck flask equipped with a magnetic stir bar was charged with 
styrene 154 (900 mg, 2.59 mmol) and CH2Cl2 (26 mL). The middle neck was fitted with 
an adaptor for the ozone line, one of the side necks was stoppered with a punctured 
plastic stopper as an outlet, and the third neck was stoppered with a glass stopper. The 
solution was cooled to –78 °C with stirring, and O2 was bubbled through for several 
minutes. O3 was then bubbled through the solution. When the solution had turned a blue 
color, the O3 was bubbled through for an additional 15 min, and then the solution and 
reaction vessel were purged with O2. When the blue color had disappeared, the solution 
was allowed to warm to room temperature, the punctured plastic stopper was replaced 
with a glass stopper, and the adapter in the center neck replaced with a rubber septum. N2 
was then bubbled through the solution for 15 min to remove O2, and DMS (7.57 mL, 104 
mmol) was added. The resulting solution was allowed to stir under N2 overnight, and then 
was concentrated under reduced pressure and purified by flash chromatography 
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extremely viscous oil. 1H NMR (500 MHz, DMSO-d6; compound exists as a 1.1:1 
mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 
7.92 (dd, J = 10.5, 6.0 Hz, 1H*, 1H§), 5.71 (d, J = 4.6 Hz, 1H*), 5.67 (d, J = 4.8 Hz, 1H§), 
4.45 (t, J = 11.0 Hz, 1H*, 1H§), 4.20 (dd, J = 7.3, 3.3 Hz, 1H*, 1H§), 4.15 – 3.97 (m, 
2H*, 2H§), 3.68 (s, 3H§), 3.60 (s, 3H*), 3.55 (dt, J = 15.3, 8.1 Hz, 1H*, 1H§), 2.68 – 2.53 
(m, 1H*, 1H§), 2.17 (dd, J = 21.3, 13.5 Hz, 1H*, 1H§), 1.14 (t, J = 7.0 Hz, 3H*, 3H§); 13C 
NMR (126 MHz, DMSO-d6; compound exists as a 1.1:1 mixture of rotamers, the major 
rotamer is designated by *, minor rotamer denoted by §) δ 177.6*, 177.5§, 171.8*, 171.7§, 
154.6*, 154.5§, 101.9§, 101.1*, 66.0*, 65.4§, 61.6*, 61.5§, 59.6§, 59.0*, 53.5§, 53.3*, 
43.5§, 42.5*, 31.7*, 30.7§, 14.2*,§; IR (NaCl/thin film): 3382, 2963, 1782, 1743, 1712, 
1454, 1387, 1352, 1293, 1254, 1200, 1157, 1122, 1057, 1038, 1022, 975, 954, 933, 856, 
775 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C11H14NO7 [M–H]– 272.0776, found 
272.0733. 
Preparation of alkynyl lactone 158 
 
Hydroxylactone 155 (1.34 g, 4.90 mmol) was transferred to an oven-dried flask as 
a solution in benzene, then concentrated under reduced pressure. A magnetic stir bar was 
added, and the flask was sealed with a rubber septum and flushed with N2. THF (25 mL) 
was added, and the resulting solution was cooled to –78 °C with stirring. 
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dropwise over 25 min via syringe pump (this appears to be somewhat exothermic, and the 
addition was paused twice during addition of the first equivalent of reagent due to violent 
bubbling of the dry ice bath). The resulting yellow-brown suspension was stirred for 
another 5 min at –78 °C, then allowed to warm to 0 °C over 25 min. During this time, the 
reaction contents solubilized to give a pale yellow-brown solution. The reaction was 
quenched with 20 mL 2 M HCl, and the THF was removed under reduced pressure. The 
resulting mixture was extracted with EtOAc (75 mL, then 3 x 50 mL), then saturated with 
NaCl and extracted again with EtOAc (50 mL). The combined organics were washed 
with brine (100 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude material was stored at –20 °C overnight to allow complete 
lactonization, and then was purified by flash chromatography (40→75% EtOAc/hexanes) 
to afford alkynyl lactone 158 (993 mg, 72% yield) as a viscous oil, which could be 
precipitated from EtOH to form a white solid. Crystals suitable for X-ray diffraction were 
obtained by vapor diffusion of pentane into a saturated solution of alkynyl lactone 158 in 
PhMe at room temperature. 1H NMR (500 MHz, CDCl3; compound exists as a 1.4:1 
mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 
5.42 (d, J = 2.0 Hz, 1H*), 5.30 (d, J = 1.3 Hz, 1H§), 4.68 (d, J = 7.8 Hz, 1H*), 4.61 (d, J 
= 7.3 Hz, 1H§), 4.58 – 4.54 (m, 1H§), 4.47 – 4.42 (m, 1H*), 4.21 – 4.08 (m, 2H*, 2H§), 
3.80 (s, 3H§), 3.71 (s, 3H*), 3.44 – 3.34 (m, 1H*, 1H§), 2.71 – 2.69 (m, 1H*, 1H§), 2.62 – 
2.49 (m, 2H*, 2H§), 1.24 (t, J = 7.1 Hz, 3H*, 3H§); 13C NMR (126 MHz, CDCl3; 
compound exists as mixture of rotamers) δ 176.0, 175.7, 170.9, 154.4, 154.0, 78.5, 78.4, 
76.9, 73.6, 72.9, 65.3, 64.6, 62.0, 59.2, 58.8, 53.4, 53.2, 43.4, 42.4, 31.7, 30.8, 13.8; IR 
(NaCl/thin film): 3263, 2961, 2125, 1784, 1742, 1709, 1451, 1386, 1348, 1292, 1248, 
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1200, 1147, 1126, 1021, 977, 950, 773 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C13H16NO6 [M+H]+ 282.0972, found 282.0967. 
Preparation of alkynyl lactone 161 
 
 To a flame dried 250 mL round bottom flask containing hydroxylactone 155 (3.36 
g, 12.3 mmol) was added 62 mL of THF and the stirred solution was cooled to –78 °C. 
Ethynylmagnesium bromide (0.5 M solution in THF, 123 mL, 61.5 mmol) was added via 
syringe pump over one hour and the solution was then allowed to stir for five minutes at 
–78 °C before being warmed to 0 °C and stirred for another 25 min. The reaction was 
then quenched with p-nitrophenol (10.3 g, 73.8 mmol), and allowed to stir for 10 min, 
resulting in a bright yellow suspension. (2-Pyridyl)diphenylphosphine (6.48 g, 24.6 
mmol) was then added, and the mixture was stirred for another 10 min before DIAD (4.8 
mL, 25 mmol) was added dropwise via syringe. After stirring for 28 h, the mixture was 
concentrated in vacuo, taken up in 1 M aq. HCl, saturated with NaCl, and extracted with 
EtOAc (500 mL, then 2x250 mL). The combined organic layers were then washed with 
brine (200 mL), dried over Na2SO4, filtered, and concentrated in vacuo to give a dark 
brown-orange oil. Purification via silica gel flash chromatography (gradient elution, 
1:1→1:2 hexanes–EtOAc) afforded 2.25 g of alkynyl lactone 161 (65% yield) as a pale 
yellow oil. 1H NMR (500 MHz, CDCl3; compound exists as a 1.2:1 mixture of rotamers, 
the major rotamer is designated by *, minor rotamer denoted by §) δ 5.34 (dd, J = 5.7, 2.3 
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8.1, 5.6 Hz, 1H*), 4.61 (dd, J = 9.4, 1.7 Hz, 1H*), 4.56 (d, J = 9.0 Hz, 1H§), 4.15 (apt q, J 
= 7.2 Hz, 2H*, 2H§), 3.72 (s, 3H§), 3.70 (s, 3H*), 3.41 – 3.33 (m, 1H*, 1H§), 2.68 (d, J = 
2.3 Hz, 1H*), 2.63 (d, J = 2.3 Hz, 1H§), 2.58 – 2.42 (m, 2H*, 2H§), 1.29 – 1.21 (m, 3H*, 
3H§); 13C NMR (126 MHz, CDCl3; compound exists as a 1.2:1 mixture of rotamers, the 
major rotamer is designated by *, minor rotamer denoted by §) δ 175.5§, 175.3*, 170.6*, 
170.6§, 155.0§, 154.5*, 77.9§, 77.6*, 75.8*, 75.6§, 72.9*, 72.8§, 61.8§, 61.8*, 61.0§, 60.3*, 
59.9*, 59.7§, 53.3§, 52.6*, 44.4*, 43.5§, 32.0§, 31.2*, 13.8*, 13.8§; IR (NaCl/thin film): 
3262, 2958, 2131, 1779, 1709, 1447, 1385, 1286, 1245, 1195, 1163, 1126, 1042, 1016, 
987, 920, 893, 856, 765, 733 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C13H16NO6 
[M+H]+ 282.0972, found 282.0968. 
Preparation of diol 162 
 
To a 500 mL round bottom flask containing alkynyl lactone 161 (2.04 g, 7.25 
mmol) dissolved in 145 mL of EtOH, sodium borohydride (1.10 g, 29.0 mmol) was 
added and the reaction was stirred vigorously. Following completion of the reaction as 
judged by TLC (45 min), the reaction was cooled to 0 °C and quenched carefully with 60 
mL of 1N aq. HCl. The solution was then saturated with NaCl, extracted with CHCl3 
(3x320 mL), then EtOAc (3x320 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification through silica gel flash 
chromatography (isocratic elution, 1:2 hexanes–EtOAc) afforded 162 as a colorless oil in 
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rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 4.68 (s, 
1H§), 4.56 (s, 1H*), 4.44 – 4.27 (m, 2H*, 2H§), 4.27 – 4.15 (m, 2H*, 2H§), 4.03 (t, J = 
10.7 Hz, 1H§), 3.92 (t, J = 10.2 Hz, 1H*), 3.81 – 3.72 (m, 1H*, 1H§), 3.69 (s, 3H*, 3H§), 
2.61 (apt dp, J = 15.0, 7.5 Hz, 1H*, 1H§), 2.49 (s, 1H*), 2.49 (s, 1H§), 2.32 (apt dt, J = 
12.8, 8.2 Hz, 1H*, 1H§), 2.10 (ddd, J = 12.1, 12.1, 12.1 Hz, 1H§), 1.99 (ddd, J = 11.5, 
11.5, 11.5 Hz, 1H*), 1.27 (t, J = 7.1 Hz, 3H*, 3H§); 13C NMR (126 MHz, CDCl3; 
compound exists as a 1.2:1 mixture of rotamers, the major rotamer is designated by *, 
minor rotamer denoted by §) δ 174.7*, 173.7§, 156.0*, 155.9§, 83.1*,§, 74.8§, 74.2*, 63.3§, 
62.6*, 61.9*, 61.7*, 61.7§, 61.5§, 60.8*,§, 59.3*, 59.1§, 53.1§, 52.7*, 44.4*, 43.8§, 32.0§, 
30.9*, 14.0*,§; IR (NaCl/thin film): 3415, 3285, 2956, 2114, 1702, 1452, 1379, 1315, 
1277, 1200, 1124, 1096, 1040, 918, 865, 819, 784, 769, 718 cm–1; HRMS (ESI) calc’d for 
C13H20NO6 [M+H]+ 286.1285, found 286.1293. 
Preparation of bis(tert-butyldimethylsilyl) ether 199 
 
 To a flame dried 250 mL round bottom flask equipped with diol 162 (1.62 g, 5.68 
mmol) was added 57 mL of CH2Cl2 and the solution was cooled to 0 °C with stirring. 
Following addition of 2,6-lutidine (3.3 mL, 28 mmol), tert-butyldimethylsilyl 
trifluoromethanesulfonate (3.3 mL, 14 mmol) was added dropwise to the reaction. Upon 
completion of the reaction as judged by TLC (~1 h), the reaction was quenched with a 
small amount of MeOH, diluted with EtOAc (180 mL), and washed with brine (180 mL). 
The resulting organic layer was dried over Na2SO4, filtered, and concentrated in vacuo. 
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EtOAc) afforded 2.13 g of 199 as a clear, colorless oil (73% yield). 1H NMR (500 MHz, 
CD3CN; compound exists as a 1:1 mixture of rotamers) δ 4.78 (s, 1H), 4.69 (s, 1H), 4.19 
(t, J = 8.5 Hz, 2H), 4.15 – 4.00 (m, 6H), 3.91 (q, J = 4.9 Hz, 2H), 3.65 (s, 3H), 3.60 (s, 
3H), 2.70 (s, 2H), 2.55 (dq, J = 14.1, 7.9 Hz, 2H), 2.45 – 2.24 (m, 4H), 1.21 (t, J = 7.1 
Hz, 6H), 0.90 (s, 18H), 0.90 (s, 18H), 0.15 – 0.11 (m, 12H),  0.05 (s, 12H); 13C NMR 
(126 MHz, CD3CN; compound exists as a 1:1 mixture of rotamers) δ 172.5, 172.1, 156.6, 
118.3, 84.8, 77.2, 64.8, 64.2, 63.8, 63.0, 63.0, 63.0, 61.5, 61.4, 60.7, 60.3, 53.2, 45.5, 
44.8, 34.5, 33.4, 26.4, 26.1, 19.0, 18.7, 14.7, -4.5, -5.0, -5.0; IR (NaCl/thin film): 3311, 
3257, 2954, 2929, 2887, 2857, 2114, 1760, 1711, 1448, 1371, 1297, 1257, 1186, 1167, 
1130, 1078, 1041, 1005, 993, 939, 838, 809, 778, 716 cm–1; HRMS (Multimode-
ESI/APCI) calc’d for C25H48NO6Si2 [M+H]+ 514.3015, found 514.3029. 
Preparation of primary alcohol 163 
 
 To a solution of bis(tert-butyldimethylsilyl) ether 199 (2.12 g, 4.13 mmol) in 
EtOH (41 mL) was added PPTS (1.04 g, 4.13 mmol), and the resulting solution was 
stirred for 14.5 h. The reaction mixture was then diluted with sat. aq. NaHCO3 (20 mL) 
and brine (20 mL), then extracted with EtOAc (100 mL, then 3x50 mL). The combined 
organics were washed with brine (100 mL), dried over Na2SO4, filtered, and concentrated 
in vacuo. Purification via silica gel flash chromatography (gradient elution, 4:1→1:2 
hexanes–EtOAc) afforded 163 as a clear, colorless oil in 63% yield (1.04 g), along with 
29% yield of recovered starting material (616 mg). 1H NMR (500 MHz, CD3CN; 
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(m, 2H), 4.16 – 4.06 (m, 6H), 3.99 (apt dd, J = 8.2, 3.7 Hz, 2H), 3.71 (apt dt, J = 11.4, 8.0 
Hz, 2H), 3.65 (s, 3H), 3.60 (s, 3H), 3.07 – 2.99 (m, 2H), 2.73 (s, 2H), 2.67 – 2.55 (m, 
2H), 2.31 – 2.17 (m, 4H), 1.21 (t, J = 7.2 Hz, 6H), 0.92 (s, 18H), 0.18 (s, 12H); 13C NMR 
(126 MHz, CD3CN; compound exists as a 1:1 mixture of rotamers) δ 172.3, 172.0, 156.5, 
84.3, 77.5, 64.9, 64.2, 64.0, 63.2, 61.4, 61.4, 61.4, 60.5, 60.1, 53.1, 45.7, 45.0, 33.2, 32.2, 
26.0, 18.7, 14.5, -4.8, -5.2, -5.2; IR (NaCl/thin film): 3506, 3255, 2955, 2932, 2888, 
2858, 2114, 1759, 1709, 1450, 1372, 1301, 1255, 1190, 1125, 1068, 1041, 1009, 987, 
939, 865, 834, 781, 715 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C19H34NO6Si 
[M+H]+ 400.2150, found 400.2148. 
Preparation of aldehyde 164 
 
To a solution of primary alcohol 163 (1.04 g, 2.60 mmol) dissolved in 26 mL of CH2Cl2 
(bulk solvent, not dried), was added pyridine (2.1 mL, 26 mmol), and Dess–Martin 
periodinane24 (2.21 g, 5.20 mmol), and the cloudy white suspension was stirred 
vigorously. After 3 h, the reaction was quenched with sat. aq. Na2S2O3 solution (30 mL) 
and sat. aq. NaHCO3 solution (30 mL) and stirred vigorously for an additional 10 min. 
The layers were then separated and the aqueous layer was washed with EtOAc (2 x 100 
mL). The combined organics were washed with sat. aq. NaHCO3 solution (100 mL), then 
brine (100 mL), dried over Na2SO4, and concentrated in vacuo. Purification through silica 
gel flash chromatography (isocratic elution, 3:1 hexanes–EtOAc) afforded 164 as a white 
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a 1.3:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted 
by §) δ 10.07 (s, 1H*), 10.05 (s, 1H§), 4.96 (s, 1H*), 4.82 (s, 1H§), 4.41 – 4.32 (m, 1H*, 
1H§), 4.32 – 4.25 (m, 1H*, 1H§), 4.25 – 4.12 (m, 2H*, 2H§), 3.75 (s, 3H§), 3.69 (s, 3H*), 
3.15 – 3.06 (m, 1H*, 1H§), 2.91 (apt dq, J = 23.2, 12.0 Hz, 1H*, 1H§), 2.46 (s, 1H§), 2.44 
(s, 1H*), 2.39 (dt, J = 14.1, 7.9 Hz, 1H*, 1H§), 1.26 (apt t, J = 7.1 Hz, 3H*, 3H§), 0.88 (s, 
9H*, 9H§), 0.17 – 0.09 (m, 6H*, 6H§); 13C NMR (126 MHz, CDCl3; compound exists as a 
1.3:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted 
by §) δ 198.3*, 198.2§, 170.8*, 170.5§, 155.4*, 155.2§, 82.7*, 82.4§, 76.8§, 76.4*, 64.6*, 
63.9§, 62.8§, 62.0*, 61.1§, 61.0*, 59.4§, 59.1*, 53.2§, 53.1§, 53.0*, 52.4*, 30.1*, 29.0§, 
25.5*,§, 18.0§, 18.0*, 14.2*, 14.2§, -5.0*,§, -5.4*, -5.5§; IR (NaCl/thin film): 3262, 2956, 
2931, 2886, 2858, 2116, 1756, 1714, 1448, 1373, 1289, 1255, 1192, 1126, 1080, 1037, 
1006, 987, 939, 864, 839, 780, 721 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C19H32NO6Si [M+H]+ 398.1993, found 398.1998. 
Preparation of carboxylic acid 166 
 
 Aldehyde 164 (60.0 mg, 0.151 mmol) was dissolved in a solution of 2-methyl-2-
butene in THF (2.0 M, 1.2 mL, 2.4 mmol) and tert-butanol (0.3 mL) was added. To the 
resulting solution was added a solution of sodium chlorite (80 wt %, 25.7 mg, 0.227 
mmol) and sodium dihydrogen phosphate monohydrate (62.5 mg, 0.453 mmol) in water 
(1.2 mL) via pipet with stirring. After 3 h, the reaction mixture was diluted with sat. aq. 
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subsequently washed with brine (20 mL), dried over Na2SO4, filtered, and concentrated in 
vacuo to provide the crude product, which was purified by silica gel flash 
chromatography (isocratic elution, 1:1 hexanes–EtOAc containing 1% AcOH) to afford 
carboxylic acid 166 (54.0 mg, 86% yield) as a white foam. 1H NMR (500 MHz, CDCl3; 
compound exists as a 1.1:1 mixture of rotamers, the major rotamer is designated by *, 
minor rotamer denoted by §) δ 4.94 (s, 1H*), 4.82 (s, 1H§), 4.44 (dd, J = 7.8, 4.1 Hz, 
1H*), 4.36 (t, J = 7.5 Hz, 2H§), 4.28 (t, J = 9.0 Hz, 1H*), 4.25 – 4.12 (m, 2H*, 2H§), 3.73 
(s, 3H§), 3.70 (s, 3H*), 3.21 (dt, J = 13.8, 7.7 Hz, 1H*, 1H§), 2.91 (ddd, J = 12.2, 12.2, 
12.2 Hz, 1H*), 2.84 (ddd, J = 12.1, 12.1, 11.8 Hz, 1H§), 2.57 – 2.47 (m, 1H*, 1H§), 2.45 
(d, J = 2.2 Hz, 1H*, 1H§), 1.26 (t, J = 7.1 Hz, 3H*, 3H§), 0.88 (s, 9H*, 9H§), 0.18 – 0.10 
(m, 6H*, 6H§); 13C NMR (126 MHz, CDCl3; compound exists as a mixture of rotamers) δ 
174.2, 173.9, 170.7, 170.4, 155.6, 81.8, 81.7, 76.1, 63.4, 63.0, 63.0, 62.6, 61.1, 58.7, 58.5, 
53.0, 52.9, 45.3, 44.7, 31.6, 30.3, 25.6, 18.1, 14.2, -4.9, -5.4; IR (NaCl/thin film): 3270, 
2956, 2929, 2117, 1712, 1451, 1381, 1252, 1189, 1090, 1031, 1003, 939, 891, 839, 779 
cm–1; HRMS (ESI) calc’d for C19H32NO7Si [M+H]+ 414.1943, found 414.1946. 
Preparation of enol lactone 168 
 
 Carboxylic acid 166 (18.7 mg, 45.2 µmol) was dissolved in CH2Cl2 (230 µL) and 
AuCl (1.1 mg, 4.52 µmol) was added. The resulting solution was stirred for 5 min, then 
filtered through SiO2 (eluting with 1:1 hexanes–EtOAc) and concentrated in vacuo to 
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exists as a 2:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer 
denoted by §) δ 5.00 (s, 1H*), 4.91 – 4.80 (m, 1H*, 1H§), 4.71 – 4.58 (m, 1H*, 2H§), 4.42 
(br s, 1H§), 4.37 (br s, 2H*), 4.20 – 4.10 (m, 2H*, 2H§), 4.07 (dd, J = 7.4, 3.4 Hz, 1H*, 
1H§), 3.77 (s, 3H§), 3.70 (s, 3H*), 3.44 – 3.34 (m, 1H*, 1H§), 2.61 – 2.36 (m, 2H*, 2H§), 
1.24 (t, J = 7.1 Hz, 3H*, 3H§), 0.87 (s, 9H*, 9H§), 0.18 – 0.07 (m, 6H*, 6H§); 13C NMR 
(126 MHz, CDCl3; compound exists as a mixture of rotamers) δ 170.8, 168.9, 155.4, 
153.7, 110.0, 98.5, 98.3, 69.0, 66.8, 62.4, 62.3, 61.5, 60.1, 59.8, 53.2, 53.0, 42.2, 41.0, 
32.7, 32.0, 29.7, 25.6, 18.0, 14.0, -5.0, -5.1; IR (NaCl/thin film): 2955, 2929, 2857, 1757, 
1718, 1669, 1448, 1375, 1260, 1217, 1192, 1131, 1087, 1044, 1003, 967, 939, 866, 839, 
779 cm–1; HRMS (ESI) calc’d for C13H18NO7 [M–C6H15OSi+H2O]+ 300.1078, found 
300.1086 (detected fragment has undergone loss of tert-butyldimethylsilanolate anion 
and gain of water). 
Preparation of tetrahydrooxepine 169 
 
 Alcohol 163 (28.7 mg, 71.8 µmol) was dissolved in dry, degassed DMF (360 µL) 
and transferred via syringe to a microwave vial equipped with a magnetic stir bar and 
sealed with a septum cap under an N2 atmosphere. A stock solution of [Rh(cod)Cl]2 (0.01 
M) and (4-FC6H4)3P (0.12 M) in dry, degassed DMF (360 µL) was added, and the 
resulting solution was heated with stirring to 85 °C in an oil bath. After 22 h, the reaction 
mixture was cooled to rt, diluted with sat. aq. NaHCO3, and extracted with EtOAc (5x5 
mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
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(gradient elution, 5:1→4:1 hexanes–EtOAc, the SiO2 was deactivated using 0.5 % Et3N 
in 5:1 hexanes–EtOAc) to afford 21.5 mg of tetrahydrooxepine 169 (75% yield) as a 
clear, colorless oil. 1H NMR (500 MHz, CDCl3; compound exists as a mixture of 
rotamers) δ 6.06 (s, 2H), 4.93 – 4.42 (m, 3H), 4.34 (s, 1H), 4.25 – 4.11 (m, 3H), 3.84 (dd, 
J = 12.3, 7.0 Hz, 1H), 3.68 (s, 3H), 2.75 (s, 1H), 2.38 – 1.97 (m, 2H), 1.25 (t, J = 7.1 Hz, 
3H), 0.88 (s, 9H), 0.09 (s, 6H); 13C NMR (126 MHz, CDCl3; compound exists as a 
mixture of rotamers) δ 172.1, 156.4, 155.8, 147.0, 146.4, 105.7, 104.9, 68.8, 68.5, 68.1, 
67.7, 67.3, 66.6, 60.9, 60.1, 60.0, 52.6, 41.4, 40.5, 30.8, 29.9, 25.8, 17.9, 14.1, -4.7, -5.0; 
IR (NaCl/thin film): 3054, 2954, 2929, 2894, 2856, 1754, 1707, 1648, 1448, 1375, 1336, 
1301, 1291, 1257, 1190, 1126, 1099, 1038, 1004, 939, 918, 900, 871, 837, 777 cm–1; 
HRMS (ESI) calc’d for C13H18NO5 [M–C6H15OSi]+ 268.1180, found 268.1186 (detected 
fragment has undergone loss of tert-butyldimethylsilylanolate anion). 
Preparation of chloroaldehyde 171 
 
To a solution of aldehyde 164 (283 mg, 0.712 mmol) in CH2Cl2 (7 mL, bulk solvent, not 
dried) was added pyrrolidine (60 µL, 0.712 mmol) followed by N-chlorosuccinimide (143 
mg, 1.07 mmol). The resulting solution was stirred under an air atmosphere for 2.5 h, and 
was subsequently quenched with sat. aq. Na2S2O3. The resulting mixture was extracted 
with CH2Cl2 (8 mL, then 2x15 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification via silica gel flash 





















Chapter 2 – Enantioselective Total Synthesis of (–)-Acetylaranotin  74 
chloroaldehyde 171 (70% yield) as a pale yellow oil. 1H NMR (500 MHz, CDCl3; 
compound exists as a 1.3:1 mixture of rotamers, the major rotamer is designated by *, 
minor rotamer denoted by §) δ 9.64 (s, 1H*), 9.62 (s, 1H§), 4.92 (dd, J = 5.0, 2.3 Hz, 
1H*), 4.79 (dd, J = 5.0, 2.3 Hz, 1H§), 4.66 (dd, J = 10.8, 7.3 Hz, 1H§),  4.58 (dd, J = 10.8, 
7.1 Hz, 1H*), 4.48 (d, J = 4.5 Hz, 1H*), 4.38 (d, J = 4.5 Hz, 1H§), 4.27 – 4.14 (m, 2H*, 
2H§), 3.78 (s, 3H§), 3.74 (s, 3H*), 3.46 (dd, J = 14.4, 10.8 Hz, 2H*), 3.42 (dd, J = 14.5, 
10.9 Hz, 1H§), 2.52 – 2.43 (m, 2H*, 2H§), 1.27 (t, J = 7.1 Hz, 2H*, 2H§), 0.89 (s, 9H*, 
9H§), 0.15 (s, 6H*, 6H§); 13C NMR (126 MHz, CDCl3; compound exists as a 1.3:1 
mixture of rotamers, the major rotamer is designated by *, minor rotamer denoted by §) δ 
187.7*, 187.6§, 170.1*, 169.8§, 155.5*, 155.2§, 128.9*, 128.6§, 80.9*, 80.6§, 77.7§, 77.6*, 
74.3*, 73.7§, 63.0§, 62.3*, 61.4§, 61.3*, 58.3§, 58.0*, 53.3§, 53.3*, 39.0*, 37.9§, 25.5*, 
25.5§, 18.0§, 18.0*, 14.2*, 14.1§, -5.0§, -5.1*, -5.5*, -5.5§; IR (NaCl/thin film): 3263, 
2956, 2930, 2885, 2859, 2116, 1762, 1719, 1448, 1371, 1307, 1255, 1198, 1165, 1134, 
1082, 1033, 1006, 988, 939, 860, 838, 782, 726 cm–1; HRMS (ESI) calc’d for 
C14H19ClNO6 [M–C6H15OSi+MeOH]+ 332.0895, found 332.0900 (detected fragment has 
undergone loss of tert-butyldimethylsilanolate anion and gain of methanol). 
Preparation of chlorohydrin 172 
 
 A solution of chloroaldehyde 171 (215 mg, 0.498 mmol) in EtOH (5 mL) was 
treated with NaBH4 (75.3 mg, 1.99 mmol). After 15 min, the reaction mixture was cooled 
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with brine (5 mL), and further saturated with solid NaCl, then extracted with CHCl3 
(3x15 mL) followed by EtOAc (3x15 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification via silica gel flash 
chromatography (gradient elution, 4:1→2:1 hexanes–EtOAc) afforded 182 mg of 
chlorohydrin 172 (84% yield) as a clear, colorless oil. 1H NMR (500 MHz, CDCl3; 
compound exists as a 1.3:1 mixture of rotamers, the major rotamer is designated by *, 
minor rotamer denoted by §) δ 4.97 (dd, J = 4.3, 2.3 Hz, 1H*), 4.85 (dd, J = 4.1, 2.3 Hz, 
1H§), 4.66 (dd, J = 10.6, 7.4 Hz, 1H§), 4.58 (dd, J = 10.5, 7.2 Hz, 1H*), 4.44 – 4.38 (m, 
1H*, 1H§), 4.34 (dd, J = 4.3, 1.3 Hz, 1H*), 4.26 (dd, J = 4.2, 1.3 Hz, 1H§), 4.25 – 4.14 
(m, 2H*, 2H§), 3.93 (dd, J = 12.8, 10.3 Hz, 1H*, 1H§), 3.76 (s, 3H§), 3.73 (s, 3H*), 3.54 
(dd, J = 11.2, 3.9 Hz, 1H*), 3.45 (dd, J = 10.8, 4.1 Hz, 1H§), 2.88 (dd, J = 13.7, 10.6 Hz, 
1H*), 2.85 (dd, J = 14.0, 10.7 Hz, 1H§), 2.57 – 2.49 (m, 2H*, 2H§), 1.26 (t, J = 7.2 Hz, 
3H§), 1.26 (t, J = 7.2 Hz, 3H*), 0.94 (s, 9H*, 9H§), 0.22 (s, 3H*), 0.22 (s, 3H*), 0.20 (s, 
6H§); 13C NMR (126 MHz, CDCl3; compound exists as a 1.3:1 mixture of rotamers, the 
major rotamer is designated by *, minor rotamer denoted by §) δ 170.6*, 170.3§, 155.6*, 
155.3§, 81.7*, 81.3§, 80.3§, 79.4*, 77.2§, 76.8*, 73.3*, 72.9§, 65.8*,§, 63.9§, 63.1*, 61.2§, 
61.1*, 58.5§, 58.1*, 53.2§, 53.2*, 41.0*, 39.8§, 25.6*, 25.6§, 18.1§, 18.1*, 14.2*, 14.2§, -
5.1§, -5.2*, -5.4*, -5.5§; IR (NaCl/thin film): 3486, 3255, 2955, 2930, 2858, 2112, 1761, 
1714, 1448, 1371, 1308, 1254, 1194, 1156, 1140, 1082, 862, 838, 782 cm–1; HRMS (ESI) 
calc’d for C19H33ClNO6Si [M+H]+ 434.1760, found 434.1764. 
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Chlorohydrin 172 (53.0 mg, 0.122 mmol) was dissolved in dry, degassed DMF 
(0.61 mL) and transferred via syringe to a Schlenk tube equipped with a magnetic stir bar 
and sealed with a septum cap under an N2 atmosphere. A stock solution of [Rh(cod)Cl]2 
(0.01 M) and (4-FC6H4)3P (0.12 M) in dry, degassed DMF (0.61 mL) was added. The 
resulting yellow solution was degassed using the freeze-pump-thaw technique. The vessel 
was sealed and the solution frozen by submersion in a bath of liquid N2. The vessel was 
then placed under vacuum for approximately five minutes before once again being sealed 
and allowed to thaw under static vacuum by removal from the liquid N2 bath. This 
procedure was repeated twice before the head-space was finally backfilled with N2, the 
vessel sealed, and the solution heated to 85 °C with stirring. After 25 h, the reaction 
mixture was cooled to rt, diluted with sat. aq. NaHCO3 (10 mL), and extracted with 
EtOAc (5x5 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated in vacuo, and the resulting material was purified via silica gel flash 
chromatography (gradient elution, 8:1→6:1 hexanes–EtOAc) to afford 45.0 mg of 
chlorotetrahydrooxepine 173 (85% yield) as a pale yellow oil. 1H NMR (500 MHz, 
CDCl3; compound exists as a mixture of rotamers) δ 6.21 – 6.04 (m, 1H), 5.20 – 4.30 (m, 
5H), 4.29 – 4.13 (m, 2H), 4.09 (d, J = 12.8 Hz, 1H), 3.72 (s, 3H), 2.77 – 2.42 (m, 1H), 
2.52 (dd, J = 13.4, 7.5 Hz, 1H), 1.27 (apt q, J = 7.9, 7.5 Hz, 3H), 0.90 (s, 9H), 0.19 – 0.04 
(m, 6H); 13C NMR (126 MHz, CDCl3; compound exists as a mixture of rotamers) δ 
171.6, 145.7, 129.0, 128.6, 68.3, 61.3, 59.0, 58.7, 53.0, 40.4, 39.6, 25.7, 17.9, 14.2, -4.7, -
5.1; IR (NaCl/thin film): 2954, 2929, 2856, 1752, 1710, 1647, 1447, 1373, 1340, 1263, 
1194, 1130, 1035, 902, 871, 838, 777, 720 cm–1; HRMS (Multimode-ESI/APCI) calc’d 
for C13H17ClNO5 [M–C6H15OSi]+ 302.0790, found 302.0797. 
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Preparation of dihydrooxepine 165 
 
 A suspension of chlorotetrahydrooxepine 173 (8.7 mg, 20 µmol), LiCl (17.0 mg, 
0.402 mmol), and Li2CO3 (59.4 mg, 0.804 mmol) in dry DMF (270 µL) was stirred 
vigorously at 100 °C for 48 h. After cooling to rt, the reaction mixture was diluted with 
Et2O (to precipitate lithium salts), filtered (rinsing with EtOAc), further diluted with 
Et2O, and filtered a second time. The resulting solution was concentrated in vacuo, then 
purified via silica gel flash chromatography (gradient elution, 12:1→10:1 hexanes–
EtOAc) to afford 4.0 mg of dihydrooxepine 165 (50% yield) as a clear, colorless oil. 1H 
NMR (400 MHz, CDCl3) δ 6.37 (s, 1H), 6.12 (dd, J = 8.1, 2.3 Hz, 1H), 4.80 (br s, 1H), 
4.71 (d, J = 8.2 Hz, 1H), 4.59 (br s, 1H), 4.42 (d, J = 7.0 Hz, 1H), 4.18 (q, J = 7.1 Hz, 
2H), 3.71 (s, 3H), 2.95 (dd, J = 15.1, 9.8 Hz, 1H), 2.60 (d, J = 15.1 Hz, 1H), 1.27 (t, J = 
7.2 Hz, 3H), 0.91 (s, 9H), 0.11 (s, 3H), 0.05 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
172.0, 138.0, 135.8, 111.2 (br), 71.2 (br), 63.5, 61.2, 58.5, 52.8, 33.6 (br), 25.8, 18.0, 
14.2, -4.8 (br), -5.4 (br); IR (NaCl/thin film): 2953, 2929, 2855, 1749, 1705, 1654, 1446, 
1369, 1340, 1301, 1285, 1250, 1182, 1141, 1101, 1066, 1032, 970, 898, 874, 838, 771, 
742 cm–1; HRMS (ESI) calc’d for C13H16NO5 [M– C6H15OSi]+ 266.1023, found 266.1024 
(detected fragment has undergone loss of tert-butyldimethylsilanolate anion). 
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Generation of brucin-OL catalyst solution: To a flame dried 2 L three neck 
round bottom flask was added brucin-OL (1.50 g, 3.50 mmol) and CuI (667 mg, 3.50 
mmol). The solids were then evacuated under vacuum, backfilled under N2 atmosphere, 
cooled to 0 °C for 10 min, and then suspended in 74 mL of CHCl3 and stirred for 24 h at 
0 °C. Note: brucin-OL was prepared according to the method of Oh and co-workers.28 
Generation of imine 152: In a separate 250 mL flame dried round bottom flask, 
ethyl glycinate hydrochloride (7.33 g, 52.5 mmol) and 20 g of MgSO4 were suspended in 
70 mL of CHCl3. To the stirred suspension was added Et3N (7.3 mL, 52 mmol) and the 
mixture was allowed to stir for 20 min after which trans-cinnamaldehyde (4.4 mL, 35 
mmol) was added. After the mixture was stirred for an additional 1.5 h, the MgSO4 was 
removed by vacuum filtration, and the resulting solution was washed with H2O (5 x 70 
mL) and 70 mL of sat. aq. brine solution. The combined organic layers were dried over 
MgSO4, filtered, and concentrated in vacuo. The resulting yellow-green oil was dissolved 
in 35 mL of CHCl3 and cooled to 0 °C. 
(1, 3)-Dipolar cycloaddition reaction: Following generation of the catalyst for 
24 h, 1,8-diazabicycloundec-7-ene (520 µL, 3.5 mmol) was added to the brucin-OL 
catalyst suspension and it was allowed to stir for 15 min at 0 °C. To the resulting green 
solution was added t-butyl acrylate (7.7 mL, 53 mmol), followed by dropwise addition 
via cannula of the cooled solution of imine 152 in CHCl3 over approximately 15 min. The 
brown solution was allowed to stir at 0 °C for 24 h after which the reaction was diluted 
with EtOAc (700 mL), washed with 5% NH4OH solution (1 x 200 mL, followed by 2 x 
100 mL), and sat. aq. Na2SO3 solution (2 x 100 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo to yield a brown oil. Purification through silica gel flash 
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chromatography (gradient elution, 9:1→1:1 hexanes–EtOAc with 0.5% Et3N) afforded 
6.07 g (50% yield) of 153 as a yellow oil. Spectroscopic data for this product were 
identical to those described for the corresponding racemic material; [α]
! 
D
25.0  = +31.1° (c = 
1.15, CHCl3) (96% ee, as assessed by conversion to the corresponding methyl carbamate 
198, as described above). Note: On scale up, it was found that tert-butylcarbonyl (Boc) 
protection of pyrrolidine 153 to furnish 200 resulted in less cumbersome 
chromatographic separations. t-Butyl carbamate 200 could subsequently be subjected to 
TFA, Et3SiH, DCM as described to yield trifluoroacetate salt 178 (see below). 
Additionally, an improved cycloaddition procedure was ultimately identified (see below), 
which resulted in more reproducible results on large scale, and obviated the need for 
conversion to 200 for the purposes of purification. 





25.0 = +21.9° (c = 0.41, CHCl3); HPLC (Chiracel AD); 5% isopropanol/hexanes; flow 
rate = 1.0 mL/min; tr (major ent.) = 15.3 min, tr (minor ent.) = 21.4 min. 
Preparation of tert-butyl carbamate 200 
 
In order to achieve less cumbersome chromatographic separations and improved 
material purity on scale up, crude mixtures of pyrrolidine 153 were converted to t-butyl 
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excess reagents/major impurities). Crude pyrrolidine 153 (25.0 g, 72.4 mmol) was 
dissolved in CHCl3 (220 mL) and di-tert-butyl dicarbonate (17.4 g, 79.7 mmol) was 
added with stirring. After 1 h, the reaction mixture was concentrated in vacuo. The 
resulting residue was purified via silica gel flash chromatography (isocratic elution, 7:1 
hexanes:EtOAc) to afford tert-butyl carbamate 200 (30.6 g, 95% yield). Note: although 
attempts were made to advance crude pyrrolidine 153 directly to trifluoroacetate salt 178 
in order to avoid chromatography, it was observed that the purity of 153 greatly 
influenced the isolated yield of 178. On large scale, the above procedure allowed 




25.0  = +28.6° (c = 1.13, CHCl3); 1H NMR (500 MHz, CDCl3; 
compound exists as a mixture of rotamers) δ 7.34 (d, J = 7.5 Hz, 4H), 7.32 – 7.15 (m, 
6H), 6.77 (d, J = 15.7 Hz, 1H), 6.65 (d, J = 15.6 Hz, 1H), 6.14 (dd, J = 15.7, 8.2 Hz, 2H), 
4.83 (dd, J = 8.0, 8.0 Hz, 1H), 4.66 (dd, J = 8.2, 8.2 Hz, 1H), 4.30 – 4.13 (m, 6H), 3.24 – 
3.13 (m, 2H), 2.44 – 2.29 (m, 4H), 1.40 (s, 18H), 1.34 (s, 9H), 1.34 (s, 9H), 1.32 – 1.25 
(m, 6H); 13C NMR (126 MHz, CDCl3; compound exists as a 1:1 mixture of rotamers) δ 
172.5, 172.2, 168.8, 168.7, 153.7, 152.9, 146.7, 136.6, 133.4, 133.3, 128.5, 128.3, 127.5, 
127.4, 126.6, 126.3, 125.1, 124.7, 85.1, 81.4, 81.4, 80.4, 80.3, 61.7, 61.2, 61.0, 59.0, 58.6, 
48.3, 47.8, 30.4, 29.6, 28.3, 28.2, 28.0, 27.3, 14.2, 14.1; IR (NaCl/thin film): 2979, 2933, 
1810, 1731, 1702, 1478, 1457, 1392, 1369, 1290, 1252, 1185, 1119, 1076, 960, 847, 757, 
694 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C20H28NO4 [M–C4H8–CO2+H]+ 
346.2013, found 346.2019 (detected fragment has undergone elimination of iso-butylene 
and CO2 from the Boc protecting group). 
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Enantioselective preparation of styrenyl pyrrolidine 153 (improved procedure) 
 
Preparation of ethyl glycinate: ethyl glycinate hydrochloride salt (29.3 g, 210 
mmol) was suspended in 150 mL of DCM and 3.56 M KOH (77 mL, 273 mmol) was 
added with vigorous swirling. The layers were separated, and the aqueous layer was 
further extracted with DCM (2 x 80 mL), dried over MgSO4, and concentrated to yield 
12.1 g (56% yield) of the free amine. The amine was used immediately to avoid 
dimerization. 
Generation of imine 152: The free amine (12.1 g, 117 mmol) was dissolved in 
235 mL CHCl3. Silica gel (35.1 g, 0.3 g SiO2 per mmol substrate) was added and the 
resulting suspension was cooled to 0 °C while open to the atmosphere. trans-
Cinnamaldehyde (14.7 mL, 117 mmol) was added dropwise and the reaction was left to 
stir at 0°C for an additional 3.5 hours, during which it turned from colorless to bright 
yellow.  The silica gel was removed via filtration and rinsed with 50 mL CHCl3, and the 
resulting imine solution was used immediately to avoid decomposition. 
(1,3)-Dipolar cycloaddition reaction: A round-bottom flasked was charged with 
CuI (2.23 g, 11.7 mmol), BrucinOL (5.01 g, 11.7 mmol), and 235 mL of CHCl3. The 
resulting suspension was cooled to 0 °C under air, and MeCN (1.22 mL, 23.4 mmol) was 
added dropwise and with stirring. After a five minute prestir, DBU (1.75 mL, 11.7 mmol) 
was added and the solution was stirred vigorously for twenty minutes during which it 
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then added, followed by the solution of imine 152 (precooled to 0 °C and transferred via 
cannula over 5 min).  After 5 h, the reaction mixture was loaded directly onto SiO2 and 
subjected to flash chromatography (gradient elution, 5:1→1:1 hexanes–EtOAc with 0.5% 
Et3N) to afford 22.4 g (55% yield) of 153 as an orange oil (97% ee, as assessed by 
conversion to the corresponding methyl carbamate 198, as described above).  
Preparation of pyrrolidinium trifluoroacetate salt 178 
 
Pyrrolidine 153 (5.43 g, 15.7 mmol) was dissolved in 56 mL of CH2Cl2 in a flame 
dried 250 mL round bottom flask. To the solution was added Et3SiH (12.5 mL, 78.5 
mmol) followed by trifluoroacetic acid (23 mL) and the solution was allowed to stir 
overnight. The solution was then concentrated in vacuo, redissolved in CHCl3 and 
azeotroped (3x), and subsequently azeotroped from toluene (3x). Upon further addition of 
toluene and CHCl3, white crystals crashed out of solution and were isolated by vacuum 
filtration to afford 178. The mother liquor was concentrated in vacuo and crystallized 
further from toluene and CHCl3, producing additional crops of 178 (over several 
iterations). Further recrystallization from hot CHCl3 affords 4.87 g (77% yield) of 178 as 
a white solid (>98% ee, as assessed by conversion to the methyl ester 202 following 
protection as the trimethylsilylethyl carbamate, as described below). Note: t-butyl 
carbamate 200 could also be subjected to the conditions described above to afford 
trifluoroacetate salt 178. [α]
! 
D
25.0 = –63.3° (c = 0.70, CHCl3); mp 108–111 °C; 1H NMR 


















Chapter 2 – Enantioselective Total Synthesis of (–)-Acetylaranotin  83 
6.85 (d, J = 15.8 Hz, 1H), 6.28 (dd, J = 8.9, 15.8 Hz, 1H), 4.66 – 4.60 (m, 2H), 4.20 – 
4.30 (m, 2H), 3.36 (ddd, J = 7.3, 7.3, 4.2 Hz, 1H), 2.70 (ddd, J = 14.0, 10.7, 7.5 Hz, 1H), 
2.54 (ddd, J = 14.0, 5.7, 4.3 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CD3CN) δ 173.8, 169.8, 161.8 (q, JC-F  = 35.1 Hz), 138.9, 136.3, 129.9, 129.8, 127.8, 
120.1, 117.6 (q, JC-F = 293.0 Hz), 65.1, 64.0, 58.9, 47.4, 31.6, 14.2; IR (NaCl/thin film): 
3189, 2981, 2913, 2730, 2532, 1726, 1661, 1652, 1565, 1474, 1436, 1251, 1189, 1137, 
973, 798, 746, 691 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C16H20NO4 [M–
C2O2F3]+ 290.1387, found 290.1381 (detected cation does not include the trifluoroacetate 
counterion). 
Preparation of trimethylsilylethyl carbamate 201 
 
Trifluoroacetate salt 178 (7.93 g, 19.7 mmol) was suspended in 39 mL of H2O and 
39 mL of dioxane in a 250 mL round bottom flask. 1-[2-
(Trimethylsilyl)ethoxycarbonyloxy]pyrrolidin-2,5-dione (7.64 g, 29.5 mmol) and Et3N 
(8.2 mL, 59 mmol) were added to the stirred suspension and the reaction mixture was 
allowed to stir overnight. The reaction mixture was then acidified with sat. aq. NaHSO4 
solution, extracted with EtOAc (3x), dried over Na2SO4, filtered, and concentrated in 
vacuo to yield a faint yellow oil. Purification through silica gel flash chromatography 




25.0 = –6.0° (c = 1.12, CHCl3); 1H NMR (500 MHz, CD3CN; compound exists 
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Hz, 1H), 6.17 (dd, J = 15.8, 7.5 Hz, 1H), 4.80 (dd, J = 7.3, 7.3 Hz, 1H), 4.32 – 4.23 (m, 
1H), 4.23 – 4.15 (m, 2H), 4.15 – 4.06 (m, 2H), 3.40 – 3.30 (m, 1H), 2.48 – 2.37 (m, 1H), 
2.34 – 2.17 (m, 1H), 1.29 – 1.23 (m, 3H), 0.98 – 0.89 (m, 2H), 0.02 and 0.00 (s, 9H); 13C 
NMR (126 MHz, CD3CN; compound exists as a mixture of rotamers) δ 173.4, 173.1, 
171.3, 171.3, 155.7, 154.9, 137.7, 133.7, 133.6, 129.7, 128.7, 127.3, 126.5, 126.4, 64.4, 
64.3, 62.1, 62.0, 61.9, 61.7, 59.9, 59.7, 48.0, 47.4, 31.4, 30.4, 18.3, 14.5, –1.5, –1.5; IR 
(NaCl/thin film): 3059, 2982, 2954, 2900, 1745, 1705, 1668, 1404, 1349, 1284, 1250, 
1186, 1114, 1075, 1061, 1038, 960, 860, 838, 740, 694 cm–1; HRMS (Multimode-
ESI/APCI) calc’d for C20H28NO6Si [M–C2H4+H]+ 406.1680, found 406.1689 (detected 
fragment has undergone elimination of ethylene from the Teoc protecting group). 
Preparation of methyl ester 202 
 
In order to determine the extent of enantioenrichment resulting from 
crystallization of trifluoroacetate salt 178, an aliquot of material was protected as the 
trimethylsilylethyl carbamate (201) as described above, then converted to methyl ester 
202. Carboxylic acid 201 (18.1 mg, 41.7 µmol) was dissolved in Et2O (0.42 mL) and 
cooled to 0 °C with stirring. A solution of diazomethane in Et2O was titrated into the 
reaction solution until a yellow color persisted. After 5 min, excess diazomethane was 
quenched by dropwise addition of AcOH (until the yellow color no longer persisted). The 
resulting solution was diluted with Et2O (2 mL) and 10% aqueous K2CO3 (2 mL), the 
phases were separated, and the aqueous layer was further extracted with Et2O (2 x 2 mL). 
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to afford methyl ester 202 (15.9 mg, 85% yield) as a clear, colorless oil. [α]
! 
D
25.0 = –5.9° (c 
= 0.87, CHCl3); 1H NMR (500 MHz, CD3CN; compound mixture of rotamers) δ 7.38 – 
7.31 (m, 4H), 7.28 – 7.24 (m, 1H), 6.76 (d, J = 15.8 Hz, 1H), 6.11 (dd, J = 15.8, 7.4 Hz, 
1H), 4.79 (dd, J = 7.8, 7.8 Hz, 1H), 4.33 – 4.24 (m, 1H), 4.24 – 4.15 (m, 2H), 4.15 – 4.06 
(m, 2H), 3.59 (s, 3H), 3.43 – 3.33 (m, 1H), 2.50 – 2.39 (m, 1H), 2.37 – 2.31 (m, 1H) 1.30 
– 1.22 (m, 3H), 0.98 – 0.89 (m, 2H), 0.01 and 0.00 (s, 9H); 13C NMR (126 MHz, CD3CN; 
compound exists as a mixture of rotamers) δ 173.4, 173.1, 171.2, 171.1, 155.7, 154.8, 
137.6, 133.6, 133.5, 129.6, 128.8, 127.3, 126.7, 64.4, 64.3, 62.3, 62.0, 61.9, 61.8, 60.0, 
59.7, 52.5, 48.3, 47.7, 31.4, 30.4, 18.3, 14.5, –1.5, –1.6; IR (NaCl/thin film): 2952, 1740, 
1701, 1451, 1409, 1374, 1343, 1285, 1250, 1186, 1109, 1031, 860, 837, 750 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C21H30NO6Si [M–C2H4+H]+ 420.1837, found 420.1845 
(detected fragment has undergone elimination of ethylene from the Teoc protecting 
group); HPLC (Chiracel OD); 5% isopropanol/hexanes; flow rate = 1.0 mL/min; tr (major 
ent.) = 21.6 min, tr (minor ent.) = 13.2 min. 
Preparation of hydroxylactone 179 
 
A solution of styrenyl carboxylic acid 201 (1.93 g, 4.45 mmol) in 45 mL of 
CH2Cl2 was cooled to –78 °C in a flame dried three-neck round bottom flask. Ozone was 
bubbled through the cooled solution until the solution turned bright blue. The solution 
was then sparged with Oxygen (until the blue color no longer persisted), warmed to room 
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mL, 178 mmol) was added and the solution was stirred overnight. The pale yellow 
solution was then concentrated in vacuo to afford a pale yellow oil. Purification by silica 
gel flash chromatography (gradient elution, 2:1→3:2 hexanes–EtOAc) afforded 1.49 g of 
179 as a colorless oil (93% yield). [α]
! 
D
25.0 = –42.4° (c = 1.04, CHCl3); 1H NMR (400 
MHz, DMSO, 60 °C) δ 7.69 (s, 1H), 5.72 (s, 1H), 4.43 (dd, J = 10.3, 1.3 Hz, 1H), 4.22 
(d, J = 7.3 Hz, 1H), 4.19 – 4.10 (m, 2H), 4.12 – 3.99 (m, 2H), 3.51 (dd, J = 8.1, 8.1 Hz, 
1H), 2.69 – 2.55 (m, 1H), 2.20 (d, J = 13.3 Hz, 1H), 1.16 (t, J = 7.1 Hz, 3H), 1.09 – 0.84 
(m, 2H), 0.03 (s, 9H); 13C NMR (101 MHz, DMSO, 60 °C) δ 176.6, 170.9, 153.4, 101.2 
(br), 100.5 (br), 65.1 (br), 64.8 (br), 63.2, 60.6, 58.7 (br), 58.5 (br), 58.4 (br), 42.8 (br), 
41.8 (br), 31.0, 30.9 (br), 30.0 (br), 28.0, 21.8, 17.1 (br), 13.5, 13.4, –1.8; IR (NaCl/thin 
film): 3380, 2957, 2901, 1783, 1747, 1706, 1682, 1417, 1347, 1251, 1198, 1119, 1038, 
944, 860, 839, 773, 696, 620 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C15H24NO7Si [M–H]– 358.1328, found 358.1309. 
Preparation of alkynyl lactone 180 
 
To a flame dried 250 mL round bottom flask containing hydroxylactone 179 (2.69 
g, 7.48 mmol) was added 37 mL of THF and the stirred solution was cooled to –78 °C. 
Ethynylmagnesium bromide (0.5 M solution in THF, 75.0 mL, 37.4 mmol) was added via 
syringe pump over one hour and the solution was then allowed to stir for five minutes at 
–78 °C before being warmed to 0 °C and stirred for another 20 min. The reaction was 
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concentrated in vacuo. Following dilution with CH2Cl2 (500 mL) the mixture was 
acidified to pH = 2.5 with Na2HPO4/KHSO4 buffer (pH = 2.5, prepared from a 10% w/v 
aq. Na2HPO4 solution by acidification with KHSO4). The mixture was then further 
diluted with CH2Cl2 and NaCl was added to further saturate the aqueous phase. The 
phases were separated and the aqueous layer was washed twice with CH2Cl2. The 
combined organic layers were then dried over Na2SO4, filtered, and concentrated in vacuo 
to a volume of 300 mL (0.025 M solution, achieved by marking the flask for the desired 
volume prior to use). The solution was then cooled to 0 °C and triphenylphosphine (5.88 
g, 22.4 mmol) was added and allowed to stir for 10 min. Diisopropylazodicarboxylate 
(3.0 mL, 15 mmol) was then added to the reaction and it was allowed to stir while 
warming to room temperature overnight. The orange solution was then concentrated in 
vacuo to yield an orange oil. Purification by silica gel flash chromatography (gradient 




25.0 = –73.0° (c = 1.01, CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as a 1:1 
mixture of rotamers) δ 5.33 (dd, J = 5.7, 2.0 Hz, 1H), 5.29 (dd, J = 5.7, 2.0 Hz, 1H), 4.96 
(dd, J = 8.0, 6.1 Hz, 1H), 4.85 (dd, J = 8.0, 6.1 Hz, 1H), 4.61 (d, J = 8.7 Hz, 1H), 4.56 (d, 
J = 9.0 Hz, 1H), 4.27 – 4.06 (m, 4H), 4.14 (q, J = 7.2 Hz, 4H), 3.40 – 3.32 (m, 2H), 2.65 
(d, J = 2.0 Hz, 1H), 2.60 (d, J = 2.0 Hz, 1H), 2.56 – 2.41 (m, 4H), 1.29 – 1.19 (m, 6H), 
1.04 – 0.91 (m, 4H), 0.01 (s, 9H), 0.00 (s, 9H); 13C NMR (126 MHz, CDCl3; compound 
exists as a mixture of rotamers) δ 175.5, 175.3, 170.7, 154.7, 154.3, 77.8, 77.7, 76.0, 
75.8, 73.0, 72.9, 64.5, 64.3, 61.6, 61.0, 60.2, 59.8, 59.6, 44.4, 43.5, 32.0, 31.2, 17.6, 17.6, 
13.8, –1.6; IR (NaCl/thin film): 3262, 2955, 2900, 2132, 1782, 1741, 1706, 1455, 1407, 
1349, 1283, 1250, 1190, 1163, 1118, 1042, 1014, 978, 938, 861, 839, 765 cm–1; HRMS 
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(Multimode-ESI/APCI) calc’d for C15H22NO6Si [M–C2H4+H]+ 340.1211, found 340.1192 
(detected fragment has undergone elimination of ethylene from the Teoc protecting 
group). 
Preparation of alkynyl lactone 13-epi-180 
 
To a stirred solution of hydroxylactone 179 (12.0 mg, 33.4 µmol) in 0.17 mL of 
THF at –78 °C was added ethynylmagnesium bromide (0.5 M solution in THF, 0.33 mL, 
0.167 mmol) dropwise. The solution was then allowed to stir for five minutes at –78 °C 
before being warmed to 0 °C and stirred for another 15 min. The reaction was then 
quenched with 0.5 mL of 1M aq. HCl solution and the reaction mixture was concentrated 
in vacuo. The resulting aqueous mixture was saturated with NaCl and extracted with 
EtOAc (5x), and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude material (~5:1 dr by 1H NMR) was purified by silica gel 
flash chromatography (gradient elution, 2:1→1:1 hexanes–EtOAc) to afford alkynyl 
lactones 13-epi-180 (8.5 mg, 69% yield) and 180 (1.6 mg, 13% yield). NOTE: the 
relative configuration of the propargylic stereocenter of 13-epi-180 was initially assigned 
by analogy to the alkynyl lactone 158.  




25.0 = –13.5° (c = 0.42, CHCl3); 1H NMR (500 MHz, CDCl3; compound exists 
as a 1.3:1 mixture of rotamers, the major rotamer is designated by *, minor rotamer 
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4.62 (d, J = 7.6 Hz, 1H§), 4.59 – 4.53 (m, 1H§), 4.49 – 4.42 (m, 1H*), 4.31 – 4.10 (m, 
4H*, 4H§), 3.44 – 3.36 (m, 1H*, 1H§), 2.70 (d, J = 2.4 Hz, 1H§), 2.70 (d, J = 2.4 Hz, 
1H*), 2.62 – 2.49 (m, 2H*, 2H§), 1.25 (t, J = 7.1 Hz, 3H*, 3H§), 1.10 – 1.04 (m, 2H§), 
1.00 – 0.94 (m, 2H*), 0.06 (s, 9H§), 0.02 (s, 9H*); 13C NMR (126 MHz, CDCl3; 
compound exists as a mixture of rotamers) δ 176.1, 175.8, 171.1, 171.0, 154.1, 153.7, 
78.6, 78.5, 76.9, 76.8, 73.8, 73.0, 65.2, 64.9, 64.7, 64.5, 62.0, 62.0, 59.1, 58.8, 43.4, 42.4, 
31.7, 30.9, 17.8, 13.8, –1.5, –1.6; IR (NaCl/thin film): 3260, 2956, 2900, 2125, 1788, 
1744, 1703, 1457, 1410, 1354, 1290, 1250, 1200, 1146, 1117, 1057, 1035, 970, 941, 861, 
839, 772 cm–1; HRMS (Multimode-ESI/APCI) calc’d for  C17H24NO6Si [M–H]– 366.1378, 
found 366.1400. 
Preparation of diol 181 
 
To a flame dried 500 mL round bottom flask equipped with alkynyl lactone 180 
(4.84 g, 13.2 mmol) dissolved in 264 mL of EtOH, sodium borohydride (2.00 g, 52.8 
mmol) was added and the reaction was stirred vigorously. Following completion of the 
reaction as judged by TLC (~1.75 h), the reaction was cooled to 0 °C and quenched 
carefully with 250 mL of 1N aq. HCl. The solution was then saturated with NaCl, diluted 
with CHCl3, and extracted (1 x 500 mL, then 2 x 250 mL). The aqueous layer was then 
extracted with EtOAc (3 x 250 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification through silica gel flash 
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oil in 86% yield (4.20 g). [α]
! 
D
25.0 = +8.0° (c = 1.22, CHCl3); 1H NMR (500 MHz, CD3CN; 
compound exists as a mixture of rotamers) δ 4.56 – 4.41 (m, 2H), 4.30 (dd, J = 9.8, 8.3 
Hz, 1H), 4.23 – 4.05 (m, 5H), 3.93 – 3.75 (m, 1H), 3.64 (ddd, J = 11.2, 6.0, 6.0 Hz, 1H), 
3.23 – 3.10 (m, 1H), 2.72 – 2.62 (m, 1H), 2.62 – 2.51 (m, 1H), 2.34 – 2.25 (m, 1H), 2.04 
– 1.84 (m, 1H), 1.24 (t, J = 7.1 Hz, 3H), 1.06 – 0.89 (m, 2H), 0.03 (s, 9H); 13C NMR (126 
MHz, CD3CN; compound exists as a mixture of rotamers) δ 175.8, 175.1, 156.7, 156.4, 
84.9, 75.5 (br), 75.4 (br), 65.0, 64.3 (br), 63.6 (br), 62.6 (br), 62.3 (br), 61.4, 60.6 (br), 
60.2 (br), 45.3, 44.6, 33.3, 32.3, 18.3, 14.5, –1.5; IR (NaCl/thin film): 3422, 3307, 2953, 
2898, 2114, 1718, 1701, 1406, 1348, 1314, 1250, 1198, 1171, 1041, 1006, 860, 838 cm–1; 
HRMS (Multimode-ESI/APCI) calc’d for C15H26NO6Si [M–C2H4+H]+ 344.1524, found 
344.1535 (detected fragment has undergone elimination of ethylene from the Teoc 
protecting group).  
Preparation of bis(tert-butyldimethylsilyl) ether 203 
 
To a flame dried 250 mL round bottom flask equipped with diol 181 (4.20 g, 11.3 
mmol) was added 113 mL of CH2Cl2 and the solution was cooled to 0 °C with stirring. 
Following addition of 2,6-lutidine (6.5 mL, 56 mmol), tert-butyldimethylsilyl 
trifluoromethanesulfonate (6.5 mL, 28 mmol) was added dropwise to the reaction. Upon 
completion of the reaction as judged by TLC (~1.5 h), the reaction was quenched with 
3.0 mL of MeOH and 300 mL of sat. aq. NaHCO3 solution was added. The mixture was 
then washed with CH2Cl2 (3 x 300 mL), and the organics were dried over Na2SO4, 
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gel flash chromatography (gradient elution, 16:1→12:1 hexanes–EtOAc) afforded 5.75 g 
of 203 as a colorless oil (85% yield). [α]
! 
D
25.0 = –11.5° (c = 1.19, CHCl3); 1H NMR (500 
MHz, CD3CN; compound exists as a 1:1 mixture of rotamers) δ 4.78 (dd, J = 4.2, 2.3 Hz, 
1H), 4.72 (dd, J = 4.1, 2.2 Hz, 1H), 4.21 – 4.01 (m, 14H), 3.91 (dd, J = 8.0, 4.2 Hz, 1H), 
3.90 (dd, J = 8.0, 4.0 Hz, 1H), 2.68 (br d, J = 2.4 Hz, 2H), 2.61 – 2.50 (m, 2H), 2.44 – 
2.25 (m, 2H), 1.22 (t, J = 6.7 Hz, 3H), 1.21 (t, J = 6.7 Hz, 3H), 1.07 – 0.97 (m, 2H), 0.91 
(s, 18H), 0.90 (s, 18H), 0.95 – 0.86 (m, 2H), 0.14 (br s, 6H), 0.13 (s, 6H), 0.05 (s, 12H), 
0.03 (s, 9H), 0.03 (s, 9H); 13C NMR (126 MHz, CD3CN; compound exists as a mixture of 
rotamers) δ 172.6, 172.2, 156.3, 84.9, 84.9, 77.3, 77.2, 64.7, 64.5, 64.5, 64.1, 63.9, 63.1, 
61.5, 61.3, 60.7, 60.4, 45.7, 44.9, 34.6, 33.5, 26.5, 26.2, 19.1, 18.8, 18.7, 18.4, 14.7, –1.3, 
–4.4, –4.5, –4.8, –4.9, –4.9, –5.0; IR (NaCl/thin film): 3312, 3257, 2955, 2931, 2895, 
2858, 2114, 1762, 1736, 1706, 1472, 1406, 1351, 1252, 1185, 1126, 1079, 839, 778 cm–1; 
HRMS (Multimode-ESI/APCI) calc’d for C27H54NO6Si3 [M–C2H4+H]+ 572.3253, found 
572.3254 (detected fragment has undergone elimination of ethylene from the Teoc 
protecting group). 
Preparation of primary alcohol 182 
 
To a 250 mL round bottom flask equipped with bis(tert-butyldimethylsilyl) ether 
203 (1.00 g, 1.67 mmol) was added 22 mL of a 1:1 mixture of THF:H2O and 33 mL of 
acetic acid. The reaction was monitored by TLC for disappearance of starting material 
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diol 181). After 6 h, the reaction was cooled to 0 °C and quenched dropwise with 520 mL 
of 1N aq. NaOH (vigorous bubbling occurs initially) and excess sat. aq. NaHCO3 
solution until the reaction stopped bubbling. The reaction was then extracted with CHCl3 
(3x) followed by EtOAc (3x), and the combined organic layers were dried over Na2SO4, 
filtered, and concentrated in vacuo. Purification through silica gel flash chromatography 




25.0 = –12.4° (c = 1.22, CHCl3); 1H NMR (500 MHz, CD3CN; compound 
exists as a 1:1 mixture of rotamers) δ 4.85 (dd, J = 3.1, 3.1 Hz, 1H), 4.77 (dd, J = 2.9, 2.9 
Hz, 1H), 4.23 – 4.04 (m, 12H), 4.01 – 3.91 (m, 2H), 3.72 (dd, J = 11.5, 7.1 Hz, 2H), 3.13 
(br s, 2H), 2.73 (d, J = 2.3 Hz, 1H), 2.72 (d, J = 2.3 Hz, 1H), 2.65 – 2.55 (m, 2H), 2.30 – 
2.22 (m, 4H), 1.22 (t, J = 6.9 Hz, 3H), 1.20 (t, J = 6.9 Hz, 3H), 1.09 – 0.96 (m, 2H), 0.92 
(s, 18H), 0.18 (s, 12H), 0.18 (s, 12H), 0.03 (s, 18H), 0.03 (s, 18H); 13C NMR (126 MHz, 
CD3CN; compound exists as a mixture of rotamers) δ 172.5, 172.1, 156.3, 84.5, 77.8, 
77.7, 64.9, 64.6, 64.6, 64.3, 64.2, 63.4, 61.6, 61.5, 61.4, 60.6, 60.3, 46.0, 45.2, 33.4, 32.4, 
26.3, 18.9, 18.8, 18.4, 14.8, –1.3, –4.4, –4.5, –4.8, –4.9; IR (NaCl/thin film): 3503, 3254, 
2954, 2896, 2857, 2113, 1759, 1734, 1704, 1472, 1405, 1348, 1251, 1185, 1042, 838, 780 
cm–1; HRMS (Multimode-ESI/APCI) calc’d for C21H40NO6Si2 [M–C2H4+H]+ 458.2389, 
found 458.2412 (detected fragment has undergone elimination of ethylene from the Teoc 
protecting group). 
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To a 250 mL round bottom flask equipped with primary alcohol 182 (2.29 g, 4.71 
mmol) dissolved in 47 mL of CH2Cl2 (bulk solvent, not dried), was added pyridine (3.8 
mL, 47.1 mmol), and Dess–Martin periodinane24 (4.00 g, 9.42 mmol), and the cloudy 
white suspension was stirred vigorously. After 3.5 h, the reaction was quenched with sat. 
aq. Na2S2O3 solution (50 mL) and sat. aq. NaHCO3 solution (50 mL), diluted with EtOAc 
(50 mL), and stirred vigorously for an additional 20 min. The layers were then separated 
and the aqueous layer was washed with EtOAc (3 x 100 mL). The combined organics 
were washed with sat. aq. NaHCO3 solution (400 mL), dried over Na2SO4, and 
concentrated in vacuo. Purification through silica gel flash chromatography (gradient 
elution, 8:1→4:1 hexanes–EtOAc) afforded 183 as a white oil in 93% yield (2.11 g). [α]
! 
D
25.0 = –35.2° (c = 1.18, CHCl3); 1H NMR (500 MHz, CD3CN; compound exists as a 1:1 
mixture of rotamers) δ 9.98 (s, 1H), 9.95 (s, 1H), 4.87 (br s, 1H), 4.82 (br s, 1H), 4.33 
(dd, J = 8.7, 4.5 Hz, 2H), 4.29 – 4.22 (m, 2H), 4.21 – 4.08 (m, 8H), 3.25 – 3.17 (m, 2H), 
2.77 (ddd, J = 11.4, 11.4, 11.4 Hz, 2H), 2.69 (s, 2H), 2.34 – 2.26 (m, 4H), 1.23 (t, J = 5.7 
Hz, 3H), 1.22 (t, J = 5.7 Hz, 3H), 1.07 – 0.99 (m, 2H), 0.98 – 0.85 (m, 2H), 0.89 (s, 18H), 
0.14 (s, 12H), 0.04 (s, 9H), 0.03 (s, 9H); 13C NMR (126 MHz, CD3CN; compound exists 
as a mixture of rotamers) δ 199.4, 199.3, 172.1, 171.7, 156.2, 156.1, 83.7, 78.0, 77.9, 
65.3, 64.8, 64.7, 64.6, 63.9, 63.3, 61.7, 61.6, 60.4, 60.1, 53.9, 53.2, 30.7, 29.7, 26.0, 18.8, 
18.7, 18.3, 14.6, –1.5, –4.6, –4.7, –5.0, –5.0; IR (NaCl/thin film): 3262, 2954, 2930, 
2897, 2857, 2116, 1758, 1706, 1472, 1405, 1348, 1251, 1188, 1079, 838, 779 cm–1; 
HRMS (Multimode-ESI/APCI) calc’d for C21H38NO6Si2 [M–C2H4+H]+ 456.2232, found 
456.2242 (detected fragment has undergone elimination of ethylene from the Teoc 
protecting group). 
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Preparation of chlorohydrin 184 
 
To a solution of aldehyde 183 (2.11 g, 4.36 mmol) in CH2Cl2 (87 mL, bulk 
solvent, not dried) was added pyrrolidinium trifluoroacetate (1.61 g, 8.72 mmol) followed 
by N-chlorosuccinimide (1.46 g, 10.9 mmol). The resulting solution was stirred under an 
air atmosphere for 30 h, and was subsequently diluted with EtOH (120 mL) and treated 
with NaBH4 (1.65 g, 43.6 mmol). After 1.5 h, the reaction mixture was cooled to 0 °C 
and carefully quenched with 1M aq. HCl (200 mL). The resulting mixture was saturated 
with NaCl, then extracted with CHCl3 (3 x 200 mL) followed by EtOAc (200 mL). The 
combined organic layers were washed with brine (400 mL), dried over Na2SO4, filtered 
and concentrated in vacuo to provide the crude product, which was purified by silica gel 
flash chromatography (gradient elution, 12:1→6:1 hexanes–EtOAc) to afford 
chlorohydrin 184 (2.11 g, 93% yield) as a clear, colorless oil. [α]
! 
D
25.0 = –8.2° (c = 0.98, 
CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as a 1.25:1 mixture of rotamers, 
the major rotamer is designated by *, minor rotamer denoted by §) δ 4.96 (dd, J = 4.3, 2.3 
Hz, 1H*), 4.85 (dd, J = 4.2, 2.3 Hz, 1H§), 4.64 (dd, J = 10.6, 7.4 Hz, 1H§), 4.56 (dd, J = 
10.6, 7.1 Hz, 1H*), 4.38 (ddd, J = 13.3, 13.3, 4.1 Hz, 1H*, 1H§), 4.32 (dd, J = 4.4, 1.3 
Hz, 1H*), 4.27 (m, 1H§), 4.26 – 4.11 (m, 3H*, 3H§), 3.96 – 3.88 (m, 1H*, 1H§), 3.53 (dd, 
J = 10.8, 4.3 Hz, 1H*), 3.42 (dd, J = 10.7, 4.4 Hz, 1H§), 2.90 – 2.81 (m, 1H*, 1H§), 2.55 
– 2.47 (m, 2H*, 2H§), 1.25 (t, J = 7.0, 3H*), 1.25 (t, J = 7.0, 3H§), 1.04 – 0.91 (m, 2H*, 
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0.01 (s, 9H*); 13C NMR (126 MHz, CDCl3; compound exists as a mixture of rotamers) δ 
170.7, 170.3, 155.3, 155.1, 81.7, 81.4, 80.4, 79.5, 77.2, 76.8 (obscured by CDCl3 signal, 
observable by acquiring spectrum in CD2Cl2), 73.1, 72.6, 65.8, 64.6, 64.5, 63.9, 63.1, 
61.1, 61.0, 58.4, 58.1, 40.9, 39.8, 25.6, 18.0, 18.0, 17.5, 14.2, 14.1, –1.6, –1.6, –5.0, –5.2, 
–5.4, –5.4; IR (NaCl/thin film): 3494, 3309, 3255, 2955, 2931, 2898, 2859, 2113, 1761, 
1708, 1404, 1350, 1307, 1252, 1191, 1082, 839, 781 cm–1; HRMS (Multimode-
ESI/APCI) calc’d for C21H39ClNO6Si2 [M–C2H4+H]+ 492.1999, found 492.2002 (detected 
fragment has undergone elimination of ethylene from the Teoc protecting group). 
Preparation of chlorotetrahydrooxepine 185 
 
A flame-dried Schlenk tube equipped with a magnetic stir bar was charged with 
[Rh(1,5-cyclooctadiene)Cl]2 (26.1 mg, 0.053 mmol, 5 mol %) and tris(4-
fluorophenyl)phosphine (201 mg, 0.636 mmol, 60 mol %). An atmosphere of N2 was 
established by evacuation/backfilling (three cycles) and a solution of chlorohydrin 184 
(553 mg, 1.06 mmol) in dry DMF (10.6 mL, including two rinses to ensure quantitative 
transfer) was added via syringe. The resulting yellow solution was degassed using the 
freeze-pump-thaw technique. The vessel was sealed and the solution frozen by 
submersion in a bath of liquid N2. The vessel was then placed under vacuum for 
approximately five minutes before once again being sealed and allowed to thaw under 
static vacuum by removal from the liquid N2 bath. This procedure was repeated twice 
before the head-space was finally backfilled with N2, the vessel sealed, and the solution 







[Rh(cod)Cl]2 (5 mol %)
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with 50 mL sat. aq. NaHCO3 solution, and extracted with EtOAc (3 x 50 mL). The 
combined organic layers were washed with water (2 x 50 mL) followed by brine (50 mL), 
dried over Na2SO4, filtered, and concentrated in vacuo to provide the crude product, 
which was purified by silica gel flash chromatography (gradient elution, 24:1→12:1 




25.0 = +91.9° (c = 1.14, CHCl3); 1H NMR (400 MHz, CD3CN, 60 °C) δ 
6.23 (dd, J = 7.5, 1.1 Hz, 1H), 4.66 (dd, J = 7.5, 3.7 Hz, 1H), 4.60 (d, J = 13.2 Hz, 1H), 
4.57 – 4.49 (m, 2H), 4.41 (dd, J = 7.8, 1.0 Hz, 1H), 4.26 – 4.07 (m, 5H), 2.57 (ddd, J = 
14.3, 7.6, 1.0 Hz, 1H), 2.49 (dd, J = 14.5, 10.0 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H), 1.04 – 
0.97 (m, 2H), 0.92 (s, 9H), 0.14 (s, 3H), 0.12 (s, 3H), 0.05 (s, 9H); 13C NMR (101 MHz, 
CD3CN, 60 °C; compound exists as a mixture of rotamers) δ 172.7, 157.3, 146.9, 109.4 
(br), 77.9, 76.8 (br), 74.8, 70.0, 65.1, 62.2, 60.5, 41.5 (br), 26.6, 18.9, 18.8, 14.8, –1.1, –
4.1, –4.3; IR (NaCl/thin film): 2954, 2929, 2896, 2856, 1757, 1707, 1647, 1406, 1352, 
1336, 1313, 1251, 1192, 1131, 1037, 863, 837, 777 cm–1; HRMS (Multimode-ESI/APCI) 
calc’d for C15H23ClNO5Si [M–C2H4–C6H15OSi]+ 360.1029, found 360.1030 (detected 
fragment has undergone elimination of ethylene from the Teoc protecting group, as well 
as loss of tert-butyldimethylsilanolate anion). 
Preparation of dihydrooxepine 186 
 
An oven-dried Schlenk tube was charged with a magnetic stir bar and dry LiCl 






















(53% yield) (14% yield)
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was then backfilled with N2, and Li2CO3 (519 mg, 7.03 mmol) was quickly added to the 
vessel. The tube was then evacuated and backfilled with N2, and this procedure was 
repeated twice to establish an inert atmosphere. Finally, chlorotetrahydrooxepine 185 
(30.5 mg, 58.6 µmol) was added as a solution in DMF (rinsing twice for a total volume of 
2.3 mL), and the mixture was heated to 100 °C with vigorous stirring. After 75 h, the 
reaction mixture was cooled to room temperature and filtered through celite, rinsing the 
vessel and filter pad with EtOAc, followed by excess Et2O. The resulting off-white 
suspension was again filtered through celite and concentrated in vacuo. This material was 
purified by preparative HPLC (normal phase, isochratic elution, 6% EtOAc in hexanes) 
to afford dihydrooxepine 186 (14.9 mg, 53% yield) and olefin isomer 204 (4.0 mg, 14% 





25.0 = –70.5° (c = 0.94, CHCl3); 1H NMR (400 MHz, CDCl3, 50 °C) δ 6.37 
(ddd, J = 2.5, 2.5, 1.1 Hz, 1H), 6.11 (dd, J = 8.2, 2.2 Hz, 1H), 4.81 – 4.68 (m, 2H), 4.62 
(br d, J = 7.6 Hz, 1H), 4.42 (ddd, J = 7.5, 2.1, 2.1 Hz, 1H), 4.34 – 4.02 (m, 4H), 2.92 
(dddd, J = 15.1, 9.8, 2.1, 2.1 Hz, 1H), 2.59 (dddd, J = 15.1, 1.6, 1.6, 1.6 Hz, 1H), 1.27 (t, 
J = 7.1 Hz, 3H), 1.06 – 0.98 (m, 2H), 0.91 (s, 9H), 0.11 (s, 3H), 0.06 (s, 3H), 0.03 (s, 
9H); 13C NMR (101 MHz, CDCl3, 50 °C) δ 172.1, 156.3 (br), 138.0, 135.8, 114.4 (br), 
111.6, 71.6, 63.9, 63.7, 61.0, 58.5, 33.9 (br), 25.9, 18.0, 17.9, 14.2, –1.5, –4.7, –5.2; IR 
(NaCl/thin film): 2954, 2928, 2897, 2855, 1750, 1723, 1699, 1687, 1652, 1407, 1330, 
1250, 1180, 1142, 1098, 1031, 860, 837, 778 cm–1; HRMS (Multimode-ESI/APCI) calc’d 
for C15H22NO5Si [M–C2H4–C6H15OSi]+ 324.1262, found 324.1267 (detected fragment has 
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undergone elimination of ethylene from the Teoc protecting group, as well as loss of tert-
butyldimethylsilanolate anion). 




25.0 = +121.9° (c = 1.02, CHCl3); 1H NMR (400 MHz, CD3CN; 60 °C) δ 6.16 
(d, J = 7.2, 1.2 Hz, 1H), 5.86 (br s, 1H), 5.08 (q, J = 1.6 Hz, 1H), 4.80 (dd, J = 7.6, 4.4 
Hz, 1H), 4.66 (dt, J = 5.6, 1.6 Hz, 1H), 4.52 (d, J = 12.4 Hz, 1H), 4.44 – 4.38 (m, 2H), 
4.28 – 4.18 (m, 4H), 1.25 (t, J = 7.2 Hz, 3H), 1.01 (t, J = 8.4 Hz, 2H), 0.93 (s, 9H), 0.12 
(s, 3H), 0.11 (s, 3H), 0.05 (s, 9H); 13C NMR (101 MHz, CD3CN, 60 °C) δ 171.1, 146.2, 
141.8, 125.9, 113.2, 73.8, 72.9, 69.0, 66.8, 64.7, 62.4, 26.7, 19.0, 18.9, 14.9, –1.1, –4.0, –
4.2; IR (NaCl/thin film): 2953, 2928, 2893, 2854, 1755, 1703, 1639, 1404, 1348, 1328, 
1251, 1189, 1128, 1103, 1058, 1027, 861, 836, 777 cm–1; HRMS (Multimode-ESI/APCI) 
calc’d for C15H22NO5Si [M–C2H4–C6H15OSi]+ 324.1262, found 324.1264 (detected 
fragment has undergone elimination of ethylene from the Teoc protecting group, as well 
as loss of tert-butyldimethylsilanolate anion). 
Preparation of carboxylic acid 191 
 
To a solution of ethyl ester 186 (47.3 mg, 97.8 µmol) in DCE (1.0 mL) was added 
trimethyltin hydroxide (177 mg, 0.978 mmol), and the resulting solution was heated 80 
°C with stirring. After 30 h, the reaction mixture was cooled to room temperature and 
diluted with Na2HPO4/KHSO4 buffer (pH = 2.5, prepared from a 10% w/v aq. Na2HPO4 
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organic layers were washed with H2O followed by brine, then dried over Na2SO4, filtered, 
and concentrated in vacuo to provide the crude product, which was purified by silica gel 
flash chromatography (gradient elution, 40:1→20:1 CH2Cl2–MeOH) to afford carboxylic 
acid 191 (40.3 mg, 90% yield) as a white foam. [α]
! 
D
25.0 = –68.6° (c = 0.890, CHCl3); 1H 
NMR (400 MHz, CDCl3, 50 °C) δ 6.43 (ddd, J = 2.1, 2.1, 2.1 Hz, 1H), 6.14 (dd, J = 8.2, 
2.2 Hz, 1H), 4.72 – 4.67 (m, 2H), 4.64 (dddd, J = 7.8, 1.8, 1.8, 1.8 Hz, 1H), 4.42 – 4.31 
(m, 1H), 4.20 – 4.10 (m, 2H), 3.03 (d, J = 16.0 Hz, 1H), 2.91 (dddd, J = 15.5, 9.6, 1.7, 1.7 
Hz, 1H), 1.13 – 1.01 (m, 2H), 0.91 (s, 9H), 0.09 (s, 3H), 0.05 (s, 9H), 0.04 (s, 3H); 13C 
NMR (101 MHz, CDCl3, 50 °C) δ 174.7 (br), 157.5 (br), 138.5, 136.4, 114.6 (br), 111.1, 
71.4, 64.8, 63.9, 58.6, 31.9 (br), 25.9, 18.0, 17.9, –1.5, –4.8, –5.1; IR (NaCl/thin film): 
3088, 2954, 2928, 2897, 2855, 1750, 1722, 1684, 1652, 1418, 1336, 1250, 1180, 1142, 
1101, 859, 837, 777 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C13H18NO5Si [M–
C2H4–C6H15OSi]+ 296.0949, found 296.0958 (detected fragment has undergone 
elimination of ethylene from the Teoc protecting group, as well as loss of tert-
butyldimethylsilanolate anion). 
Preparation of amine 187 
 
To a stirred solution of trimethylsilylethyl carbamate 185 (677 mg, 1.30 mmol) in 
THF (26 mL) at 0 °C was added a solution of TBAF (1.0 M in THF, 5.2 mL, 5.20 mmol). 
After 2.5 h, the solution was diluted with sat. aq. Na2SO4 solution (125 mL) and H2O 
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washed with sat. aq. Na2SO4 solution (250 mL), H2O (2 x 250 mL), and brine (250 mL), 
then dried over Na2SO4, filtered, and concentrated in vacuo to provide the crude product, 
which was purified by silica gel flash chromatography (isocratic elution, 6:1 hexanes–




+117.4° (c = 1.07, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.19 (dd, J = 7.5, 0.7 Hz, 1H), 
4.66 (d, J = 11.6 Hz, 1H), 4.54 (dd, J = 7.4, 5.1 Hz, 1H), 4.31 (ddd, J = 6.9, 5.2, 0.8 Hz, 
1H), 4.24 – 4.14 (m, 2H), 4.08 (d, J = 12.2 Hz, 2H), 3.74 (s, 1H), 2.42 (dd, J = 13.7, 5.9 
Hz, 2H), 2.30 (dd, J = 13.7, 10.8 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 0.90 (s, 9H), 0.09 (s, 
3H), 0.08 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 172.4, 146.8, 105.5, 76.3, 74.5, 74.4, 
68.5, 61.1, 58.1, 43.6, 25.7, 18.0, 14.2, –4.6, –4.9; IR (NaCl/thin film): 2954, 2929, 2886, 
2856, 1741, 1646, 1472, 1286, 1252, 1192, 1138, 1088, 1057, 1035, 872, 838, 778 cm–1; 
HRMS (Multimode-ESI/APCI) calc’d for C17H31ClNO4Si [M+H]+ 376.1705, found 
376.1728. 
Preparation of dihydrooxepine amine 188 
 
An oven-dried Schlenk tube was charged with a magnetic stir bar and dry LiCl 
(454 mg, 10.7 mmol), and its contents were flame-dried under vacuum. The headspace 
was then backfilled with N2, and Li2CO3 (1.58 g, 21.4 mmol) was quickly added to the 
vessel. The tube was then evacuated and backfilled with N2, and this procedure was 
repeated twice to establish an inert atmosphere. Finally, chlorotetrahydrooxepine 187 
(67.0 mg, 0.178 mmol) was added as a solution in DMF (rinsing twice for a total volume 
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reaction mixture was cooled to room temperature and filtered through celite, rinsing the 
vessel and filter pad with EtOAc, followed by excess Et2O. The resulting off-white 
suspension was again filtered through celite and concentrated in vacuo. Residual DMF 
was removed by distillation under high vacuum with gentle heating (water bath, 40 °C) to 
give the crude product as a brown oil. This material was purified by silica gel flash 
chromatography (isocratic elution, 8:1 hexanes–EtOAc) to afford dihydrooxepine 188 
(41.1 mg) as a pale brown oil. NOTE: This material was contaminated with ~5 wt% 
starting material, giving a corrected yield of 65%. Material of this purity was typically 
used without further purification; however, analytically pure samples could be obtained 
with further purification by silica gel flash chromatography (gradient elution, 0→5% 
EtOAc–CH2Cl2 with 0.5% Et3N).  [α]
! 
D
25.0 = –28.2° (c = 1.30, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 6.33 (ddd, J = 2.1, 2.1, 2.1 Hz, 1H), 6.09 (dd, J = 8.2, 2.3 Hz, 1H), 4.62 
(dd, J = 8.2, 1.8 Hz, 1H), 4.20 – 4.13 (m, 3H), 3.86 (dd, J = 7.7, 5.8 Hz, 1H), 3.81 (dddd, 
J = 7.2, 2.0, 2.0, 2.0 Hz, 1H), 2.85 (dddd, J = 14.9, 7.7, 1.7, 1.7 Hz, 1H), 2.64 (dddd, J = 
14.9, 5.8, 1.9, 1.9 Hz, 1H), 2.74 – 2.49 (br s, 1H), 1.26 (t, J = 7.1 Hz, 3H), 0.93 (s, 9H), 
0.18 (s, 3H), 0.15 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 173.9, 138.5, 135.0, 115.7, 
110.2, 71.7, 64.8, 60.8, 58.3, 33.8, 25.8, 18.1, 14.2, –4.5, –4.5; IR (NaCl/thin film): 3376, 
2955, 2929, 2886, 2856, 1737, 1688, 1651, 1472, 1463, 1368, 1295, 1279, 1252, 1203, 
1175, 1119, 1090, 1035, 1005, 882, 838, 778 cm–1; HRMS (Multimode-ESI/APCI) calc’d 
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Preparation of amino acid 189 
 
 LiOH (242 mg, 10.1 mmol) was dissolved in 7 mL H2O, and the resulting solution 
was added via pipet to a stirring solution of ethyl ester 188 (343 mg, 1.01 mmol) in 14 
mL of THF/MeOH (1:1) under an air atmosphere. The resulting biphasic mixture was 
stirred vigorously for 1 h, then diluted with 100 mL sat. aq. Na2HPO4 and extracted with 
CHCl3 (3 x 100 mL). The combined organic layers were then dried over Na2SO4, filtered, 
and concentrated to afford 321 mg (quantitative yield) of amino acid 189 as a yellow 
solid. Though this material was generally used without further purification, it was found 




25.0 = –60.5 ° (c = 1.59, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.35 (ddd, J = 
1.9, 1.9, 1.9 Hz, 1H), 6.13 (dd, J = 7.8, 2.3 Hz, 1H), 4.76 (dd, J = 8.0, 2.1 Hz, 1H), 4.43 
(ddd, J = 8.0, 2.3, 2.3 Hz, 1H), 4.22 (dd, J = 8.2, 2.2 Hz, 1H), 4.10 (dd, J = 8.2, 2.1 Hz, 
1H), 3.09 – 2.93 (m, 2H), 0.90 (s, 9H), 0.20 (s, 3H), 0.13 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 173.1, 138.8, 136.2, 110.5, 110.0, 69.2, 62.2, 57.5, 34.1, 25.8, 17.8, -4.3, -4.9; 
IR (NaCl/thin film): 3067, 2954, 2929, 2886, 2858, 2368, 1688, 1652, 1472, 1464, 1444, 
1368, 1332, 1300, 1260, 1220, 1190, 1142, 1108, 1080, 1006, 960, 938, 872, 839, 780, 
754, 724 cm–1; LRMS (ESI/APCI) calc’d for C15H26NO4Si [M+H]+ 312.2, found 312.1. 
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 In a 1-dram vial equipped with a magnetic stir bar, amino acid 189 (40.6 mg, 
0.130 mmol) was dissolved in 1.3 mL pyridine. Solid EDC•HCl (125 mg, 0.650 mmol) 
was then added in one portion, and the resulting suspension was stirred vigorously for 18 
hours. The mixture was then diluted with H2O, giving a yellow precipitate that was 
filtered off through a cotton plug and rinsed with an excess of further H2O. The crude 
product was then recovered by elution through the cotton plug with CH2Cl2. Purification 
via flash chromatography (gradient elution, 2:1→1:1 hexanes–EtOAc) afforded 
diketopiperazine 190 (19.9 mg, 52% yield) as an off-white solid. [α]
! 
D
25.0 = –92.3 ° (c = 
1.29, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.53 (dd, J = 2.0, 2.0 Hz, 2H), 6.22 (dd, J = 
8.3, 1.9 Hz, 2H), 4.68 (ddd, J = 8.2, 2.1, 2.1 Hz, 2H), 4.61 (dd, J = 8.3, 1.4 Hz, 2H), 4.25 
(dd, J = 11.6, 7.2 Hz, 2H), 4.06 (ddd, J = 8.2, 1.7, 1.7 Hz, 2H), 2.94 (ddd, J = 15.7, 7.2, 
1.0 Hz, 2H), 2.68 (dddd, J = 15.8, 11.8, 2.7, 2.7 Hz, 2H), 0.92 (s, 18H), 0.10 (s, 6H), 0.06 
(s, 6H); 13C NMR (126 MHz, CDCl3) δ 169.9, 140.6, 138.2, 117.7, 109.3, 71.1, 64.0, 
63.5, 29.0, 25.8, 18.1, -3.8, -4.5; IR (NaCl/thin film): 3391, 3059, 2947, 2926, 2854, 
1702, 1645, 1470, 1462, 1360, 1330, 1289, 1256, 1245, 1231, 1197, 1163, 1138, 1127, 
1097, 1062, 993, 980, 956, 937, 897, 860, 836, 775, 713 cm–1; LRMS (ESI/APCI) calc’d 
for C24H31N2O5Si [M–C6H15OSi]+ 455.2, found 455.2 (detected fragment has undergone 
loss of tert-butyldimethylsilanolate anion). 
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To a stirred solution of amine 188 (59.2 mg, 0.174 mmol) and carboxylic acid 191 
(73.9 mg, 0.162 mmol) in CH2Cl2 (1.6 mL) was added triethylamine (226 µL, 1.62 mmol) 
followed by BOP-Cl (206 mg, 0.810 mmol). After 24 h, the reaction mixture was diluted 
with sat. aq. NaHCO3 solution and extracted with EtOAc (5x). Each organic fraction was 
filtered individually through a plug of SiO2, which was then rinsed with excess EtOAc. 
The combined organic filtrates were concentrated in vacuo to provide the crude product, 
which was purified by silica gel flash chromatography (gradient elution, 16:1→4:1 




–46.8° (c = 1.86, CHCl3); 1H NMR (400 MHz, CDCl3, 50 °C) δ 6.43 – 6.36 (m, 2H), 6.15 
(dd, J = 8.2, 2.2 Hz, 1H), 6.12 (dd, J = 8.2, 2.2 Hz, 1H), 5.63 (s, 1H), 5.34 (d, J = 8.2 Hz, 
1H), 5.01 (d, J = 9.9 Hz, 1H), 4.80 (dd, J = 8.2, 2.1 Hz, 1H), 4.66 (dd, J = 8.2, 1.7 Hz, 
1H), 4.60 (d, J = 7.3 Hz, 1H), 4.50 (apt dddd, J = 12.3, 7.9, 2.0, 2.0 Hz, 2H), 4.28 – 4.01 
(m, 4H), 2.97 – 2.87 (m, 1H), 2.87 – 2.77 (m, 1H), 2.76 – 2.68 (m, 1H), 2.67 – 2.58 (m, 
1H), 1.26 (t, J = 7.1 Hz, 3H), 1.01 (apt dd, J = 9.9, 8.1 Hz, 2H), 0.94 (s, 9H), 0.88 (s, 9H), 
0.17 (s, 3H), 0.09 (s, 3H), 0.04 (s, 3H), 0.02 (s, 9H), –0.08 (s, 3H); 13C NMR (101 MHz, 
CDCl3, 50 °C) δ 172.8, 171.7, 156.5, 138.3, 138.0, 136.0, 134.6, 116.1, 115.4, 111.1, 
110.7, 71.4, 70.7, 64.6, 64.1, 63.3, 61.2, 57.1, 55.7, 34.5, 32.6, 26.3, 25.8, 18.3, 18.0, 
18.0, 14.2, –1.6, –3.3, –4.7, –5.2, –5.8; IR (NaCl/thin film): 2954, 2929, 2896, 2856, 
1746, 1718, 1685, 1653, 1430, 1331, 1302, 1251, 1190, 1179, 1141, 1091, 865, 837, 780 
cm–1; HRMS (Multimode-ESI/APCI) calc’d for C26H33N2O7Si [M–C6H16OSi–C6H15OSi]+ 
513.2052, found 513.2051 (detected fragment has undergone elimination of tert-
butyldimethylsilanol, as well as loss of tert-butyldimethylsilanolate anion). 
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Preparation of diketopiperazine 194 (or tetraol 193) 
 
An oven-dried Schlenk tube was charged with a magnetic stir bar, TBAF(t-
BuOH)431 (248 mg, 0.445 mmol), and a solution of dipeptide 192 (57.6 mg, 74.1 µmol) in 
dry MeCN (1.5 mL). The resulting solution was degassed using the freeze-pump-thaw 
technique. The vessel was sealed and the solution frozen by submersion in a bath of 
liquid N2. The vessel was then placed under vacuum for ca. five minutes before once 
again being sealed and allowed to thaw under static vacuum by removal from the liquid 
N2 bath. This procedure was repeated three times before the head-space was finally 
backfilled with N2, the vessel sealed, and the solution heated to 70 °C with stirring. After 
2 h and 20 min, the reaction mixture was cooled to rt, was diluted with sat. aq. Na2SO4 
solution, and extracted with EtOAc (5x). Each organic fraction was passed individually 
through a plug of SiO2, which was then rinsed with excess EtOAc. The combined organic 
filtrates were then concentrated in vacuo to provide the crude product, which was purified 
by silica gel flash chromatography (isocratic elution, 1% MeOH in 1:1 CH2Cl2–EtOAc) 
to afford diketopiperazine 194 (20.3 mg, 76% yield) as a white solid. Crystals suitable for 
X-ray diffraction were obtained by slow evaporation of a solution of diketopiperazine 
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performed under an air atmosphere, tetraol 193 was formed. This oxidation process 
displays a great degree of apparent diastereoselectivity, as no other diastereomers of the 
dihydroxylated product are observed in significant quantities. Tetraol 193 could be 
isolated as a white solid (27% yield) by preparative HPLC (reverse phase, gradient 
elution, 20→40% MeCN in H2O). Crystals suitable for X-ray diffraction were obtained as 
follows: the material was dissolved in a minimal amount of THF and diluted with 
CH2Cl2, then benzene and iso-octane were sequentially layered over the resulting solution 





25.0 = –624.5° (c = 1.01, CHCl3); mp 200–222 °C (dec); 1H NMR (500 MHz, 
CDCl3) δ 6.53 (ddd, J = 2.6, 2.6, 1.0 Hz, 2H), 6.18 (dd, J = 8.2, 2.3 Hz, 2H), 5.07 (s, 2H), 
4.91 (dddd, J = 7.9, 1.7, 1.7, 1.7 Hz, 2H), 4.87 (dd, J = 8.2, 1.9 Hz, 2H), 4.50 – 4.44 (m, 
2H), 4.35 (ddd, J = 7.9, 2.1 Hz, 2H), 3.01 (dddd, J = 14.9, 6.9, 1.2, 1.2 Hz, 2H), 2.84 
(dddd, J = 15.1, 11.2, 2.2, 2.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 167.1, 138.3, 
137.8, 110.3, 109.6, 71.0, 64.1, 57.8, 33.9; IR (NaCl/thin film): 3244, 3164, 2923, 2895, 
2848, 1675, 1638, 1623, 1438, 1284, 1187, 1131, 1046, 749 cm–1; HRMS (Multimode-
ESI/APCI) calc’d for C18H17N2O6 [M–H]– 357.1092, found 357.1089. 
Tetraol 193 
1H NMR (500 MHz, CD3CN) δ 6.54 (ddd, J = 2.6, 2.6, 0.9 Hz, 2H), 6.25 (dd, J = 
8.3, 2.3 Hz, 2H), 4.82 – 4.76 (m, 4H), 4.39 (ddd, J = 7.7, 2.2, 2.2 Hz, 2H), 2.95 (ddd, J = 
15.4, 2.4, 2.4 Hz, 2H), 2.78 (ddd, J = 15.4, 1.5, 1.0 Hz, 2H); 13C NMR (126 MHz, 
CD3CN) δ 167.9, 139.1, 138.2, 111.2, 111.1, 87.8, 73.1, 65.0, 42.0; IR (NaCl/thin film): 
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3583, 3300, 2916, 2848, 1653, 1647, 1420, 1320, 1197, 1148, 1063, 1014 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C18H17N2O8 [M–H]– 389.0990, found 389.0960.  
Preparation of epitetrathiodiketopiperazine 197 (published procedure) 
 
To a stirred suspension of S8 (22.4 mg, 87.3 µmol) in THF (5.8 mL) under a N2 
atmosphere was added a solution of NaHMDS in PhMe (0.6 M, 437 µL, 0.262 mmol) 
over two minutes. The S8 solids dissolved over the course of the addition, giving initially 
a dark green solution that evolved to an orange-brown color towards the end of the 
addition. While this solution was allowed to stir for an additional one minute, a solution 
of NaHMDS in PhMe (0.6 M, 145 µL, 87.3 µmol) was added to a stirred solution of 
diketopiperazine 194 (3.13 mg, 8.73 µmol) in THF (1.0 mL) under a N2 atmosphere. The 
resulting pale brown solution was then added dropwise via syringe to the previously 
described solution of reagents over one minute, rinsing once with THF (0.25 mL) 
(rinsings transferred over an additional one minute) to give a slightly opaque yellow-
orange solution. After an additional one minute, a solution of NaHMDS in PhMe (0.6 M, 
292 µL, 0.175 mmol) was added dropwise to the reaction mixture. After 50 min, the 
reaction was quenched with sat. aq. NaHCO3 solution and extracted with EtOAc. The 
combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo to 
provide the crude product, which was purified by silica gel flash chromatography 
(gradient elution, 3:1→3:2 hexanes–EtOAc) to afford epitetrathiodiketopiperazine 197 
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obtained as follows: iso-octane was carefully layered over a solution of 
epitetrathiodiketopiperazine 197 in CHCl3 and the resulting phases were allowed to 
slowly diffuse at ambient temperature. [α]
! 
D
25.0 = –548.9° (c = 0.135, CHCl3); mp 148–165 
°C (dec); 1H NMR (500 MHz, CDCl3) δ 6.54 (dd, J = 2.5 Hz, 2H), 6.21 (dd, J = 8.2, 2.3 
Hz, 2H), 5.02 (d, J = 7.6 Hz, 2H), 4.92 (dd, J = 8.1, 1.9 Hz, 2H), 4.73 (s, 2H), 4.49 – 4.43 
(m, 2H), 3.29 (ddd, J = 16.0, 2.2 Hz, 2H), 3.03 (d, J = 16.1 Hz, 2H); 13C NMR (126 MHz, 
CDCl3) δ 169.5, 138.9, 138.0, 110.4, 106.4, 74.5, 71.4, 65.4, 41.1; IR (NaCl/thin film): 
3369, 2919, 2849, 1689, 1662, 1391, 1337, 1193, 1133, 1082, 1046, 748 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C18H16ClN2O6S4 [M+Cl]– 518.9585, found 518.9614. 
Preparation of epitetrathiodiketopiperazine 197 (improved procedure) 
 
 To a stirred suspension of S8 (212 mg, 0.825 mmol) in THF (27 mL) under a N2 
atmosphere was added a solution of NaHMDS in PhMe (0.6 M, 16.5 mL, 9.90 mmol) 
over two minutes. After an additional 1 minute, a solution of diketopiperazine 194 (59.2 
mg, 0.165 mmol) in 18 mL THF was added dropwise via syringe to the previously 
described solution of reagents over 1.5 minutes (the flask that had contained the solution 
of 194 was rinsed with an additional 9 mL portion of THF, which was transferred to the 
reaction vessel). After 50 min, the reaction was quenched with sat. aq. NaHCO3 solution 
and extracted with EtOAc (3x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated in vacuo to provide the crude product, which was purified by 
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100% EtOAc) to afford epitetrathiodiketopiperazine 197 (61.0 mg, 76% yield) as a 
yellow solid. 
Preparation of diacetate 205 
 
To a stirred solution of diol 197 (3.11 mg, 6.43 µmol) and DMAP (20 mg, 0.16 
mmol) in CH2Cl2 (0.64 mL) at 0 °C was added acetyl chloride (6.9 µL, 97 µmol). After 
10 min, the ice bath was removed and the reaction mixture was allowed to warm to room 
temperature. After an additional 30 min, the reaction mixture was quenched with H2O 
and extracted five times with a mixture of hexanes and EtOAc (1:1). Each organic 
fraction was passed individually through a plug of SiO2, which was subsequently rinsed 
with excess hexanes/EtOAc. The combined filtrates were concentrated in vacuo to 
provide the crude product, which was purified by silica gel flash chromatography 
(gradient elution, 3:1→3:2 hexanes–EtOAc) to afford diacetate 205 (2.57 mg, 70% yield) 
as a yellow solid. [α]
! 
D
25.0 = –476.6° (c = 0.1285, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
6.57 (ddd, J = 2.5, 2.5, 0.9 Hz, 2H), 6.27 (dd, J = 8.2, 2.4 Hz, 2H), 5.30 (ddd, J = 8.5, 2.6, 
1.4 Hz, 2H), 5.20 (ddd, J = 8.4, 2.2, 2.2 Hz, 2H), 4.70 (dd, J = 8.2, 1.9 Hz, 2H), 3.36 
(ddd, J = 16.4, 2.2, 2.2 Hz, 2H), 3.07 (ddd, J = 16.3, 1.2, 1.2 Hz, 2H), 2.18 (s, 6H); 13C 
NMR (126 MHz, CDCl3) δ 170.4, 165.7, 139.7, 138.7, 108.0, 106.0, 75.7, 71.1, 60.8, 
41.7, 21.5; IR (NaCl/thin film): 2917, 2849, 1739, 1695, 1370, 1237, 1136 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C20H17N2O6S4 [M–C2H3O2]+ 508.9964, found 508.9961 
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Preparation of acetylaranotin (11) 
 
A solution of tetrasulfide 205 (2.40 mg, 4.22 µmol) in CH2Cl2 (0.5 mL) was 
diluted with MeCN (12 mL), then treated with a solution of Et3N in MeCN (0.2 µL, 1.4 
µmol in 50 µL of MeCN), followed by propanedithiol (42 µL, 0.42 mmol). The resulting 
mixture was allowed to stand for 20 min, and was then washed with hexanes (5 x 8 mL, 
the final hexanes wash was back-extracted once with MeCN to ensure material recovery), 
and concentrated in vacuo. The resulting residue was dissolved in CH2Cl2/PhMe and 
loaded onto a short plug of SiO2. Residual propanedithiol and other nonpolar impurities 
were eluted with 4:1 hexanes–EtOAc before the presumed dithiol intermediate was eluted 
with 100% EtOAc. The EtOAc fractions (~25 mL total) were combined and diluted with 
EtOAc (10 mL) and MeOH (70 mL), and the resulting solution was sparged with O2 for 
15 min, then allowed to stand under an O2 atmosphere for ~6 h. The solution was then 
concentrated in vacuo, and purified by preparative HPLC (normal phase, isocratic 




25.0 = –401.5° (c = 0.048, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.61 
(ddd, J = 2.1, 2.1, 2.1 Hz, 2H), 6.30 (dd, J = 8.2, 2.2 Hz, 2H), 5.67 (ddd, J = 8.5, 2.0, 2.0 
Hz, 2H), 5.10 (dddd, J = 8.4, 1.7, 1.7, 1.7 Hz, 2H), 4.60 (dd, J = 8.2, 1.8 Hz, 2H), 4.10 
(ddd, J = 18.2, 2.3, 1.3 Hz, 2H), 2.98 (ddd, J = 18.2, 1.7, 1.7 Hz, 2H), 2.02 (s, 6H); 1H 
NMR (500 MHz, DMSO-d6) δ 6.82 (ddd, J = 2.1, 2.1, 2.1 Hz, 2H), 6.45 (dd, J = 8.2, 2.2 
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4.60 (dd, J = 8.0, 1.8 Hz, 2H), 3.85 (ddd, J = 18.3, 2.5, 1.3 Hz, 2H), 3.23 (ddd, J = 18.3, 
1.6, 1.6 Hz, 2H), 1.90 (s, 6H); 13C NMR (126 MHz, DMSO-d6) δ 169.7, 162.3, 141.6, 
139.2, 114.0, 105.4, 76.4, 70.0, 62.9, 34.1, 21.2; IR (NaCl/thin film): 2917, 2849, 1739, 
1709, 1652, 1356, 1231, 1141, 1040 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C20H17N2O6S2 [M–C2H3O2]+ 445.0523, found 445.0522 (detected fragment has undergone 
loss of acetate anion). 
Table 2.7. Comparison of spectroscopic data for natural and synthetic 
acetylaranotin (11). 
 
1H NMR Data (CDCl3, data for synthetic material referenced to CHCl3 at 7.26 ppm)a 
Reported (τ)1c Reported (δ) Synthetic 
3.37 6.63 (ddd, J = 2.3, 2.2, 1.4 Hz, 2H) 6.61 (ddd, J = 2.1, 2.1, 2.1 Hz, 2H) 
3.68 6.32 (dd, J = 7.5, 2.1 Hz, 2H) 6.30 (dd, J = 8.2, 2.2 Hz, 2H) 
4.32 5.68 (ddd, J = 8.7, 2.1, 1.5 Hz, 2H) 5.67 (ddd, J = 8.5, 2.0, 2.0 Hz, 2H) 
4.91 5.09 (dddd, J = 8.7, 2.3, 1.4, 1.3 Hz, 2H) 5.10 (dddd, J = 8.4, 1.7, 1.7, 1.7 Hz, 2H) 
5.37 4.63 (dd, J = 7.5, 1.5 Hz, 2H) 4.60 (dd, J = 8.2, 2.2 Hz, 2H) 
5.88 4.12 (ddd, J = 18.0, 2.2, 1.3 Hz, 2H) 4.10 (ddd, J = 18.2, 2.3, 1.3 Hz, 2H) 
7.03b 2.97 (ddd, J = 18.0, 1.4, 1.4 Hz, 2H) 2.98 (ddd, J = 18.2, 1.7, 1.7 Hz, 2H) 
– c – c 2.02 (s, 6H) 
aReported data was referenced to TMS as an internal standard. 
bReported value is 7.30 ppm, but this is assumed to be a typographical error based on the plot of the 
spectrum. 
cValue not tabulated. 
 
1H NMR Data (DMSO-d6, data for synthetic material referenced to DMSO at 2.50 ppm)a 
Reported4 Synthetic 
6.82 (ddd, J = 2.5, 2.0, 1.5 Hz, 2H) 6.82 (ddd, J = 2.1, 2.1, 2.1 Hz, 2H) 
6.45 (dd, J = 8.0, 2.5 Hz, 2H) 6.45 (dd, J = 8.2, 2.2 Hz, 2H) 
5.42 (ddd, J = 8.5, 2.5, 2.0 Hz, 2H) 5.42 (ddd, J = 8.5, 2.0, 2.0 Hz, 2H) 
5.01 (br ddt, J = 8.5, 2.0, 1.5 Hz, 2H) 5.02 (dddd, J = 8.5, 1.9, 1.4, 1.4 Hz, 2H) 
4.59 (dd, J = 8.0, 2.0 Hz, 2H) 4.60 (dd, J = 8.0, 1.8 Hz, 2H) 
3.84 (br ddd, J = 18.0, 2.5, 1.5 Hz, 2H) 3.85 (ddd, J = 18.3, 2.5, 1.3 Hz, 2H) 
3.22 (br ddd, J = 18.0, 1.5, 1.5 Hz, 2H) 3.23 (ddd, J = 18.3, 1.6, 1.6 Hz, 2H) 
1.90 (s, 6H) 1.90 (s, 6H) 
aReference value not provided for previously reported data. 
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Appendix 1 – Spectra Relevant to Chapter 2 212










X-Ray Crystallography Reports Relevant to Chapter 2: 
Enantioselective Total Synthesis of (–)-Acetylaranotin† 
  
                                                
† The work disclosed in this appendix for the X-ray crystallographic analysis of 158, 193, 
194, and 197 was completed entirely by Larry Henling and Dr. Michael Day in the 
Caltech X-ray crystallography lab. 




A2.1 CRYSTAL STRUCTURE ANALYSIS OF ALKYNYL LACTONE 158 
Figure A2.1. Alkynyl lactone 158. Crystallographic data have been deposited at the 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on 









Table A2.1.  Crystal data and structure refinement for alkynyl lactone 158 (CCDC 
771581). 
Empirical formula  C13H15NO6 
Formula weight  281.26 
Crystallization Solvent  Toluene/pentane 
Crystal Habit  Colorless 
Crystal size 0.21 x 0.17 x 0.10 mm3 
Crystal color  Fragment  
 Data Collection  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 9198 reflections used 
in lattice determination  2.39 to 31.03° 
Unit cell dimensions a = 6.9163(3) Å α= 90° 
 b = 20.5882(8) Å β= 95.402(2)° 
 c = 9.3847(3) Å γ = 90° 
Volume 1330.39(9) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  P 21/n 
Density (calculated) 1.404 Mg/m3 
F(000) 592 
Data collection program Bruker APEX2 v2009.7-0 
θ range for data collection 1.98 to 31.11° 
Completeness to θ = 31.11° 99.8 %  
Index ranges -9 ≤ h ≤ 10, -29 ≤ k ≤ 29, -13 ≤ l ≤ 13 
Data collection scan type  ω scans; 10 settings 
Data reduction program  Bruker SAINT-Plus v7.66A 
Reflections collected 30667 
Independent reflections 4258 [Rint= 0.0413] 
Absorption coefficient 0.112 mm-1 
Absorption correction None 
Max. and min. transmission 0.9889 and 0.9768




Table A2.1 (cont.) 
Structure Solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Difference Fourier map 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 4258 / 0 / 241 
Treatment of hydrogen atoms  Unrestrained 
Goodness-of-fit on F2 2.394 
Final R indices [I>2σ(I),  3426 reflections] R1 = 0.0424, wR2 = 0.0612 
R indices (all data) R1 = 0.0536, wR2 = 0.0618 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.001 
Average shift/error  0.000 
Largest diff. peak and hole 0.382 and -0.339 e.Å-3 
 Special Refinement Details  
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under 
a nitrogen stream at 100K. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 




by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
 
 
Table A2.2.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for alkynyl lactone 158 (CCDC 771581).  U(eq) is defined as 
the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________ 
 x y z Ueq 
________________________________________________________________________________ 
O(1) 3264(1) 3891(1) 8422(1) 25(1) 
O(2) 1757(1) 4780(1) 7535(1) 34(1) 
O(3) 2341(1) 4207(1) 3372(1) 23(1) 
O(4) 4388(1) 3848(1) 5210(1) 30(1) 
O(5) 2648(1) 1926(1) 6592(1) 18(1) 
O(6) 2464(1) 2173(1) 4217(1) 20(1) 
N(1) 1720(1) 2918(1) 5876(1) 16(1) 
C(1) 1757(2) 4201(1) 7692(1) 24(1) 
C(2) 199(2) 3722(1) 7140(1) 20(1) 
C(3) 1193(1) 3064(1) 7317(1) 16(1) 
C(4) 2952(2) 3193(1) 8406(1) 20(1) 
C(5) 2628(1) 2973(1) 9855(1) 21(1) 
C(6) 2323(2) 2785(1) 11000(1) 27(1) 
C(7) -420(2) 3806(1) 5542(1) 22(1) 
C(8) 1125(1) 3416(1) 4825(1) 18(1) 
C(9) 2840(1) 3838(1) 4511(1) 18(1) 
C(10) 3752(2) 4688(1) 2984(1) 26(1) 
C(11) 3121(2) 4898(1) 1483(1) 28(1) 
C(12) 2296(1) 2326(1) 5454(1) 16(1) 
C(13) 3016(2) 1257(1) 6242(1) 24(1) 
________________________________________________________________________________ 
  




Table A2.3.   Bond lengths [Å] and angles [°] for alkynyl lactone 158 (CCDC 
771581). 
O(1)-C(1)  1.3532(13) 
O(1)-C(4)  1.4520(13) 
O(2)-C(1)  1.2015(13) 
O(3)-C(9)  1.3300(12) 
O(3)-C(10)  1.4601(13) 
O(4)-C(9)  1.2022(11) 
O(5)-C(12)  1.3522(12) 
O(5)-C(13)  1.4453(13) 
O(6)-C(12)  1.2184(11) 
N(1)-C(12)  1.3522(13) 
N(1)-C(8)  1.4560(13) 
N(1)-C(3)  1.4645(12) 
C(1)-C(2)  1.5150(15) 
C(2)-C(3)  1.5211(14) 
C(2)-C(7)  1.5305(15) 
C(2)-H(2)  0.969(11) 
C(3)-C(4)  1.5368(14) 
C(3)-H(3)  0.965(9) 
C(4)-C(5)  1.4700(15) 
C(4)-H(4)  0.974(10) 
C(5)-C(6)  1.1802(15) 
C(6)-H(6)  0.976(12) 
C(7)-C(8)  1.5406(15) 
C(7)-H(7A)  0.988(11) 
C(7)-H(7B)  1.024(10) 
C(8)-C(9)  1.5210(14) 
C(8)-H(8)  0.965(10) 
C(10)-C(11)  1.4991(16) 
C(10)-H(10A)  0.983(11) 
C(10)-H(10B)  1.021(12) 
C(11)-H(11A)  1.007(13) 
C(11)-H(11B)  1.031(13) 
C(11)-H(11C)  0.998(11) 
C(13)-H(13A)  1.000(11) 
C(13)-H(13B)  0.959(12) 












































































Table A2.4.   Anisotropic displacement parameters (Å2x 104) for alkynyl lactone 
158 (CCDC 771581).  The anisotropic displacement factor exponent takes the 
form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
O(1) 280(4)  222(5) 254(4)  -47(3) -6(3)  -56(3) 
O(2) 413(5)  169(5) 459(6)  -39(4) 98(4)  -32(4) 
O(3) 222(4)  237(5) 239(4)  101(3) 1(3)  -57(3) 
O(4) 212(4)  369(5) 298(5)  107(4) -25(3)  -50(4) 
O(5) 246(4)  132(4) 170(4)  14(3) 7(3)  15(3) 
O(6) 201(4)  238(4) 153(4)  -28(3) 18(3)  7(3) 
N(1) 201(4)  143(5) 136(4)  14(3) 20(3)  8(4) 
C(1) 252(6)  223(7) 249(6)  -59(5) 92(5)  -10(5) 
C(2) 181(5)  172(6) 241(6)  -5(5) 69(4)  14(4) 
C(3) 161(5)  163(6) 158(5)  2(4) 31(4)  -5(4) 
C(4) 199(5)  194(6) 196(5)  -43(5) 20(4)  -2(5) 
C(5) 184(5)  235(6) 218(6)  -47(5) -12(4)  49(5) 
C(6) 226(6)  355(8) 223(6)  -7(5) 0(5)  89(5) 
C(7) 187(5)  188(6) 273(6)  56(5) 24(4)  17(5) 
C(8) 185(5)  169(6) 167(5)  25(4) -6(4)  -11(4) 
C(9) 216(5)  162(6) 174(5)  8(4) 43(4)  12(4) 
C(10) 266(6)  260(7) 255(6)  60(5) 43(5)  -86(5) 
C(11) 312(7)  288(8) 252(6)  77(6) 53(5)  -41(6) 
C(12) 136(5)  162(6) 178(5)  -1(4) 4(4)  -21(4) 
C(13) 297(6)  131(6) 293(7)  -11(5) 1(5)  9(5) 
______________________________________________________________________________ 
  




Table A2.5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters 
(Å2x 103) for alkynyl lactone 158 (CCDC 771581). 
________________________________________________________________________________ 
 x  y  z  Uiso 
________________________________________________________________________________ 
H(2) -877(16) 3765(5) 7724(12) 28(3) 
H(3) 409(12) 2722(5) 7667(10) 11(3) 
H(4) 4127(14) 3003(5) 8087(10) 17(3) 
H(6) 2132(16) 2633(6) 11963(13) 48(4) 
H(7A) -460(15) 4264(6) 5225(11) 25(3) 
H(7B) -1755(15) 3605(5) 5260(11) 25(3) 
H(8) 612(13) 3212(5) 3944(11) 14(3) 
H(10A) 5033(17) 4477(5) 3075(12) 34(3) 
H(10B) 3760(16) 5060(6) 3703(13) 37(4) 
H(11A) 3197(17) 4525(7) 796(14) 48(4) 
H(11B) 4040(19) 5264(7) 1218(14) 57(4) 
H(11C) 1742(16) 5048(5) 1402(12) 32(3) 
H(13A) 1871(16) 1088(6) 5623(12) 35(3) 
H(13B) 3193(15) 1035(6) 7144(13) 34(3) 
H(13C) 4195(17) 1226(6) 5752(13) 40(4) 
________________________________________________________________________________ 
  




A2.2 CRYSTAL STRUCTURE ANALYSIS OF TETRAOL 193 
Figure A2.2. Tetraol 193. Crystallographic data have been deposited at the CCDC, 
12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on request, 










Table A2.6.  Crystal data and structure refinement for tetraol 193 (CCDC 844563). 
Empirical formula  C18H18N2O8 • 0.5(C6H6) • H2O 
Formula weight  447.41 
Crystallization Solvent  Benzene 
Crystal Habit  Blade 
Crystal size 0.39 x 0.16 x 0.07 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for ? reflections used 
in lattice determination  ? to ?° 
Unit cell dimensions a = 20.744(4) Å α= 90° 
 b = 7.7389(15) Å β= 97.41(3)° 
 c = 12.557(3) Å γ = 90° 
Volume 1999.0(7) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  C 2 
Density (calculated) 1.487 Mg/m3 
F(000) 940 
Data collection program Bruker APEX2 v2009.7-0 
θ range for data collection 1.98 to 30.52° 
Completeness to θ = 30.52° 98.6 %  
Index ranges -29 ≤ h ≤ 29, 0 ≤ k ≤ 11, 0 ≤ l ≤ 17 
Data collection scan type  ω scans; 8 settings 
Data reduction program  Bruker SAINT-Plus v7.68A 
Reflections collected 4904 
Independent reflections 4905 [Rint= 0.0000] 
Absorption coefficient 0.118 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7461 and 0.6457




Table A2.6 (cont.) 
Structure Solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 4905 / 1 / 295 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 2.523 
Final R indices [I>2σ(I),  3856 reflections] R1 = 0.0475, wR2 = 0.0570 
R indices (all data) R1 = 0.0724, wR2 = 0.0586 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.003 
Average shift/error  0.000 
Absolute structure determination Unknown 
Absolute structure parameter 0.0(15) 
Largest diff. peak and hole 0.360 and -0.387 e.Å-3 
 Special Refinement Details  
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under 
a nitrogen stream at 100K. 
The crystal is a twin. Below is a summary of cell_now‡ and TWINABS results§; 
 
Cell for domain  1:   20.744    7.739   12.557    89.89    97.41    90.05 
341 reflections within tolerance assigned to domain  1, 
341 of them exclusively;   109 reflections not yet assigned to a domain 
 
Cell for domain  2:   20.744    7.739   12.557    89.89    97.41    90.05 
Rotated from first domain by 180.0 degrees about 
reciprocal axis  1.000  0.000 -0.077  and real axis  1.000  0.002  0.003 
                                                
‡ cell_now v2008/2, Bruker-AXS, Madison, WI 
§ TWINABS v2008/4, Bruker-AXS, Madison, WI 




319 reflections within tolerance assigned to domain  2, 
 107 of them exclusively;     2 reflections not yet assigned to a domain 
 
PART 1 - Refinement of parameters to model systematic errors 
4095 data (   1047 unique ) involve domain  1 only,  mean I/sigma   7.3 
4126 data (   1039 unique ) involve domain  2 only,  mean I/sigma   7.7 
12800 data (   2820 unique ) involve   2 domains,  mean I/sigma   7.0 
  




Table A2.7.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for tetraol 193 (CCDC 844563).  U(eq) is defined as the trace 
of the orthogonalized Uij tensor.  
________________________________________________________________________________ 
 x y z Ueq 
________________________________________________________________________________ 
O(1) 8553(1) 4178(3) 4236(2) 21(1) 
O(2) 9325(1) 5646(3) 1137(2) 15(1) 
O(3) 8215(1) 4557(4) -488(2) 15(1) 
O(4) 9086(1) 2056(3) -1515(2) 15(1) 
O(5) 7924(2) -1604(3) -4248(2) 21(1) 
O(6) 9132(1) -3189(3) -1136(2) 14(1) 
O(7) 8311(1) -2039(4) 519(2) 16(1) 
O(8) 9346(1) 470(3) 1510(2) 16(1) 
N(1) 8556(1) 2544(4) 781(3) 10(1) 
N(2) 8441(1) -47(4) -763(3) 11(1) 
C(1) 8832(2) 5634(6) 3838(3) 21(1) 
C(2) 9097(2) 5893(5) 2959(3) 18(1) 
C(3) 9160(2) 4676(5) 2034(3) 15(1) 
C(4) 8514(2) 3673(6) 1726(3) 15(1) 
C(5) 8410(2) 2421(5) 2610(3) 14(1) 
C(6) 8462(2) 2676(6) 3657(3) 17(1) 
C(7) 8399(2) 3089(7) -234(4) 14(1) 
C(8) 8487(2) 1779(5) -1118(3) 14(1) 
C(9) 7949(2) 1845(5) -2059(3) 15(1) 
C(10) 7994(2) 94(5) -2581(3) 14(1) 
C(11) 7903(2) -121(6) -3625(3) 19(1) 
C(12) 8189(2) -3099(6) -3834(3) 20(1) 
C(13) 8577(2) -3429(5) -2933(3) 19(1) 
C(14) 8812(2) -2223(5) -2026(3) 14(1) 
C(15) 8243(2) -1186(6) -1697(3) 11(1) 
C(16) 8442(2) -553(7) 253(4) 13(1) 
C(17) 8679(2) 731(5) 1142(3) 12(1) 
C(18) 8300(2) 625(5) 2108(3) 14(1) 
 
O(21) 0 3462(6) 0 17(1) 
 
O(22) 10000 8951(5) 10000 15(1) 
 
C(21) 9865(2) 2553(5) 5484(3) 34(1) 
C(22) 9715(2) 1029(6) 5951(3) 39(1) 
C(23) 9852(2) -546(5) 5471(3) 45(1) 
 
  




Table A2.8.   Bond lengths [Å] and angles [°] for tetraol 193 (CCDC 844563). 
 
O(1)-C(1)  1.389(5) 
O(1)-C(6)  1.371(5) 
O(2)-C(3)  1.432(4) 
O(3)-C(7)  1.227(5) 
O(4)-C(8)  1.413(4) 
O(5)-C(11)  1.393(5) 
O(5)-C(12)  1.355(5) 
O(6)-C(14)  1.434(4) 
O(7)-C(16)  1.238(5) 
O(8)-C(17)  1.414(4) 
N(1)-C(7)  1.342(6) 
N(1)-C(4)  1.485(5) 
N(1)-C(17)  1.486(5) 
N(2)-C(16)  1.334(6) 
N(2)-C(8)  1.489(5) 
N(2)-C(15)  1.483(5) 
C(1)-C(2)  1.310(5) 
C(2)-C(3)  1.514(5) 
C(3)-C(4)  1.553(5) 
C(4)-C(5)  1.510(5) 
C(5)-C(6)  1.320(5) 
C(5)-C(18)  1.531(5) 
C(7)-C(8)  1.531(6) 
C(8)-C(9)  1.518(5) 
C(9)-C(10)  1.514(5) 
C(10)-C(11)  1.311(5) 
C(10)-C(15)  1.527(6) 
C(12)-C(13)  1.327(5) 
C(13)-C(14)  1.505(5) 
C(14)-C(15)  1.528(5) 
C(16)-C(17)  1.528(6) 
C(17)-C(18)  1.531(5) 
C(21)-C(21)#1  1.403(8) 
C(21)-C(22)  1.371(6) 
C(22)-C(23)  1.405(6) 

























































Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y,-z+1 
  




Table A2.9.   Anisotropic displacement parameters (Å2x 104) for tetraol 193 (CCDC 
844563).  The anisotropic displacement factor exponent takes the form: -2p2[ 
h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
O(1) 251(17)  240(19) 131(15)  -80(14) 42(14)  -6(14) 
O(2) 143(15)  152(17) 156(17)  9(13) 12(13)  -1(15) 
O(3) 190(18)  78(18) 164(19)  26(14) -25(14)  13(14) 
O(4) 136(15)  179(17) 135(16)  -8(13) 22(13)  -34(14) 
O(5) 286(16)  190(20) 141(14)  -62(13) -5(16)  69(16) 
O(6) 151(15)  94(16) 191(18)  -10(12) 23(13)  -17(15) 
O(7) 178(18)  104(18) 180(20)  -22(14) 35(15)  -28(14) 
O(8) 134(15)  179(17) 156(17)  5(13) -20(13)  40(13) 
N(1) 160(20)  29(18) 140(20)  -10(16) 54(16)  2(15) 
N(2) 140(20)  75(19) 110(20)  -35(16) 30(16)  10(15) 
C(1) 230(20)  150(30) 230(30)  -60(20) -10(20)  -20(20) 
C(2) 230(20)  130(20) 190(20)  -77(19) 24(19)  -70(20) 
C(3) 140(20)  180(20) 140(20)  1(19) 40(18)  -40(20) 
C(4) 200(30)  120(20) 130(20)  -40(20) 60(20)  0(20) 
C(5) 130(20)  110(20) 170(20)  -15(19) 34(18)  8(17) 
C(6) 170(20)  110(20) 240(30)  10(20) 50(20)  0(20) 
C(7) 100(20)  130(30) 170(30)  -120(20) 20(20)  -40(20) 
C(8) 140(20)  150(30) 130(20)  50(20) 18(18)  -20(20) 
C(9) 190(20)  120(20) 130(20)  0(20) 2(18)  -29(19) 
C(10) 120(20)  120(20) 160(20)  11(18) 16(18)  -10(17) 
C(11) 210(20)  190(30) 170(30)  -20(20) -10(20)  -40(20) 
C(12) 220(20)  180(30) 190(30)  -90(20) 20(20)  -50(20) 
C(13) 220(20)  190(30) 170(20)  -42(18) 80(20)  0(20) 
C(14) 170(20)  140(20) 120(20)  5(18) 24(18)  0(20) 
C(15) 70(20)  130(20) 135(19)  -10(20) 0(20)  -13(19) 
C(16) 90(20)  190(30) 110(30)  70(20) 40(20)  90(20) 
C(17) 190(20)  50(20) 130(20)  30(20) 36(18)  -10(20) 
C(18) 180(20)  130(20) 120(20)  -4(19) 52(18)  -40(19) 
 
O(21) 100(30)  100(30) 280(30)  0 -20(20)  0 
 
O(22) 190(30)  120(30) 130(30)  0 10(20)  0 
 
C(21) 280(20)  410(30) 320(30)  -60(20) -80(20)  50(20) 
C(22) 320(20)  570(30) 280(20)  80(30) 10(30)  -40(30) 
C(23) 550(30)  350(30) 410(30)  90(20) -100(30)  -20(30) 
 
  




Table A2.10.  Hydrogen bonds for tetraol 193 (CCDC 844563) [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 O(2)-H(2)...O(7)#2 0.84 1.97 2.795(4) 168.8 
 O(4)-H(4)...O(21)#3 0.84 1.92 2.733(3) 162.9 
 O(6)-H(6)...O(3)#4 0.84 1.95 2.779(4) 171.0 
 O(6)-H(6)...O(2)#4 0.84 2.69 2.970(3) 101.0 
 O(8)-H(8)...O(22)#5 0.84 1.90 2.736(3) 174.8 
 O(21)-H(21A)...O(2)#6 0.96 1.82 2.715(4) 153.3 
 O(22)-H(22A)...O(6)#7 0.84 1.92 2.712(4) 156.7 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y,-z+1     
#2 x,y+1,z     
#3 x+1,y,z     
#4 x,y-1,z      
#5 x,y-1,z-1     








A2.3 CRYSTAL STRUCTURE ANALYSIS OF DIKETOPIPERAZINE 194 
Figure A2.3. Diketopiperazine 194. Crystallographic data have been deposited at 
the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained 









Table A2.11.  Crystal data and structure refinement for diketopiperazine 194 
(CCDC 832361). 
Empirical formula  C18H18N2O6 
Formula weight  358.34 
Crystallization Solvent  THF 
Crystal Habit  Block 
Crystal size 0.37 x 0.37 x 0.30 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 6587 reflections used 
in lattice determination  2.18 to 27.57° 
Unit cell dimensions a = 9.8372(4) Å α= 90° 
 b = 7.2818(3) Å β= 108.626(2)° 
 c = 11.6037(5) Å γ = 90° 
Volume 787.67(6) Å3 
Z 2 
Crystal system  Monoclinic 
Space group  P 21 
Density (calculated) 1.511 Mg/m3 
F(000) 376 
Data collection program Bruker SMART v5.630 
θ range for data collection 1.85 to 42.08° 
Completeness to θ = 42.08° 97.7 %  
Index ranges -18 ≤ h ≤ 18, -13 ≤ k ≤ 13, -21 ≤ l ≤ 21 
Data collection scan type  ω scans at 7 settings 
Data reduction program  Bruker SAINT-Plus v7.66A 
Reflections collected 24528 
Independent reflections 10286 [Rint= 0.0425] 
Absorption coefficient 0.115 mm-1 
Absorption correction None 
Max. and min. transmission 0.9664 and 0.9587




Table A2.11 (cont.) 
Structure Solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Difference Fourier map 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 10286 / 1 / 307 
Treatment of hydrogen atoms  Unrestrained 
Goodness-of-fit on F2 1.822 
Final R indices [I>2σ(I),  8534 reflections] R1 = 0.0456, wR2 = 0.0767 
R indices (all data) R1 = 0.0564, wR2 = 0.0781 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.001 
Average shift/error  0.000 
Absolute structure determination Not determined 
Absolute structure parameter 0.1(5) 
Largest diff. peak and hole 0.524 and -0.394 e.Å-3 
 Special Refinement Details  
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under 
a nitrogen stream at 100K. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
  




Table A2.12.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for diketopiperazine 194 (CCDC 832361).  U(eq) is defined 
as the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________ 
 x y z Ueq 
________________________________________________________________________________ 
O(1) 8348(1) -1783(1) 4697(1) 20(1) 
O(2) 6071(1) -327(1) 9389(1) 22(1) 
O(3) 5737(1) 4976(1) 7307(1) 36(1) 
O(4) 6036(1) 4590(1) 5142(1) 19(1) 
O(5) 9107(1) 3564(1) 885(1) 22(1) 
O(6) 9445(1) -1772(1) 2927(1) 20(1) 
N(1) 7024(1) 1926(1) 6068(1) 12(1) 
N(2) 8058(1) 1240(1) 4124(1) 12(1) 
C(1) 8126(1) -153(1) 4894(1) 13(1) 
C(2) 8002(1) 363(1) 6130(1) 13(1) 
C(3) 7351(1) -1162(1) 6684(1) 15(1) 
C(4) 6691(1) -122(1) 7499(1) 13(1) 
C(5) 6665(1) -897(2) 8531(1) 17(1) 
C(6) 5583(1) 1426(2) 9415(1) 21(1) 
C(7) 5717(1) 2919(2) 8810(1) 22(1) 
C(8) 6405(1) 3310(1) 7852(1) 19(1) 
C(9) 6176(1) 1723(1) 6930(1) 13(1) 
C(10) 6855(1) 3264(1) 5249(1) 13(1) 
C(11) 7799(1) 3142(1) 4437(1) 12(1) 
C(12) 7135(1) 4037(1) 3200(1) 16(1) 
C(13) 7916(1) 3080(1) 2440(1) 14(1) 
C(14) 8397(1) 4055(2) 1682(1) 17(1) 
C(15) 9449(1) 1776(2) 741(1) 19(1) 
C(16) 9583(1) 353(2) 1481(1) 19(1) 
C(17) 9450(1) 160(1) 2730(1) 15(1) 
C(18) 8087(1) 1087(1) 2835(1) 13(1) 
  




Table A2.13.   Bond lengths [Å] and angles [°] for diketopiperazine 194 (CCDC 
832361). 
O(1)-C(1)  1.2410(12) 
O(2)-C(6)  1.3671(14) 
O(2)-C(5)  1.3706(12) 
O(3)-C(8)  1.4282(14) 
O(3)-H(3)  0.834(15) 
O(4)-C(10)  1.2378(12) 
O(5)-C(15)  1.3685(13) 
O(5)-C(14)  1.3719(12) 
O(6)-C(17)  1.4250(13) 
O(6)-H(6)  0.842(13) 
N(1)-C(10)  1.3342(12) 
N(1)-C(2)  1.4772(11) 
N(1)-C(9)  1.5006(11) 
N(2)-C(1)  1.3399(12) 
N(2)-C(11)  1.4748(12) 
N(2)-C(18)  1.5094(11) 
C(1)-C(2)  1.5250(12) 
C(2)-C(3)  1.5231(12) 
C(2)-H(2)  0.998(10) 
C(3)-C(4)  1.5107(13) 
C(3)-H(3A)  0.960(11) 
C(3)-H(3B)  0.919(13) 
C(4)-C(5)  1.3312(13) 
C(4)-C(9)  1.5110(13) 
C(5)-H(5)  0.917(14) 
C(6)-C(7)  1.3232(15) 
C(6)-H(6A)  0.929(13) 
C(7)-C(8)  1.5024(13) 
C(7)-H(7)  0.935(14) 
C(8)-C(9)  1.5415(13) 
C(8)-H(8)  0.985(12) 
C(9)-H(9)  0.972(11) 
C(10)-C(11)  1.5222(12) 
C(11)-C(12)  1.5212(13) 
C(11)-H(11)  0.941(11) 
C(12)-C(13)  1.5118(13) 
C(12)-H(12A)  1.004(11) 
C(12)-H(12B)  1.011(13) 
C(13)-C(14)  1.3301(13) 
C(13)-C(18)  1.5151(14) 
C(14)-H(14)  0.910(13) 
C(15)-C(16)  1.3255(15) 
C(15)-H(15)  0.982(13) 
C(16)-C(17)  1.5025(13) 
C(16)-H(16)  0.958(12) 
C(17)-C(18)  1.5405(13) 
C(17)-H(17)  0.969(12) 




































































































Table A2.14.   Anisotropic displacement parameters (Å2x 104) for diketopiperazine 
194 (CCDC 832361).  The anisotropic displacement factor exponent takes the 
form: -2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
O(1) 321(4)  98(3) 241(4)  6(3) 168(3)  39(3) 
O(2) 327(4)  205(4) 204(3)  28(3) 179(3)  9(3) 
O(3) 794(7)  123(4) 315(5)  22(4) 374(5)  66(4) 
O(4) 269(4)  158(3) 171(3)  26(3) 99(3)  99(3) 
O(5) 302(4)  203(4) 213(3)  19(3) 172(3)  7(3) 
O(6) 285(4)  124(3) 235(4)  12(3) 156(3)  43(3) 
N(1) 153(3)  88(3) 136(3)  10(3) 75(3)  11(3) 
N(2) 169(3)  93(3) 126(3)  0(3) 70(3)  20(3) 
C(1) 147(4)  114(4) 154(4)  4(3) 66(3)  9(3) 
C(2) 142(4)  114(4) 140(4)  11(3) 66(3)  9(3) 
C(3) 203(4)  102(4) 160(4)  25(3) 89(3)  19(3) 
C(4) 157(4)  111(4) 148(4)  -7(3) 68(3)  -17(3) 
C(5) 199(4)  159(4) 180(4)  21(4) 94(3)  2(4) 
C(6) 266(5)  206(5) 184(4)  -18(4) 127(4)  -10(4) 
C(7) 358(6)  174(5) 189(5)  -33(4) 165(4)  3(4) 
C(8) 290(5)  139(4) 183(4)  -48(4) 128(4)  -44(4) 
C(9) 149(4)  106(4) 141(4)  -17(3) 71(3)  -16(3) 
C(10) 155(4)  111(4) 115(3)  -13(3) 46(3)  1(3) 
C(11) 157(4)  100(3) 119(3)  -2(3) 52(3)  11(3) 
C(12) 206(4)  134(4) 138(4)  25(3) 71(3)  45(3) 
C(13) 164(4)  139(4) 113(4)  0(3) 39(3)  13(3) 
C(14) 231(5)  149(4) 152(4)  7(4) 76(3)  12(4) 
C(15) 216(4)  220(5) 158(4)  -17(4) 95(4)  11(4) 
C(16) 223(5)  205(5) 181(4)  -23(4) 112(4)  26(4) 
C(17) 157(4)  143(4) 154(4)  -6(3) 60(3)  15(3) 
C(18) 152(4)  123(4) 113(3)  -9(3) 47(3)  1(3) 
 
  




Table A2.15.   Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (Å2x 103) for diketopiperazine 194 (CCDC 832361). 
________________________________________________________________________________ 
 x  y  z  Uiso 
________________________________________________________________________________ 
H(3) 5794(18) 4960(30) 6606(14) 51(5) 
H(6) 9043(14) -1890(20) 3463(11) 32(4) 
H(2) 8996(11) 669(14) 6656(9) 3(2) 
H(3A) 6590(12) -1706(18) 6037(10) 13(3) 
H(3B) 8040(13) -1983(19) 7104(11) 21(3) 
H(5) 7075(13) -2035(19) 8718(11) 22(3) 
H(6A) 5086(14) 1432(17) 9974(13) 18(3) 
H(7) 5272(15) 3970(20) 8980(12) 34(4) 
H(8) 7436(13) 3600(18) 8181(10) 23(3) 
H(9) 5163(12) 1697(17) 6458(10) 14(3) 
H(11) 8687(12) 3694(16) 4850(9) 10(3) 
H(12A) 6089(12) 3711(16) 2898(10) 13(3) 
H(12B) 7244(13) 5419(18) 3235(11) 17(3) 
H(14) 8278(13) 5295(18) 1621(11) 19(3) 
H(15) 9612(13) 1605(18) -45(12) 22(3) 
H(16) 9814(11) -782(17) 1168(9) 13(3) 
H(17) 10269(13) 679(17) 3350(11) 15(3) 
H(18) 7275(12) 325(16) 2409(10) 12(3) 
 
  




Table A2.16.  Hydrogen bonds for diketopiperazine 194 (CCDC 832361) [Å and 
°]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 O(3)-H(3)...O(4) 0.834(15) 1.809(15) 2.6365(11) 171.2(19) 








A2.4. CRYSTAL STRUCTURE ANALYSIS OF TETRASULFIDE 197 
Figure A2.4. Tetrasulfide 197. Crystallographic data have been deposited at the 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK and copies can be obtained on 









Table A2.17.  Crystal data and structure refinement for tetrasulfide 197 (CCDC 
838235). 
Empirical formula  C18H16N2O6S4 
Formula weight  484.57 
Crystallization Solvent  Chloroform/isooctane 
Crystal Habit  Plate 
Crystal size 0.48 x 0.20 x 0.05 mm3 
Crystal color  Light yellow  
 Data Collection  
Type of diffractometer  Bruker KAPPA APEX II 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 9912 reflections used 
in lattice determination  2.61 to 29.28° 
Unit cell dimensions a = 7.6944(3) Å α= 90° 
 b = 9.6777(3) Å β= 90° 
 c = 26.3981(9) Å γ = 90° 
Volume 1965.71(12) Å3 
Z 4 
Crystal system  Orthorhombic 
Space group  P 212121 
Density (calculated) 1.637 Mg/m3 
F(000) 1000 
Data collection program Bruker APEX2 v2009.7-0 
θ range for data collection 2.24 to 29.30° 
Completeness to θ = 29.30° 99.9 %  
Index ranges -10 ≤ h ≤ 10, -13 ≤ k ≤ 13, -36 ≤ l ≤ 36 
Data collection scan type  ω scans; 9 settings 
Data reduction program  Bruker SAINT-Plus v7.68A 
Reflections collected 42286 
Independent reflections 5365 [Rint= 0.0472] 
Absorption coefficient 0.525 mm-1 
Absorption correction None 
Max. and min. transmission 0.9742 and 0.7868




Table A2.17 (cont.) 
Structure Solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 5365 / 0 / 273 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 2.797 
Final R indices [I>2σ(I),  4892 reflections] R1 = 0.0433, wR2 = 0.0639 
R indices (all data) R1 = 0.0483, wR2 = 0.0642 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.000 
Average shift/error  0.000 
Absolute structure determination Anomalous dispersion 
Absolute structure parameter -0.02(6) 
Largest diff. peak and hole 1.078 and -0.643 e.Å-3 
 Special Refinement Details  
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under 
a nitrogen stream at 100K. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
 




Table A2.18.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for tetrasulfide 197 (CCDC 838235).  U(eq) is defined as the 
trace of the orthogonalized Uij tensor.  
________________________________________________________________________________ 
 x y z Ueq 
________________________________________________________________________________ 
S(1) 3450(1) 7409(1) 3420(1) 21(1) 
S(2) 1537(1) 5992(1) 3477(1) 23(1) 
S(3) 429(1) 6398(1) 4176(1) 23(1) 
S(4) -1817(1) 7354(1) 3987(1) 23(1) 
O(1) 4095(2) 9173(2) 1605(1) 31(1) 
O(2) -845(2) 7303(2) 2186(1) 24(1) 
O(3) 3157(2) 10233(2) 4085(1) 23(1) 
O(4) -2156(2) 9030(2) 2905(1) 20(1) 
O(5) 2022(2) 9505(2) 5062(1) 38(1) 
O(6) -2979(2) 11716(2) 5196(1) 28(1) 
N(1) 760(3) 8971(2) 3011(1) 12(1) 
N(2) 315(2) 9677(2) 4025(1) 13(1) 
C(1) 2554(3) 8757(3) 1390(1) 25(1) 
C(2) 1178(3) 8178(3) 1600(1) 22(1) 
C(3) 847(3) 7836(3) 2144(1) 19(1) 
C(4) 1153(3) 9144(3) 2464(1) 14(1) 
C(5) 3062(3) 9543(3) 2471(1) 17(1) 
C(6) 4231(4) 9471(3) 2113(1) 24(1) 
C(7) 3548(3) 9946(3) 3003(1) 17(1) 
C(8) 2289(3) 9089(3) 3326(1) 14(1) 
C(9) 1969(3) 9709(3) 3845(1) 15(1) 
C(10) -888(3) 9024(2) 3189(1) 14(1) 
C(11) -1150(3) 9105(3) 3753(1) 14(1) 
C(12) -2663(3) 10049(3) 3900(1) 15(1) 
C(13) -3277(3) 11166(3) 4725(1) 21(1) 
C(14) -2160(3) 10581(3) 4418(1) 15(1) 
C(15) -220(3) 10389(3) 4500(1) 14(1) 
C(16) 198(3) 9562(3) 4976(1) 20(1) 
C(17) -555(3) 10219(3) 5442(1) 22(1) 
C(18) -1787(4) 11133(3) 5517(1) 24(1) 
 
  




Table A2.19.   Bond lengths [Å] and angles [°] for tetrasulfide 197 (CCDC 838235). 
S(1)-C(8)  1.872(3) 
S(1)-S(2)  2.0170(9) 
S(2)-S(3)  2.0698(10) 
S(3)-S(4)  2.0224(10) 
S(4)-C(11)  1.875(3) 
O(1)-C(6)  1.376(3) 
O(1)-C(1)  1.374(3) 
O(2)-C(3)  1.405(3) 
O(3)-C(9)  1.223(3) 
O(4)-C(10)  1.230(3) 
O(5)-C(16)  1.423(3) 
O(6)-C(13)  1.372(3) 
O(6)-C(18)  1.370(3) 
N(1)-C(10)  1.352(3) 
N(1)-C(8)  1.444(3) 
N(1)-C(4)  1.485(3) 
N(2)-C(9)  1.358(3) 
N(2)-C(11)  1.447(3) 
N(2)-C(15)  1.488(3) 
C(1)-C(2)  1.320(4) 
C(2)-C(3)  1.495(3) 
C(3)-C(4)  1.540(3) 
C(4)-C(5)  1.519(3) 
C(5)-C(6)  1.306(3) 
C(5)-C(7)  1.507(3) 
C(7)-C(8)  1.533(3) 
C(8)-C(9)  1.517(3) 
C(10)-C(11)  1.505(3) 
C(11)-C(12)  1.531(3) 
C(12)-C(14)  1.510(3) 
C(13)-C(14)  1.310(3) 
C(14)-C(15)  1.520(3) 
C(15)-C(16)  1.524(3) 
C(16)-C(17)  1.502(3) 
































































Table A2.20.   Anisotropic displacement parameters (Å2x 104) for tetrasulfide 197 
(CCDC 838235).  The anisotropic displacement factor exponent takes the form: -
2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
S(1) 186(3)  209(4) 241(4)  12(3) -16(3)  49(3) 
S(2) 258(4)  206(4) 214(4)  7(3) -2(3)  3(3) 
S(3) 254(4)  226(4) 216(4)  20(3) 3(3)  41(3) 
S(4) 192(3)  189(4) 300(4)  44(3) 3(3)  -19(3) 
O(1) 225(10)  517(14) 174(11)  -12(10) 67(9)  -18(10) 
O(2) 245(10)  230(11) 243(11)  -85(9) 72(8)  -102(9) 
O(3) 89(9)  382(12) 205(11)  -71(9) -4(8)  -28(9) 
O(4) 94(9)  311(11) 188(10)  -50(9) -31(8)  -3(9) 
O(5) 197(11)  697(17) 243(12)  143(12) -46(9)  85(12) 
O(6) 303(11)  320(12) 208(11)  -99(9) -6(9)  68(10) 
N(1) 120(11)  120(11) 126(11)  9(9) -11(9)  5(9) 
N(2) 129(11)  156(11) 102(11)  6(9) -9(9)  -6(9) 
C(1) 319(17)  277(17) 150(15)  -33(12) 20(12)  36(14) 
C(2) 267(16)  211(15) 174(15)  -59(11) -5(12)  5(12) 
C(3) 187(14)  161(14) 210(15)  -41(11) 19(11)  -9(12) 
C(4) 137(13)  136(13) 133(13)  13(10) 4(10)  0(11) 
C(5) 164(14)  157(13) 181(14)  20(11) 9(12)  -22(12) 
C(6) 185(15)  331(17) 189(16)  12(12) -9(12)  -21(13) 
C(7) 91(13)  232(14) 183(14)  3(11) 1(11)  10(12) 
C(8) 85(12)  170(13) 177(14)  -1(11) -11(10)  41(11) 
C(9) 113(13)  179(14) 165(14)  30(11) -5(11)  34(11) 
C(10) 138(13)  101(12) 170(14)  2(11) -11(11)  -13(11) 
C(11) 80(12)  172(13) 162(14)  26(11) 1(10)  -31(11) 
C(12) 105(12)  179(13) 154(14)  2(11) 10(10)  -2(11) 
C(13) 185(14)  244(15) 193(14)  -12(12) -6(12)  36(13) 
C(14) 130(13)  172(14) 140(14)  37(11) -5(11)  -4(11) 
C(15) 166(14)  146(13) 120(13)  -7(10) 3(11)  -9(11) 
C(16) 160(14)  269(16) 168(14)  14(12) -3(12)  20(12) 
C(17) 199(14)  298(16) 149(14)  25(12) -13(12)  -64(13) 
C(18) 321(16)  273(16) 123(13)  -38(12) 29(13)  -81(15) 
______________________________________________________________________________ 
 








Enantioselective Total Synthesis of C2-Symmetric Dihydrooxepine-




Having completed an enantioselective total synthesis of acetylaranotin (11),1 and 
in doing so developed a strategy towards the synthesis of dihydrooxepine-containing ETP 
natural products, our attention turned to the extention of this strategy to the preparation of 
related targets. These efforts have culminated in the synthesis of a small panel of 
epitetrathiodiketopiperazines, including natural products as well as analogs, which are 
currently being evaluated for biological activity. Furthermore, we have conducted 
preliminary investigations into the synthesis of dihydrooxepine-containing macrocycles, 
with a particular focus on the preparation of bis(ortho-methoxyaryl) ethers. Herein, a 
detailed account of these endeavors is presented. 
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3.2 C2-SYMMETRIC DIHYDROOXEPINE-CONTAINING 
EPIPOLYTHIODIKETOPIPERAZINE NATURAL PRODUCTS 
 
With access to tetrasulfide diol 197, our successful completion of the total 
synthesis of acetylaranotin (11) left us well-positioned for preparation of related C2-
symmetric dihydrooxepine-containing ETP natural products, such as SCH64874 (42), 
SCH64877 (44),2 and emethallicin C (101)3 (see Figure 3.1). We anticipated that the 
successful preparation of these natural products and related unnatural analogs might 
allow for a more comprehensive understanding of the role of their peripheral structure in 
biological target specificity and/or biophysical properties. Furthermore, a better 
understanding of structure/activity relationships might ultimately inform the synthesis of 
chemical probes for molecular target validation. 
Figure 3.1. C2-Symmetric ETP natural products containing the dimeric aranotin core 
 
As the stereochemistry of the SCH sidechains was not disclosed in the original 
isolation report, we first sought to develop a divergent approach to access all eight 
isomers of 3-hydroxy-2,4-dimethylhexanoic acid derivatives (206). Classically, one 
might expect to form the desired stereotriad in a stereocontrolled manner using aldol 
chemistry (see Scheme 3.1). Nelson and coworkers have developed an enantioselective, 
organocatalytic cyclocondensation reaction for the preparation of β-lactones 211 from 























































 emethallicin C (101)
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attractive variant of the aldol reaction. This transformation is appealing because in 
addition to possessing all of the required stereocenters, the β-lactones themselves could 
potentially serve as acylating agents for the formation of the various candidate isomers of 
SCH64874 (42) and SCH64877 (44). 
Scheme 3.1. Retrosynthetic analysis of the SCH64874 carboxylate side chain 
 




Our investigation began with the preparation of model 2,4-dimethyl-3-
hydroxyhexanoate esters for spectroscopic analysis. To this end, synthetic studies 
commenced with the reaction between racemic 2-methylbutyraldehyde (208) and 
propionyl chloride (209) in the presence of quinidine-derived catalyst 212 (Scheme 3.3). 













































2.0 equiv 68-85% yield
>97% ee






































Cyclocondensation approach to SCH64874/SCH64877 side chain candidate isomers:
Nelson, 2004:
209 210 211
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with excess benzyl alcohol in the presence of La(Oi-Pr)3 to afford the corresponding 
benzyl esters (219 and 220), 5  which could be readily separated by simple flash 
chromatography. 
Scheme 3.3. Synthesis of model syn,anti- and syn,syn- esters 219 and 220 
 
Likewise, epimerization of mixture 218 could be carried out with LiHMDS to 
formally give the anti aldol products (221), which could be converted to the benzyl esters 
222 and 223 as before (Scheme 3.4). In this case, however, it was necessary to use 
preparative HPLC to separate the two diastereomers. Despite the low overall yields for 
these two routes, they allowed for rapid access to all four possible diastereomers of the 
2,4-dimethyl-3-hydroxyhexanoate esters (219, 220, 222, and 223) starting from 
inexpensive materials. Furthermore, the ability to use either the quinidine- or quinine-
derived catalyst (212 or 213, respectively) provided access to either of the enantiomers of 
a particular ester.  
Scheme 3.4. Synthesis of model anti,anti- and anti,syn- esters 222 and 223 
 
With isomers 219, 220, 222, and 223 in hand, a comparison was made of their 1H 
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appendages shared by the natural products each contain three methine hydrogens, two 
methylene hydrogens, and nine methyl hydrogens. Inspection of the corresponding 
chemical shifts of the four benzyl esters reveals that there are three diagnostic shifts for 
each stereotriad: those of the β-methine (C(3’)–H) and the δ-methylene (C(5’)–Ha and 
C(5’)–Hb) (see Table 3.1). As assigned by Hegde and coworkers, the chemical shift for 
C(3’)–H is 3.72 ppm for SCH64874 (42) and 3.81 ppm for SCH64877 (44). On the other 
hand, the chemical shift for the down-field C(5’)–Ha is 1.84 ppm (42) and 1.85 ppm (44), 
and that for the up-field C(5’)–Hb is 1.24-1.25 ppm (42) and 1.13-1.10 ppm (44). The 
anti,anti diastereomer (222) can be ruled out, as its chemical shift for C(3’)–H is too far 
up-field (3.39 ppm). Likewise, the chemical shift for C(5’)–Ha in anti,syn diastereomer 
223 is too far up-field (1.51-1.39 ppm), whereas the chemical shift for C(5’)–Hb is too far 
down-field (1.33–1.23 ppm). Similarly, the chemical shift for C(5’)–Ha in syn,syn 
diastereomer 220 is too far up-field (1.46-1.33 ppm). By contrast, the 1H NMR data for 
syn,anti diastereomer 219 appear to be consistent with those of 42 and 44. Furthermore, 
the 13C shifts for the three methyl groups of 42 and 44 most closely match those of benzyl 
ester 219. Taken together, these comparisons suggest that the SCH carboxylate side chain 
posseses the syn,anti configuration. Preliminary experiments revealed that the patterns 
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Table 3.1. Comparison of relevant 1H and 13C NMR data for SCH64874 (42), 
SCH64877 (44), and model carboxylates 219, 220, 222, and 223 
 
 
Important 1H NMR Chemical Shifts (ppm) for 42, 44, 219, 222, 223, and 220 
 
C# SCH64874 SCH64877 219 222 223 220 
1’ – – – – – – 
2’ 2.67 2.8 2.72 2.77 2.69 2.72 
3’ 3.72 3.81 3.68 3.39 3.64 3.69 













6’ 0.94 0.95 0.89 0.88 0.90 0.87 
7’ 1.17 1.28 1.20 1.26 1.18 1.23 
8’ 0.83 0.84 0.82 0.90 0.87 0.94 
 
Important 13C NMR Chemical Shifts (ppm) for 42, 44, 219, 222, 223, and 220 
 
SCH64874 SCH64877 219 222 223 220 
175.0 175.8 176.5 176.3 176.3 175.9 
73.3 73.9 75.0 77.9 75.7 75.2 
41.0 41.9 41.5 42.0 43.1 42.4 
36.0 36.8 36.8 38.2 36.8 37.0 
25.0 25.3 24.7 23.6 26.6 25.9 
14.4 14.9 14.9 15.8 14.5 13.9 
10.4 10.9 10.9 15.1 12.4 11.6 
8.3 9.1 9.8 11.4 11.7 11.2 
 
 Though at this stage we were confident that we had identified the correct relative 
stereochemistry for the SCH carboxylate appendage, the question remained as to the 
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been prepared in 60% ee using the sequence described above. We therefore sought to 
modify our sequence in such a way that it would provide not only diastereoselective 
access to either enantiomer of 219, but also improved enantioselectivity. Inspired by 
Evans and coworkers’ seminal studies on the hydroxyl-directed transformations of aldol 
adducts formed using chiral auxiliary technology,6 we hypothesized that a directed 
hydrogenation approach might address the former challenge. Thus, in analogy to the 
synthesis of 219 and 220, cyclocondensation between propionyl chloride (209) and 2-
ethylacrolein (224) was carried out in the presence of quinidine-derived catalyst 212, and 
the resulting β-lactone opened to give benzyl ester 226 (Scheme 3.5). Gratifyingly, at 
82% ee, the optical activity of this material was substantially improved. Furthermore, 
directed hydrogenation using 2.5 mol % of Brown’s catalyst under 640 psi of hydrogen 
afforded the desired hydroxy ester 219 as a 9:1 mixture of readily separable 
diastereomers. Alcohol 219 was converted to TBS-protected hydroxy acid 227 by a two-
step sequence involving treatment with TBSOTf and 2,6-lutidine followed by 
hydrogenolysis of the benzyl ester. An identical sequence was employed using quinine-
derived catalyst 213 to obtain ent-227. 








































    2,6-lutidine









    EtOAc
(91% yield over 2 steps)
(56% yield)
(67% yield)
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 With carboxylic acids 227 and ent-227 in hand, what remained in the syntheses of 
the two putative SCH64877 candidates was the coupling of these fragments to the 
tetrasulfide diol core 197 and cleavage of the TBS ethers. Though the acid chloride 
derived from 227 and ent-227 reacted sluggishly with 197, it was ultimately determined 
that the desired ester formation could be accomplished using Yamaguchi’s reagent7 in the 
presence of DMAP and DIPEA in CH2Cl2 to afford dicarboxylate 228 (when 227 was 
used as the coupling partner, see Scheme 3.6). The final deprotection step was carried out 
using aqueous H2SiF6 in MeCN to afford a product that was found to be spectroscopically 
identical to SCH64877 (44). Synthesis of 229 (Figure 3.2) using an identical sequence 
but with ent-227 as the coupling partner confirmed that this structure was inconsistent 
with the natural product.  
Scheme 3.6. Synthesis of SCH64877 (44) 
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 Having completed a total synthesis and structural assignment of SCH64877 (44) 
(and with epimeric analog 229 in hand), we next set out to prepare emethallicin C (101) 
as well as several structural analogs, in order to complete our desired panel of 
epitetrathiodiketopiperazines for biological evaluation. The synthesis of emethallicin C 
(101), as well as bis(hydroxyacetate) 233 and bis(β-hydroxypropionate) 234, could be 
accomplished by DMAP-promoted reaction of diol 197 with acid chlorides 230,8 231,9 or 
232,10 respectively, followed by subsequent removal of the TBS groups with H2SiF2 as 
described above (Scheme 3.7). 
Scheme 3.7. Synthesis of emethallicin C (101) and unnatural analogs 233 and 234 
 
 
3.3 MACROCYCLIC DIHYDROOXEPINE-CONTAINING 
EPIDITHIODIKETOPIPERAZINE NATURAL PRODUCTS 
 
Whereas the intrinsic symmetry of molecules like acetylaranotin (11) and 
SCH84877 (44) simplifies their chemical synthesis, the extension of our synthetic 
strategy towards the macrocyclic structures of emestrin (235) 11  or the MPC1001 
congeners (13, 236, 237, see Figure 3.3)12 requires examination of a larger array of 
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Figure 3.3. Macrocyclic ETP natural products containing the aranotin monomer 
 
 As it possesses the same oxidation pattern at C(11) as the monomer unit 
developed during our synthesis of C2-symmetric dihydrooxepine-containing ETPs, our 
initial efforts towards accessing the macrocycles shown in Figure 3.3 have focused on 
MPC1001B (13).13 Retrosynthetically, the most straightforward initial disconnection 
involves late-stage diketopiperazine sulfenylation, as in the synthesis of acetylaranotin 
(11) described in Chapter 2 (see Scheme 3.8). This would involve the intermediacy of 
macrocycle 238, which can be further simplified to monomer unit 188 and biaryl ether-
containing amino acid fragment 239. The joining of these two fragments could 
conceivably be carried out via a stepwise diketopiperazine formation (as in Chapter 2), 
followed by macrolactonization. 
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 Construction of biaryl ether amino acid fragment 23914 has been envisioned to 
proceed in one of two ways (see Scheme 3.9). In the first, Ullman-type coupling (or a 
variant thereof)15 between a phenol 240 and halostyrene 241 would furnish the desired 
ether, while Sharpless asymmetric aminohydroxylation16 would provide enantioselective 
access to the β-hydroxy amino acid moiety of 239. Of course, depending on the coupling 
conditions employed, it might also be feasible to perform the aminohydroxylation prior to 
biaryl ether formation. Alternatively, the β-hydroxy amino acid moiety might be formed 
via condensation of a glycine-derived nucleophile 242 and carboxylic acid derivative 243 
(or a biaryl ether-containing derivative), followed by dynamic kinetic resolution to obtain 
the desired stereochemistry at the benzylic position.17,18 
Scheme 3.9. Strategies for constructing biaryl ether amino acid 239 
 
 Pivotal to these or any other strategies for the synthesis of MPC1001B (13) is the 
ability to successfully carry out the biaryl ether coupling to form a bis(ortho-
methoxyaryl) ether. There is generally a lack of literature regarding the formation of such 
structural motifs, and indeed our preliminary efforts in this regard were largely met with 
failure. Attempts at coupling ortho-methoxy aryl iodides with ortho-methoxy phenols 
using a variety of transition metal catalysts suffered either from negligible conversion or 
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Lam-type coupling between ortho-methoxy aryl boronic acids and ortho-methoxy 
phenols were plagued by substrate protodeborylation.20 
Scheme 3.10. Unsuccessful approaches to the construction of bis(ortho-
methoxyaryl) ethers (246) 
 
 
 Recently, diaryl iodonium salts have received much attention as highly reactive 
electrophiles for a variety of transition metal-mediated processes.21 In fact, Olofsson and 
coworkers have demonstrated that such iodonium reagents can undergo coupling with 
phenols under very mild, transition metal-free conditions.22 These reports have suggested 
that para-methoxyphenyl ligands on the I(III) center are electronically disfavored for 
transfer to nucleophiles. Furthermore, Pike and coworkers have demonstrated that 
although ortho-substituted aryl ligands are generally more favorable for transfer to 
nucleophiles relative to unsubstituted ligands,23 ortho-methoxy ligands are the exception 
to this rule (being highly disfavored for transfer).24 We therefore reasoned that an 
ortho,para-dimethoxyphenyl ligand might be an excellent non-transferable ligand, 




















CuI, Cs2CO3, TMHD, DMF, 120 °C
Cu2O, pyridine, reflux
CuBr•SMe2, K2CO3, pyridine, MeCN, 75 °C
CuI, picolinic acid, K3PO4, DMSO, 100 °C
Pd(OAc)2, di(t-Bu)XPhos (or t-BuBrettPhos), K3PO4, PhMe, 100 °C
Conditions Attempted:
Cu(OAc)2, base (Et3N, pyridine, pyrazine, DMAP, etc.), CH2Cl2, 4ÅMS
244 245 246
246247244
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appropriately functionalized for advancement to the southern amino acid fragment of 
MPC1001B. 
 To test the above hypothesis, iodonium tosylate 250 was synthesized from aryl 
iodide 249 and 1,3-dimethoxybenzene (248) via oxidation in the presence of m-CPBA 
and p-TsOH•H2O in CH2Cl2/TFE (see Scheme 3.11).25 In the event, we observed that 250 
readily underwent coupling with ortho-methoxy phenol 251 in the presence of KOt-Bu in 
PhMe at 40 °C, providing biaryl ether 252 in 69% yield. Ongoing efforts are focused on 
the application of this chemistry to the synthesis of MPC1001B (13). 
Scheme 3.11. Synthesis and biaryl ether coupling of iodonium tosylate 250 
 
 
3.4 CONCLUDING REMARKS 
We have successfully prepared a panel of epitetrathiodiketopiperazines, which 
includes the natural products SCH64877 (44) and emethallicin C (101), as well as several 
structural analogs (229, 233, 234) and previously described intermediates (diol 197,  
diacetate 205). These efforts involved elucidation of the stereochemical configuration of 
the carboxylate appendages of 44, which was accomplished via rapid synthesis of four 



































Chapter 3 – C2-Symmetric Dihydrooxepine-Containing ETPs and MPC1001B  258 
efforts include the biological screening of these tetrasulfides in both cell viability and 
biochemical assays, with the goal of comprehensively examining structure-activity 
relationships. Though our studies toward the synthesis of MPC1001B (13) and related 
molecules are still preliminary, further development of the biaryl ether coupling reaction 
described above may ultimately allow for biological investigations of macrocyclic 
structures as well.  
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3.5 EXPERIMENTAL SECTION 
3.5.1 Materials and Methods 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 
acetonitrile (MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by 
passing through activated alumina columns. Unless otherwise stated, chemicals and 
reagents were used as received. N,N-Diisopropylethamine (DIPEA) was distilled over 
calcium hydride prior to use. All reactions were monitored by thin-layer chromatography 
using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were visualized by 
UV, p-anisaldehyde, or KMnO4 staining. Flash column chromatography was performed 
either as described by Still et al.26 using silica gel (particle size 0.032-0.063) purchased 
from Silicycle or using pre-packaged RediSep®Rf columns on a CombiFlash Rf system 
(Teledyne ISCO Inc.). Optical rotations were measured on a Jasco P-2000 polarimeter 
using a 100 mm path-length cell at 589 nm. 1H and 13C NMR spectra were recorded on a 
Varian 400 MR (at 400 MHz and 101 MHz, respectively), a Varian Inova 500 (at 500 
MHz and 126 MHz, respectively), or a Varian Inova 600 (at 600 MHz and 150 MHz, 
respectively), and are reported relative to internal CHCl3 (1H, δ = 7.26), MeCN (1H, δ = 
1.94), acetone (1H, δ = 2.05), or DMSO (1H, δ = 2.50), and CDCl3 (13C, δ = 77.0), MeCN 
(13C, δ = 118.26), acetone-d6 (13C, δ = 206.26) or DMSO (13C, δ = 40.0). Data for 1H 
NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling 
constant (Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
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frequency of absorption (cm–1). HRMS were acquired using an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI), or mixed (MM) ionization mode. Analytical chiral 
HPLC was performed with an Agilent 1100 Series HPLC utilizing Chiralpak AD or 
Chiralcel OD-H columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, 
Ltd with visualization at 254 nm. Preparative HPLC was performed with an Agilent 1100 
Series HPLC utilizing an Agilent Eclipse XDB-C18 5μm column (9.4 x 250 mm) or an 
Agilent Zorbax RX-SIL 5µm column (9.4 x 250 mm). Melting points were determined 
using a Büchi B-545 capillary melting point apparatus and the values reported are 
uncorrected. 
3.5.2 Preparative Procedures and Spectroscopic Data 
Preparation of benzyl esters 219 and 220 
 
 Preparation of β-lactone 218: In a glovebox under an N2 atmosphere, a flame-
dried round-bottom flask equipped with a magnetic stir bar was charged with anhydrous 
LiClO4 (4.64 g, 43.6 mmol). The vessel was then sealed with a septum cap, removed 
from the glovebox, and placed under a positive pressure of N2. Et2O (13 mL) was then 
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To this solution was added a solution of TMSQ (212, 525 mg, 1.32 mmol) in CH2Cl2 (26 
mL) via syringe, and the mixture was cooled to –40 °C. DIPEA (5.53 mL, 33.0 mmol) 
was then added dropwise, followed by 2-methylbutyraldehyde (208, 1.41 mL, 13.2 
mmol). Finally, a solution of propionyl chloride (209, 2.31 mL, 26.4 mmol) in CH2Cl2 
(6.6 mL) was added dropwise over 6 h (using a syringe pump). The resulting solution 
was allowed to stir overnight at –40 °C before being diluted with Et2O and filtered 
through a plug of SiO2, eluting with excess Et2O and concentrating to afford a crude oil. 
Purification via column chromatography (gradient elution, 16:1→8:1 pentanes–Et2O) 
afforded β-lactone 218 (686 mg, 37% yield, mixture of diastereomers) as a clear, 
colorless oil. 
 Preparation of benzyl esters 219 and 220: In a glovebox, a 20-mL scintillation 
vial equipped with a magnetic stir bar was charged with La(Oi-Pr)3 (29 mg, 0.092 mmol), 
then sealed with a septum cap, removed from the glovebox, and placed under a positive 
pressure of N2. A solution of β-lactone 218 (300 mg, 2.11 mmol) and benzyl alcohol (952 
µL, 9.2 mmol) in 9.2 mL of THF was then added via syringe, and the resulting mixture 
was stirred vigorously for 48 h. The reaction mixture was then diluted with sat. aq. 
NH4Cl and extracted with Et2O (3x). The combined organic layers were dried over 
MgSO4, filtered, and concentrated, and the resulting crude oil was purified via flash 
chromatography (gradient elution, 0→15% hexanes–EtOAc) to afford diastereomerically 
pure benzyl esters 219 (207 mg, 39% yield) and 220 (131 mg, 25% yield) as well as 164 
mg (31% yield) of a 1:1 mixture of 219 and 220. 
219 (syn,anti)27: 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.31 (m, 5H), 5.15 (s, 2H), 
3.68 (ddd, J = 8.4, 3.1, 3.1 Hz, 1H), 2.72 (qd, J = 7.2, 3.1 Hz, 1H), 2.52 (d, J = 3.7 Hz, 
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1H), 1.77 (dqd, J = 13.3, 7.6, 3.1 Hz, 1H), 1.50 – 1.41 (m, 1H), 1.20 (d, J = 7.2 Hz, 3H), 
1.21 – 1.11 (m, 1H), 0.89 (t, J = 7.5 Hz, 3H), 0.82 (d, J = 6.8 Hz, 3H); 13C NMR (126 
MHz, CDCl3) δ 176.5, 135.7, 128.6, 128.3, 128.1, 75.0, 66.4, 41.5, 36.8, 24.7, 14.9, 10.9, 
9.8; IR (NaCl/thin film): 3503, 3066, 3033, 2964, 2935, 2877, 1730, 1498, 1456, 1382, 
1330, 1259, 1176, 1110, 1079, 1054, 1029, 971, 916, 751 cm–1; HRMS (ESI) calc’d for 
C15H23O3 [M+H]+ 251.1642, found 251.1642. (60% ee, as determined by conversion to 
the Mosher ester using (S)-(+)-α-methoxy-α-trifluoromethylphenylacetyl chloride 
followed by NMR analysis). 
220 (syn,syn): 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.31 (m, 5H), 5.14 (s, 2H), 
3.69 (ddd, J = 5.9, 4.7, 4.7 Hz, 1H), 2.72 (qd, J = 7.1, 5.3 Hz, 1H), 2.20 (d, J = 4.8 Hz, 
1H), 1.46 – 1.33 (m, 2H), 1.23 (d, J = 7.1 Hz, 3H), 1.19 – 1.09 (m, 1H), 0.94 (d, J = 6.6 
Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 175.9, 135.8, 128.6, 
128.3, 128.1, 75.2, 66.3, 42.4, 37.0, 25.9, 13.9, 11.6, 11.2; IR (NaCl/thin film): 3497, 
3066, 3034, 2963, 2935, 2877, 1730, 1498, 1456, 1380, 1336, 1261, 1167, 1109, 1052, 
1028, 991, 957, 916, 752 cm–1; HRMS (ESI) calc’d for C15H23O3 [M+H]+ 251.1642, 
found 251.1647. 
Preparation of benzyl esters 222 and 223 
 
 Preparation of β-lactone 221: In a flame-dried round-bottom flask, β-lactone 
218 (193 mg, 1.36 mmol) was dissolved in 27 mL THF. The resulting solution was 
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2.7 mmol). After 15 min, the reaction was quenched with 30 mL sat. aq. NH4Cl, and 
allowed to warm to ambient temperature. The mixture was then extracted with Et2O (60 
mL, then 2x30 mL), and the combined organic layers were dried over MgSO4, filtered, 
and concentrated to afford the crude product as a clear oil. Purification via flash 
chromatography (gradient elution, 16:1→4:1 pentanes–Et2O) afforded β-lactone 221 
(87.8 mg, 45% yield, mixture of diastereomers) as a clear, colorless oil. 
 Preparation of benzyl esters 222 and 223: In a glovebox, a 20-mL scintillation 
vial equipped with a magnetic stir bar was charged with La(Oi-Pr)3 (9.2 mg, 0.029 
mmol), then sealed with a septum cap, removed from the glovebox, and placed under a 
positive pressure of N2. A solution of β-lactone 221 (82.3 mg, 0.579 mmol) and benzyl 
alcohol (300 µL, 2.90 mmol) in 2.9 mL of THF was then added via syringe, and the 
resulting mixture was stirred vigorously for 48 h. The reaction mixture was then diluted 
with sat. aq. NH4Cl and extracted with Et2O (3x). The combined organic layers were 
dried over MgSO4, filtered, and concentrated, and the resulting crude oil was purified via 
flash chromatography (gradient elution, 8:1→4:1 pentanes–Et2O) to afford benzyl esters 
222 and 223 (118 mg, 81% yield) as a 3:2 mixture of diastereomers. Diastereomerically 
pure materials could be obtained via preparative HPLC (normal phase, gradient elution, 
5→7.5% EtOAc in hexanes). 
222 (anti,anti)28: 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.31 (m, 5H), 5.15 (s, 2H), 
3.39 (ddd, J = 8.0, 5.9, 5.9 Hz, 1H), 2.77 (qd, J = 7.2, 5.4 Hz, 1H), 2.58 (d, J = 8.1 Hz, 
1H), 1.62 (dqd, J = 13.4, 7.5, 3.2 Hz, 1H), 1.44 (ddqd, J = 9.9, 6.7, 6.7, 3.3 Hz, 1H), 1.26 
(d, J = 7.2 Hz, 3H), 1.22 – 1.11 (m, 1H), 0.90 (d, J = 6.8 Hz, 3H), 0.88 (t, J = 7.5 Hz, 
3H); 13C NMR (126 MHz, CDCl3) δ 176.3, 135.7, 128.6, 128.3, 128.1, 77.9, 66.3, 42.0, 
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38.2, 23.6, 15.8, 15.1, 11.4; IR (NaCl/thin film): 3523, 3034, 2963, 2935, 2876, 1719, 
1498, 1456, 1383, 1351, 1261, 1166, 1043, 996, 958, 750 cm–1; HRMS (ESI) calc’d for 
C15H23O3 [M+H]+ 251.1642, found 251.1643. 
223 (anti,syn): 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.31 (m, 5H), 5.16 (s, 2H), 
3.64 (ddd, J = 7.7, 6.3, 3.5 Hz, 1H), 2.69 (dq, J = 7.3, 7.3 Hz, 1H), 2.41 (d, J = 6.4 Hz, 
1H), 1.51 – 1.39 (m, 2H), 1.33 – 1.23 (m, 1H), 1.18 (d, J = 7.2 Hz, 3H), 0.90 (t, J = 7.3 
Hz, 3H), 0.87 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 176.3, 135.8, 128.6, 
128.3, 128.1, 75.7, 66.4, 43.1, 36.8, 26.6, 14.5, 12.4, 11.7; IR (NaCl/thin film): 3514, 
3034, 2963, 2935, 2877, 1728, 1498, 1456, 1383, 1351, 1311, 1262, 1166, 1037, 991, 
958, 750 cm–1; HRMS (ESI) calc’d for C15H23O3 [M+H]+ 251.1642, found 251.1642. 
Preparation of benzyl ester 226 
 
 Preparation of β-lactone 225: In a glovebox under an N2 atmosphere, a flame-
dried round-bottom flask equipped with a magnetic stir bar was charged with anhydrous 
LiI (402 mg, 3.00 mmol). The vessel was then sealed with a septum cap, removed from 
the glovebox, and placed under a positive pressure of N2. To the flask was added a 
solution of TMSQ (212, 59 mg, 0.150 mmol) in 4.7 mL CH2Cl2, followed by 0.53 mL 
Et2O. The resulting mixture was stirred vigorously until all of the LiI had dissolved, and 
then cooled to –40 °C. DIPEA (628 µL, 3.75 mmol) was then added dropwise, followed 
by 2-ethylacrolein (224, 85 wt%, 173 µL, 1.5 mmol). Finally, a solution of propionyl 





























Chapter 3 – C2-Symmetric Dihydrooxepine-Containing ETPs and MPC1001B  265 
(using a syringe pump). The resulting solution was allowed to stir for an additional 3 h 
before being diluted with Et2O and filtered through a plug of SiO2, eluting with excess 
Et2O and concentrating to afford a crude oil. Purification via column chromatography 
(gradient elution, 24:1→8:1 pentanes–Et2O) afforded β-lactone 225 (149 mg, corrected 
for Et2O contamination to 117 mg, 56% yield) as a clear, colorless, and volatile oil.  
 Preparation of benzyl ester 226: In a glovebox, a 20-mL scintillation vial 
equipped with a magnetic stir bar was charged with La(Oi-Pr)3 (13 mg, 0.042 mmol), 
then sealed with a septum cap, removed from the glovebox, and placed under a positive 
pressure of N2. A solution of β-lactone 225 (117 mg, 0.835 mmol) and benzyl alcohol 
(433 µL, 4.18 mmol) in 4.2 mL of THF was then added via syringe, and the resulting 
mixture was stirred vigorously for 1.5 h. The reaction mixture was then diluted with sat. 
aq. NH4Cl and extracted with Et2O (3x). The combined organic layers were dried over 
MgSO4, filtered, and concentrated, and the resulting crude oil was purified via flash 
chromatography (gradient elution, 12:1→6:1 hexanes–EtOAc) to afford benzyl ester 226 
(139 mg, 67% yield) as a clear, colorless oil. [α]
! 
D
25.0 = –14.1° (c = 1.33, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.40 – 7.31 (m, 5H), 5.17 (d, J = 12.3 Hz, 1H), 5.13 (d, J = 12.3 Hz, 
1H), 5.12 (dddd, J = 1.3, 1.3, 1.3, 1.3 Hz, 1H), 4.95 (dddd, J = 1.5, 1.5, 1.5, 1.5 Hz, 1H), 
4.48 (d, J = 3.6 Hz, 1H), 2.73 (qd, J = 7.2, 4.0 Hz, 1H), 2.43 (s, 1H), 2.07 – 1.90 (m, 2H), 
1.15 (d, J = 7.1 Hz, 3H), 1.05 (t, J = 7.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 175.6, 
149.6, 135.7, 128.6, 128.3, 128.2, 109.7, 74.1, 66.5, 42.5, 25.0, 12.1, 10.3; IR (NaCl/thin 
film): 3488, 3090, 3066, 3034, 2967, 2939, 2880, 1734, 1648, 1498, 1456, 1382, 1340, 
1257, 1213, 1174, 1123, 1081, 1063, 1028, 991, 955, 904, 752 cm–1; HRMS (ESI) calc’d 
for C15H21O3 [M+H]+ 249.1485, found 249.1489. (82% ee, as determined by conversion 
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to the Mosher ester using (S)-(+)-α-methoxy-α-trifluoromethylphenylacetyl chloride 
followed by NMR analysis). The opposite enantiomer (ent-226) was prepared via an 
analogous sequence using TMSq (213) as the cyclocondensation catalyst. [α]
! 
D
25.0  =   
+14.6 ° (c = 1.38, CHCl3). 
Diastereoselective preparation of benzyl ester 219 
 
 In a glovebox under a N2 atmosphere, a stainless steel autoclave lined with a glass 
insert and equipped with a magnetic stir bar was charged with a solution of allylic alcohol 
226 (66.7 mg, 0.269 mmol) and [Rh(dppb)(cod)]BF4 (4.9 mg, 6.76 µmol) in 9.7 mL 
CH2Cl2. The apparatus was then sealed, removed from the glovebox, and connected to a 
high-pressure hydrogen inlet. The vessel was pressurized to 200 psi with H2, then 
carefully vented, and this process was repeated once more before pressurizing to a final 
H2 pressure of 640 psi. The reaction was allowed to proceed with stirring behind a blast 
shield for 22 h, at which time it was carefully vented, and the reaction mixture was 
filtered through a plug of SiO2, eluting with 1:1 hexanes–EtOAc. Purification of the 
resulting crude mixture (9:1 dr) via flash chromatography (gradient elution, 0→15% 




25.0 = –4.38 ° (c = 1.30, CHCl3). Ent-219 : [α]
! 
D
25.0 = +4.20° (c = 0.997, CHCl3). 
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(91% yield over 2 steps)
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 A solution of benzyl ester 219 (51.6 mg, 0.206 mmol) in 4.1 mL of CH2Cl2 was 
cooled to 0 °C with stirring under a N2 atmosphere. 2,6-lutidine (72 µL, 0.62 mmol) was 
then added followed by TBSOTf (71 µL, 0.31 mmol). After 2 h, the reaction mixture was 
quenched with a small amount of MeOH, diluted with sat. aq. NaHCO3, and extracted 
with CH2Cl2 (3x). The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo. The resulting crude intermediate was then dissolved in 4.1 mL 
EtOAc and Pd/C (10 wt % Pd, 28.4 mg) was added. The resulting suspension was sealed 
with a septum cap, and the headspace purged with N2. After 5 min, the headspace was 
purged with H2 (for 5 min), and then left under a balloon of H2 for 1 h. The headspace 
was once more purged with N2, and the reaction mixture was filtered through celite, 
rinsing with excess EtOAc, and concentrated to afford carboxylic acid 227 (51.6 mg, 
91% yield) as a clear, colorless oil. [α]
! 
D
25.0 = +4.31 ° (c = 1.18, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 11.48 (s, 1H), 3.92 (dd, J = 4.9, 4.9 Hz, 1H), 2.63 (qd, J = 7.0, 4.7 Hz, 
1H), 1.58 – 1.46 (m, 2H), 1.15 (d, J = 7.0 Hz, 3H), 1.14 – 1.02 (m, 1H), 0.92 – 0.86 (m, 
15H), 0.07 (s, 3H), 0.03 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 181.8, 76.7, 42.6, 40.1, 
26.0, 24.9, 18.3, 15.3, 12.0, 11.9, -4.3, -4.3; IR (NaCl/thin film): 2959, 2930, 2883, 2858, 
1708, 1472, 1463, 1412, 1383, 1361, 1283, 1252, 1117, 1091, 1059, 1020, 1005, 938, 
894, 836, 810, 774 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C14H29O3Si [M–H]– 
273.1891, found 273.1893. Ent-227: [α]
! 
D
25.0 = –5.78 ° (c = 0.960, CHCl3). 
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 In a 1-dram vial, carboxylic acid 227 (52.4 mg, 0.191 mmol) was dissolved in a 
stock solution of DIPEA (43.2 µL, 0.248 mmol) in CH2Cl2 (0.48 mL), solid DMAP (117 
mg, 0.955 mmol) was added, and the mixture was swirled until homogeneous. A stock 
solution of Yamaguchi’s reagent (35.8 µL, 0.229 mmol) in CH2Cl2 (0.48 mL) was then 
added, and the resulting mixture was swirled until homogeneous and allowed to sit. After 
10 min, the resulting acylating solution was added to a 1-dram vial containing a magnetic 
stir bar and solid diol 197 (18.5 mg, 0.0382 mmol). The resulting solution was capped 
and stirred for 20 h. The reaction mixture was then diluted with sat. aq. NaHCO3 and 
extracted with CH2Cl2 (3x). The combined organic layers were dried over Na2SO4, then 
filtered through SiO2, eluting with 3:1 hexanes–EtOAc. The resulting crude material was 
purified via flash chromatography (gradient elution, 8:1→4:1 hexanes–EtOAc) to afford 
dicarboxylate 228 (22.0 mg, 58% yield) as a white, amorphous solid. [α]
! 
D
25.0 = –306 ° (c = 
1.10, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.56 (dd, J = 2.1, 2.1 Hz, 2H), 6.26 (dd, J = 
8.2, 2.3 Hz, 2H), 5.29 (dddd, J = 8.5, 1.8, 1.8, 1.8 Hz, 2H), 5.19 (ddd, J = 8.5, 2.2, 2.2 
Hz, 2H), 4.60 (dd, J = 8.2, 2.0 Hz, 2H), 4.12 (dd, J = 4.5, 4.5 Hz, 2H), 3.36 (ddd, J = 
16.5, 2.2, 2.2 Hz, 2H), 3.06 (d, J = 16.3 Hz, 2H), 2.70 (qd, J = 7.2, 4.5 Hz, 2H), 1.56 – 
1.45 (m, 4H), 1.30 (d, J = 7.2 Hz, 6H), 1.17 – 1.07 (m, 2H), 0.97 – 0.80 (m, 30H), 0.10 
(s, 6H), 0.06 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 175.0, 165.3, 139.6, 138.6, 108.2, 
106.1, 75.6, 74.7, 70.9, 60.8, 42.8, 41.7, 40.6, 26.1, 25.0, 18.4, 15.7, 12.7, 12.1, -3.9, -4.3; 
IR (NaCl/thin film): 3369, 2957, 2928, 2855, 1731, 1698, 1462, 1366, 1343, 1302, 1276, 
1250, 1235, 1213, 1185, 1136, 1117, 1093, 1055, 971, 938, 895, 863, 836, 815, 774, 737, 
721 cm–1; HRMS (ESI) calc’d for C32H43N2O7S4Si [M–C14H29O3Si]+ 723.1717, found 
723.1717 (detected fragment has undergone loss of one of the carboxylate side chains). 
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Preparation of SCH64877 (44) 
 
 A 1-dram vial equipped with a magnetic stir bar was charged with bis(tert-
butyldimethylsilylether) 228 (22.0 mg, 0.0221 mmol), followed by MeCN (2 mL) and 
H2SiF6 (20-25 wt % aq. solution, 100 µL). The resulting suspension was stirred 
vigorously (with occasional shaking to ensure exposure of material to the reaction 
medium) for 24 h, then quenched with sat. aq. NaHCO3, and extracted with EtOAc (5x). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The material was then purified via preparative HPLC (reverse phase, gradient 
elution, 60→95% MeCN in H2O) to afford SCH64877 (44, 9.2 mg, 54% yield) as a 
white, amorphous solid. [α]
! 
D
25.0 = –411 ° (c = 0.46, CHCl3); 1H NMR (500 MHz, CDCl3) 
δ 6.58 (dd, J = 1.8, 1.8 Hz, 2H), 6.28 (dd, J = 8.4, 1.9 Hz, 2H), 5.30 (s, 4H), 4.59 (dd, J = 
8.3, 1.2 Hz, 2H), 3.81 (ddd, J = 9.5, 2.1, 2.1 Hz, 2H), 3.37 (ddd, J = 16.4, 2.5, 1.2 Hz, 
2H), 3.11 (d, J = 16.7 Hz, 2H), 3.06 (d, J = 3.4 Hz, 2H), 2.79 (qd, J = 7.2, 1.8 Hz, 2H), 
1.84 (dqd, J = 13.5, 7.6, 3.1 Hz, 2H), 1.56 – 1.47 (m, 2H), 1.27 (d, J = 7.3 Hz, 6H), 1.25 
– 1.16 (m, 2H), 0.92 (t, J = 7.5 Hz, 6H), 0.85 (d, J = 6.8 Hz, 6H); 13C NMR (126 MHz, 
CDCl3) δ 175.8, 165.9, 139.9, 138.9, 108.0, 105.8, 75.4, 73.9, 70.9, 60.9, 41.9, 41.5, 36.7, 
25.3, 14.9, 10.8, 9.1; IR (NaCl/thin film): 3529, 2962, 2929, 2874, 1719, 1693, 1457, 
1370, 1343, 1301, 1279, 1243, 1183, 1136, 1052, 972, 739, 722 cm–1; HRMS 
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Preparation of bis(tert-butyldimethylsilyl) 2’,3’,4’-epi-SCH64877 (253) 
 
 Following an analogous procedure to that for the conversion of 197 to 228, 
coupling of diol 197 (9.27 mg, 0.0192 mmol) and carboxylic acid ent-227 (26.3 mg, 




25.0 = –336 ° (c = 0.655, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.57 (ddd, J = 
2.5, 2.5, 1.3 Hz, 2H), 6.26 (dd, J = 8.3, 2.2 Hz, 2H), 5.31 – 5.26 (m, 2H), 5.22 (ddd, J = 
8.4, 2.1, 2.1 Hz, 2H), 4.60 (dd, J = 8.2, 1.9 Hz, 2H), 3.96 (dd, J = 6.0, 3.9 Hz, 2H), 3.35 
(ddd, J = 16.5, 2.2, 2.2 Hz, 2H), 3.05 (ddd, J = 16.4, 1.2, 1.2 Hz, 2H), 2.75 (dd, J = 7.2, 
6.0 Hz, 2H), 1.63 – 1.53 (m, 2H), 1.53 – 1.44 (m, 2H), 1.26 (d, J = 7.0 Hz, 6H), 1.18 – 
1.07 (m, 2H), 0.95 (d, J = 6.8 Hz, 6H), 0.91 (t, J = 7.3 Hz, 6H), 0.90 (s, 18H), 0.08 (s, 
12H); 13C NMR (126 MHz, CDCl3) δ 175.2, 165.4, 139.7, 138.7, 108.3, 105.9, 76.5, 
75.5, 70.7, 61.0, 42.7, 41.7, 40.8, 26.1, 24.5, 18.4, 15.9, 13.8, 12.3, -3.8, -3.9; IR 
(NaCl/thin film): 3364, 2957, 2929, 2881, 2856, 1721, 1697, 1463, 1372, 1348, 1305, 
1278, 1235, 1212, 1186, 1138, 1109, 1061, 1005, 973, 866, 835, 815, 775, 738, 718 cm–1; 
HRMS (Multimode-ESI/APCI) calc’d for C32H43N2O7S4Si [M–C14H29O3Si]+ 723.1717, 
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Preparation of 2’,3’,4’-epi-SCH64877 (229) 
 
Following an analogous procedure to that for the conversion of 228 to 44, 
deprotection of bis(tert-butyldimethylsilyl) ether 253 (13.1 mg, 0.0131 mmol) afforded 
2’,3’,4’-epi-SCH64877 (229, 7.4 mg, 73% yield) as a pale yellow, amorphous solid. [α]
! 
D
25.0 = –357 ° (c = 0.37, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.59 (ddd, J = 2.5, 2.5, 0.9 
Hz, 2H), 6.27 (dd, J = 8.3, 2.3 Hz, 2H), 5.32 (dddd, J = 8.5, 2.8, 1.7, 1.7 Hz, 2H), 5.24 
(ddd, J = 8.5, 2.1, 2.1 Hz, 2H), 4.61 (dd, J = 8.2, 1.9 Hz, 2H), 3.84 (d, J = 8.8 Hz, 2H), 
3.37 (ddd, J = 16.5, 2.2, 2.2 Hz, 2H), 3.08 (ddd, J = 16.6, 1.2, 1.2 Hz, 2H), 2.77 (qd, J = 
7.2, 2.3 Hz, 2H), 2.73 (br s, 2H), 1.82 (dqd, J = 13.4, 7.5, 3.2 Hz, 2H), 1.55 – 1.46 (m, 
2H), 1.27 (d, J = 7.2 Hz, 6H), 1.29 – 1.16 (m, 2H), 0.93 (t, J = 7.4 Hz, 6H), 0.86 (d, J = 
6.8 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 175.7, 165.8, 139.8, 138.9, 108.0, 105.9, 
75.5, 74.0, 71.0, 60.9, 42.1, 41.5, 37.1, 25.2, 15.1, 11.0, 9.5; IR (NaCl/thin film): 3503, 
2962, 2929, 2874, 1726, 1695, 1457, 1369, 1344, 1301, 1279, 1184, 1135, 971, 738, 723 
cm–1; HRMS (Multimode-ESI/APCI) calc’d for C34H44ClN2O10S4  [M+Cl]– 803.1573, 
found 803.1563. 








































































    DMAP, CH2Cl2
2. H2SiF6, MeCN
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 To a solution of diol 197 (8.74 mg, 0.0181 mmol) and DMAP (33.2 mg, 0.272 
mmol) in 0.9 mL CH2Cl2 was added 0.9 mL (~0.181 mmol) of a stock solution of acid 
chloride 230 (0.320 mmol in 1.5 mL CH2Cl2). The resulting solution was stirred for 40 
min, then diluted with sat. aq. NaHCO3 and extracted with CH2Cl2 (3x). Each organic 
layer was individually passed through a plug of SiO2, which was then flushed with excess 
1:1 hexanes–EtOAc, and the resulting filtrate concentrated in vacuo. Purification via 
flash chromatography (gradient elution, 4:1→2:1 hexanes–EtOAc) afforded 
dicarboxylate 254 (10.4 mg, 59% yield) as a white, amorphous solid. 




25.0 = –307 ° (c = 0.520, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.67 – 7.62 (m, 4H), 7.39 – 7.34 (m, 4H), 7.32 
– 7.28 (m, 2H), 6.55 (dd, J = 1.8, 1.8 Hz, 2H), 6.08 (dd, J 
= 8.2, 1.8 Hz, 2H), 5.34 (s, 2H), 5.27 – 5.20 (m, 4H), 4.16 (dd, J = 8.2, 1.4 Hz, 2H), 3.38 
(ddd, J = 16.3, 2.5, 1.4 Hz, 2H), 3.13 (ddd, J = 16.3, 1.1, 1.1 Hz, 2H), 0.93 (s, 18H), 0.15 
(s, 6H), 0.02 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 171.0, 165.5, 139.7, 139.0, 138.7, 
128.2, 128.0, 127.0, 108.0, 105.5, 75.7, 74.1, 71.2, 60.6, 41.7, 25.8, 18.4, -4.7, -4.7; IR 
(NaCl/thin film): 3369, 3066, 3033, 2952, 2927, 2855, 1752, 1696, 1659, 1472, 1364, 
1341, 1301, 1252, 1174, 1134, 1073, 1006, 971, 907, 865, 837, 779, 729 cm–1; HRMS 
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Bis[α-(tert-butyldimethylsiloxy)acetate] 255 
Following the procedure described above for the 
conversion of 197 to 254, coupling of diol 197 (8.74 mg, 
0.0181 mmol) and acid chloride 231 (0.181 mmol) 
afforded dicarboxylate 255 (10.0 mg, 67% yield). [α]
! 
D
25.0 = –262 ° (c = 0.500, CHCl3); 1H 
NMR (500 MHz, CDCl3) δ 6.58 (ddd, J = 2.5, 2.5, 0.9 Hz, 2H), 6.27 (dd, J = 8.2, 2.2 Hz, 
2H), 5.29 – 5.26 (m, 2H), 5.24 (ddd, J = 8.4, 2.0, 2.0 Hz, 2H), 4.69 (dd, J = 8.2, 1.8 Hz, 
2H), 4.40 (d, J = 17.4 Hz, 2H), 4.35 (d, J = 17.4 Hz, 2H), 3.34 (ddd, J = 16.4, 2.2, 2.2 Hz, 
2H), 3.06 (ddd, J = 16.3, 1.1, 1.1 Hz, 2H), 0.93 (s, 18H), 0.14 (s, 6H), 0.12 (s, 6H); 13C 
NMR (126 MHz, CDCl3) δ 171.0, 165.7, 139.8, 138.8, 107.8, 105.7, 75.7, 71.2, 62.0, 
60.8, 41.6, 25.8, 18.5, -5.2, -5.3; IR (NaCl/thin film): 3583, 2952, 2928, 2855, 1762, 
1693, 1472, 1437, 1363, 1342, 1302, 1253, 1185, 1134, 1006, 838, 781 cm–1; HRMS 
(ESI) calc’d for C34H48ClN2O10S4Si2 [M+Cl]– 863.1424, found 863.1452. 
Bis[β-(tert-butyldimethylsiloxy)propionate] 256 
Following the procedure described above for the 
conversion of 197 to 254, coupling of diol 197 (8.74 
mg, 0.0181 mmol) and acid chloride 232 (0.181 mmol) 
afforded dicarboxylate 256 (9.0 mg, 58% yield). [α]
! 
D
25.0 = –343 ° (c = 0.450, CHCl3); 1H 
NMR (500 MHz, CDCl3) δ 6.57 (ddd, J = 2.5, 2.5, 0.9 Hz, 2H), 6.25 (dd, J = 8.2, 2.3 Hz, 
2H), 5.29 (dddd, J = 8.5, 2.9, 1.7, 1.7 Hz, 2H), 5.22 (ddd, J = 8.4, 2.1, 2.1 Hz, 2H), 4.68 
(dd, J = 8.0, 1.8 Hz, 2H), 3.97 (apt qt, J = 10.2, 6.6 Hz, 4H), 3.35 (ddd, J = 16.4, 2.2, 2.2 
Hz, 2H), 3.05 (ddd, J = 16.4, 1.2, 1.2 Hz, 2H), 2.72 – 2.59 (m, 4H), 0.89 (s, 18H), 0.08 (s, 
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106.1, 75.6, 70.9, 60.8, 58.7, 41.6, 38.4, 25.9, 18.3, -5.3, -5.3; IR (NaCl/thin film): 3583, 
3369, 2952, 2927, 2854, 1734, 1696, 1473, 1364, 1343, 1302, 1255, 1181, 1137, 1099, 
1064, 1006, 971, 939, 836, 812, 778, 723 cm–1; HRMS (ESI) calc’d for 
C36H52ClN2O10S4Si2 [M+Cl]– 891.1737, found 891.1745.  
Typical procedure for the preparation of bis(hydroxycarboxylates) 101, 233, and 
234 
 A 1-dram vial equipped with a magnetic stir bar was charged with bis(tert-
butyldimethylsilylether) 254 (10.4 mg, 0.0106 mmol), followed by MeCN (1 mL) and 
H2SiF6 (20-25 wt % aq. Solution, 50 µL). The resulting suspension was stirred vigorously 
(with occasional shaking to ensure exposure of material to the reaction medium) for 17 h, 
then quenched with sat. aq. NaHCO3, and extracted with EtOAc (3x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. The material 
was then purified via preparative TLC (2:1 PhMe–acetone) to afford emethallicin C (101, 
5.8 mg, 73% yield) as a pale yellow, amorphous solid. 




25.0 = –316 ° (c = 0.19, CHCl3); 1H NMR (500 MHz, 
(CD3)2CO) δ 7.68 – 7.65 (m, 4H), 7.41 – 7.37 (m, 4H), 
7.35 – 7.30 (m, 2H), 6.78 (ddd, J = 2.5, 2.5, 1.0 Hz, 2H), 
6.33 (dd, J = 8.2, 2.2 Hz, 2H), 5.36 (d, J = 4.8 Hz, 2H), 5.25 (dddd, J = 8.6, 2.8, 1.5, 1.5 
Hz, 2H), 5.20 (ddd, J = 8.5, 2.0, 2.0 Hz, 2H), 4.90 (d, J = 5.4 Hz, 2H), 4.41 (dd, J = 8.2, 
1.8 Hz, 2H), 3.57 (ddd, J = 16.4, 2.6, 1.7 Hz, 2H), 3.21 (ddd, J = 16.3, 1.2, 1.2 Hz, 2H); 
13C NMR (126 MHz, (CD3)2CO) δ 172.7, 167.0, 141.2, 140.2, 139.4, 129.1, 128.8, 127.9, 
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1683, 1373, 1344, 1235, 1185, 1137, 1090, 1069, 1015, 968, 861, 815, 722 cm–1; HRMS 
(Multimode-ESI/APCI) calc’d for C34H28ClN2O10S4 [M+Cl]– 787.0321, found 787.0298. 
Bis(α-hydroxyacetate) 233 
Following the procedure described above for the conversion 
of 254 to 101, deprotection of bis(tert-
butyldimethylsilylether) 255 (10.0 mg, 0.0121 mmol) 
afforded bis(hydroxyacetate) analog 233 (5.0 mg, 69% yield). [α]
! 
D
25.0 = –462 ° (c = 0.25, 
acetone); 1H NMR (500 MHz, (CD3)2CO) δ 6.78 (ddd, J = 2.5, 2.5, 0.9 Hz, 2H), 6.42 (dd, 
J = 8.2, 2.2 Hz, 2H), 5.23 (dddd, J = 8.5, 2.6, 1.5, 1.5 Hz, 2H), 5.20 (ddd, J = 8.5, 2.0, 2.0 
Hz, 2H), 4.76 (dd, J = 8.2, 1.7 Hz, 2H), 4.21 (d, J = 6.0 Hz, 4H), 4.09 (t, J = 6.5 Hz, 2H), 
3.51 (ddd, J = 16.4, 2.6, 1.7 Hz, 2H), 3.13 (ddd, J = 16.3, 1.2, 1.2 Hz, 2H); 13C NMR 
(126 MHz, (CD3)2CO) δ 172.6, 167.0, 140.9, 139.4, 110.5, 106.5, 77.4, 72.0, 62.1, 61.9, 
41.8; IR (NaCl/thin film): 3306, 2916, 2849, 1743, 1689, 1374, 1344, 1303, 1235, 1186, 
1137, 1095, 816, 723 cm–1; HRMS (Multimode-ESI/APCI) calc’d for C22H20ClN2O10S4 
[M+Cl]– 634.9695, found 634.9686.  
Bis(β-hydroxypropionate) 234 
Following the procedure described above for the 
conversion of 254 to 101, deprotection of bis(tert-
butyldimethylsilylether) 256 (9.0 mg, 0.0105 mmol) 
afforded bis(hydroxypropionate) analog 234 (4.8 mg, 73% yield). [α]
! 
D
25.0 = –404 ° (c = 
0.24, acetone); 1H NMR (500 MHz, (CD3)2CO) δ 6.77 (ddd, J = 2.5, 2.5, 0.9 Hz, 2H), 
6.39 (dd, J = 8.2, 2.3 Hz, 2H), 5.28 – 5.23 (m, 2H), 5.19 (ddd, J = 8.5, 2.1, 2.1 Hz, 2H), 
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= 16.3, 2.1, 2.1 Hz, 2H), 3.12 (ddd, J = 16.4, 1.2, 1.2 Hz, 2H), 2.61 (t, J = 6.1 Hz, 4H); 
13C NMR (126 MHz, (CD3)2CO) δ 171.9, 166.9, 140.7, 139.3, 110.8, 107.1, 77.3, 71.7, 
62.0, 58.3, 41.8, 39.4; IR (NaCl/thin film): 3368, 2916, 2848, 1726, 1686, 1560, 1369, 
1302, 1235, 1186, 1136, 1043, 815, 723 cm–1; HRMS (Multimode-ESI/APCI) calc’d for 
C24H24ClN2O10S4 [M+Cl]– 663.0008, found 662.9992. 
Preparation of (trimethylsilyl)ethyl ester 251 
 
 To a solution of iso-vanillic acid (257, 500 mg, 2.97 mmol) and DMAP (72.6 mg, 
0.594 mmol) in 3.0 mL CH2Cl2 were added Et3N (414 µL, 2.97 mmol) and Boc2O (1.57 
mL, 6.83 mmol). NOTE: the resulting mixture effervesced for ~10 min. After 2 h, 2-
(trimethylsilyl)ethanol (1.28 mL, 8.91 mmol) was added (resulting in slight 
effervescence). After 45 min, EDC•HCl (569 mg, 2.97 mmol) was added. After 6 h, 
piperidine (22 mL, 223 mmol) was added. After 1.5 h, the reaction mixture was diluted 
with EtOAc (100 mL), then washed with 1 M HCl (2x100 mL), H2O (100 mL), and brine 
(100 mL). The organic layer was then dried over Na2SO4, filtered, and concentrated in 
vacuo (under high vacuum until most of the piperidine had evaporated). Purification via 
flash chromatography (gradient elution, 8:1→4:1 hexanes–EtOAc) afforded 
(trimethylsilyl)ethyl ester 251 (756 mg, 95% yield) as a white, amorphous solid with a 
melting point close to ambient temperature. 1H NMR (500 MHz, CDCl3) δ 7.62 – 7.58 
(m, 2H), 6.86 (d, J = 8.3 Hz, 1H), 5.76 (s, 1H), 4.40 – 4.35 (m, 2H), 3.92 (s, 3H), 1.13 – 
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123.81, 122.60, 115.50, 109.75, 62.98, 55.95, 17.34, -1.47; IR (NaCl/thin film): 3414, 
2953, 2898, 2844, 1710, 1616, 1591, 1512, 1457, 1442, 1379, 1352, 1283, 1251, 1220, 
1182, 1126, 1093, 1026, 965, 952, 860, 838, 763 cm–1; HRMS (ESI) calc’d for 
C11H17O4Si [M–C2H4+H]+ 241.0891, found 241.0896. 
Preparation of λ3-iodane 250 
 
 A 1-dram vial equipped with a magnetic stir bar was charged with aryl iodide 249 
(50 mg, 0.16 mmol), m-CPBA (85 wt %, 32 mg, 0.16 mmol), p-TsOH•H2O (30 mg, 0.16 
mmol), and 0.62 mL of CH2Cl2/TFE (1:1). To the resulting solution was added 1,3-
dimethoxybenzene (248, 21 µL, 0.16 mmol) with stirring. After 3 h, the reaction mixture 
was concentrated in vacuo to give a dark brown residue. The residue was dissolved in 
acetone (~1 mL), then added dropwise via pipet to a vigorously stirring volume of Et2O 
(~30 mL). The resulting precipitate was filtered off to afford λ3-iodane 250 (28 mg, 29% 
yield) as a pale purple solid. 1H NMR (500 MHz, CDCl3) δ 7.87 – 7.83 (m, 1H), 7.63 – 
7.57 (m, 3H), 7.55 (d, J = 2.0 Hz, 1H), 7.45 (d, J = 16.0 Hz, 1H), 7.05 (d, J = 7.6 Hz, 
2H), 6.99 (d, J = 8.6 Hz, 1H), 6.54 – 6.50 (m, 2H), 6.22 (d, J = 16.0 Hz, 1H), 3.95 (s, 
3H), 3.85 (s, 3H), 3.83 (s, 3H), 3.78 (s, 3H), 2.31 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
166.9, 165.4, 158.6, 157.6, 142.7, 141.9, 139.3, 139.0, 133.7, 132.7, 130.2, 128.4, 126.0, 
117.9, 112.3, 108.7, 104.6, 99.9, 91.4, 57.2, 56.9, 55.9, 51.8, 21.3; IR (NaCl/thin film): 
3459, 2946, 2847, 1714, 1632, 1595, 1580, 1493, 1459, 1437, 1399, 1319, 1284, 1264, 
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[M–C7H7O3S]+ 455.0350, found 455.0371 (detected fragment does not include the para-
toluenesulfonate ligand). 
Preparation of diaryl ether 252 
 
 To a solution of phenol 251 (5.3 mg, 0.020 mmol) in 0.25 mL PhMe was added 
KOt-Bu (1.0 M in THF, 22 µL, 0.022 mmol), and the resulting mixture was stirred for 15 
min. Solid iodane 250 (15 mg, 0.024 mmol) was then added, and the mixture was heated 
to 40 °C. After 3 h, the reaction mixture was diluted with H2O and extracted with CH2Cl2 
(3x). The combined organic layers were dried over Na2SO4, filtered, and concentrated, 
and the resulting crude material was purified by flash chromatography (gradient elution, 
8:1→4:1 hexanes–EtOAc) to afford biaryl ether 252 (6.5 mg, 71% yield) as a white, 
amorphous solid. 1H NMR (500 MHz, CDCl3) δ 7.84 (dd, J = 8.5, 2.1 Hz, 1H), 7.54 (d, J 
= 15.9 Hz, 1H), 7.49 (d, J = 2.0 Hz, 1H), 7.26 (dd, J = 8.5, 2.0 Hz, 1H), 7.01 (d, J = 8.6 
Hz, 1H), 6.98 (s, 1H), 6.98 (d, J = 10.0 Hz, 1H), 6.17 (d, J = 15.9 Hz, 1H), 4.37 – 4.32 
(m, 2H), 3.91 (s, 3H), 3.88 (s, 3H), 3.76 (s, 3H), 1.09 – 1.03 (m, 2H), 0.03 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ 167.5, 166.0, 154.2, 152.3, 145.7, 145.0, 144.1, 127.5, 126.5, 
125.2, 123.5, 119.8, 117.5, 115.9, 112.4, 111.5, 63.1, 56.1, 56.0, 51.6, 17.3, -1.5; IR 
(NaCl/thin film): 3400, 2952, 2840, 1712, 1636, 1607, 1573, 1511, 1430, 1378, 1266, 
1219, 1175, 1124, 1094, 1025, 980, 946, 859, 838, 765 cm–1; HRMS (ESI) calc’d for 
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has undergone loss of trimethylsilyl cation, ethylene, and methoxide anion and gain of 
H+). 
Table 3.2. Comparison of spectroscopic data for natural and synthetic SCH64877 
(44) 
 
1H NMR Data (CDCl3, data for synthetic material referenced to CHCl3 at 7.26 ppm) 
 
Reported chemical shift (δ)2 Synthetic Δ  
3.28a (dd, J = 15, 1 Hz, 2H) 3.37 (ddd, J = 16.4, 2.5, 1.2 Hz, 2H) +0.09 
3.11 (d, J = 15 Hz, 2H) 3.11 (d, J = 16.7 Hz, 2H) 0 
5.30 (s, 2H) 5.30 (s, 2H) 0 
5.30 (s, 2H) 5.30 (s, 2H) 0 
4.6 (d, J = 10 Hz, 2H) 4.59 (dd, J = 8.3, 1.2 Hz, 2H) –0.01 
6.28 (d, J = 8 Hz, 2H) 6.28 (dd, J = 8.4, 1.9 Hz, 2H) 0 
6.60 (s, 2H)) 6.58 (dd, J = 1.8, 1.8 Hz, 2H) –0.02 
2.8 (dqb, J = 8, 2 Hz, 2H) 2.79 (qd, J = 7.2, 1.8 Hz, 2H) –0.01 
3.81 (dd, J = 10, 1 Hz, 2H) 3.81 (ddd, J = 9.5, 2.1, 2.1 Hz, 2H) 0 
1.5 (m, 2H) 1.56 – 1.47 (m, 2H) +0.02 
1.13-1.10c (m, 2H) 1.25 – 1.16 (m, 2H) +0.09 
1.85 (dq, J = 8, 2 Hz, 2H) 1.84 (dqd, J = 13.5, 7.6, 3.1 Hz, 2H) –0.01 
0.95 (t, J = 8 Hz, 6H) 0.92 (t, J = 7.5 Hz, 6H) –0.03 
1.28 (d, J = 8 Hz, 6H) 1.27 (d, J = 7.3 Hz, 6H) –0.01 
0.84 (d, J = 8 Hz, 6H) 0.85 (d, J = 6.8 Hz, 6H) +0.01 
a This is suspected to be a typographical error. b This is suspected to be a typographical error, based on the 
reported J value for the C(7’) methyl group. cThis is suspected to be a typographical error, based on the 
reported chemical shift for SCH64874 (42). 
 
13C NMR Data (CDCl3, data for synthetic material referenced to CDCl3 at 77.0 ppm) 
 
Reported chemical shift (δ)2 Synthetic Δ  
165.9 165.9 0 
75.5 75.4 –0.1 
41.5 41.5 0 
108.0 108.0 0 
61.0 60.9 –0.1 
70.9 70.9 0 
105.8 105.8 0 
139.9 139.9 0 
138.9 138.9 0 
175.8 175.8 0 
41.9 41.9 0 
73.9 73.9 0 
36.8 36.7 –0.1 
25.3 25.3 0 
10.9 10.8 –0.1 
9.1 9.1 0 
14.9 14.9 0 
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Table 3.3. Comparison of spectroscopic data for natural and synthetic emethallicin 
C (101) 
 
1H NMR Data (acetone-d6, data for synthetic material referenced to acetone-d5 at 2.05 
ppm) 
 
Reported chemical shift (δ)3 Synthetic 
3.212 (d, J = 16.4 Hz, 2H) 3.21 (ddd, J = 16.3, 1.2, 1.2 Hz, 2H) 
3.566 (ddd, J = 16.4, 2.5, 2.0 Hz, 2H) 3.57 (ddd, J = 16.4, 2.6, 1.7 Hz, 2H) 
4.409 (dd, J = 8.2, 1.7 Hz, 2H) 4.41 (dd, J = 8.2, 1.8 Hz, 2H) 
4.873 (d, J = 5.6 Hz, 2H) 4.90 (d, J = 5.4 Hz, 2H) 
5.202 (ddd, J = 8.5, 2.0, 2.0 Hz, 2H) 5.20 (ddd, J = 8.5, 2.0, 2.0 Hz, 2H) 
5.256 (ddd, J = 8.5, 2.2, 1.7 Hz, 2H) 5.25 (dddd, J = 8.6, 2.8, 1.5, 1.5 Hz, 2H) 
5.362 (d, J = 5.6 Hz, 2H) 5.36 (d, J = 4.8 Hz, 2H) 
6.332 (dd, J = 8.2, 2.2 Hz, 2H) 6.33 (dd, J = 8.2, 2.2 Hz, 2H) 
6.780 (dd, J = 2.5, 2.0 Hz, 2H) 6.78 (ddd, J = 2.5, 2.5, 1.0 Hz, 2H) 
7.325 (br t, J = 7.3 Hz, 2H) 7.35 – 7.30 (m, 2H) 
7.391 (br t, J = 7.3 Hz, 4H) 7.41 – 7.37 (m, 4H) 
7.667 (br d, J = 7.3 Hz, 4H) 7.68 – 7.65 (m, 4H) 
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Spectra Relevant to Chapter 3: 
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Further Investigation of Side Reactions† 
 
4.1 INTRODUCTION 
One of the goals of any total synthesis research program is the discovery and 
development of new chemical reactions. This can occur either via the design of a novel 
transformation with a particular structural target in mind, or via the serendipitous 
observation of unintended yet interesting reactivity. Our synthetic studies toward 
acetylaranotin (11) required the development of several key transformations, such as the 
chlorohydrin cycloisomerization/elimination sequence for constructing the 
dihydrooxepine ring (see Chapter 2).1 Furthermore, we observed several notable side 
reactions over the course of our efforts; in addition to the fluoride-promoted C–H 
oxidation mentioned in Chapter 2, we also observed a cascade cycloaddition process 
during our optimization of the enantioselective (1,3)-dipolar cycloaddition (1,3-DCA) 
                                                
† Part of this chapter was published as the following communication: Lim, A. D.; Codelli, 
J. A.; Reisman, S. E. Chem. Sci. 2013, 4, 650. The research discussed in this chapter was 
completed in collaboration with Andrew D. Lim, a graduate student in the Reisman Lab. 
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that initiates our synthetic route. Though these reactions were not productive with respect 
to our total synthesis efforts, our curiosity prompted the further investigation of their 
scope and mechanism. 
4.2 AN ENANTIOSELECTIVE CASCADE CYCLOADDITION 
PROCESS TO FORM HIGHLY SUBSTITUTED PYRROLIZIDINES 
 
During studies aimed at optimizing the (1,3)-dipolar cycloaddition reaction 
utilized to prepare pyrrolidine 153 for the synthesis of acetylaranotin, we observed that 
under sub-optimal conditions the reaction stalls and a significant amount of pyrrolizidine 
258 is isolated (Scheme 4.1). The structure of 258 was confirmed by single-crystal X-ray 
diffraction analysis of the corresponding TFA salt 260 (Scheme 4.2). We hypothesized 
that this product was being formed via a second (1,3)-dipolar cycloaddition, in which the 
initial pyrrolidine product 153 condenses with an equivalent of cinnamaldehyde or 
cinnamaldimine 152 to give ylide 259, which then undergoes further reaction with tert-
butyl acrylate to produce the final product (258).2,3  
Scheme 4.1. Observed formation of pyrrolizidine 258 during optimization of the 












CuI (10 mol %)
Brucin-OL (10 mol %)
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Scheme 4.2. Formation and X-ray crystal structure of TFA salt 260 
 
Given the presence of the pyrrolizidine ring system in a variety of bioactive 
natural products and pharmaceutical agents (see Figure 4.1),4 as well as the general lack 
of methods for the rapid enantioselective preparation of highly substituted pyrrolizidine 
derivatives,5 we sought to further develop this reaction, investigate its scope, and explore 
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Figure 4.1. Pyrrolizidine-containing natural products and pharmaceutical agents 
 
In our initial survey of conditions for the enantioselective (1,3)-dipolar 
cycloaddition reaction to produce pyrrolidine 153,6,7 we had identified the CuI/Brucin-OL 
catalyst system8 as optimal for the scalable preparation of 153. On the other hand, the 
operational simplicity of the AgOAc/(S)-QUINAP catalyst conditions9 prompted us to 
use this system for investigations of pyrrolizidine formation.10 Following preliminary 
experimentation, we were pleased to find that treatment of a mixture of cinnamaldehyde-
derived α-imino ester 152, AgOAc (3 mol %), QUINAP (3 mol %) and DIPEA (10 mol 
%) with tert-butyl acrylate  (141, 1.5 equiv) in THF at –45 °C for 24 h, followed by 
addition of cinnamaldehyde (1.0 equiv) and additional 141 (5.0 equiv) with warming to 
23 °C provided pyrrolizidine 258 in 74% yield and 90% ee (Scheme 4.3).11,12 Notably, 
warmer temperatures are required for the second (1,3)-DCA, which proceeds very slowly 
at –45 °C. It is important that imine 152 is consumed before the reagents are added for 
the second cycloaddition; if 152 remains, it reacts rapidly and less selectively with tert-
butyl acrylate upon warming to give 153, 13  which can lead to the isolation of 
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Scheme 4.3. Optimized conditions for preparation of pyrrolizidine 258 
 
With conditions in hand to prepare pyrrolizidine 258 in good yield and high ee, 
attention turned to evaluating the substrate scope of the reaction (Table 4.1). A variety of 
substituted aryl aldehyde-derived α-imino esters 268 furnished the corresponding 
pyrrolizidines 269 in good yields with high enantioselectivity. Substitution at the ortho-, 
meta-, and para-positions of the arene with both electron-donating and electron-
withdrawing substituents is well-tolerated. In particular, α-imino esters bearing electron-
withdrawing aryl substituents provide the pyrrolizidine products with uniformly high 
levels of enantioselectivity (Table 4.1, 269f–j, 269m–o). Notably, the α-imino ester 
derived from pyridine 3-carboxaldehyde is a suitable substrate, providing pyridyl-
substituted pyrrolizidine 269r in good yield and good ee (Entry 18). Alternatively, the 2-
pyridyl α-imino ester provided pyrrolizidine 269s in low yield and modest ee (Entry 19). 
It is possible that the proximal nitrogen results in an alternative binding mode between 
the azomethine ylide and the catalyst, decreasing the enantioselectivity during the first 
(1,3)-DCA.14 In addition, the pyrrolidine intermediate or the pyrrolizidine product (269s) 




AgOAc (3 mol%) 
(S)-QUINAP (3 mol%)
DIPEA (10 mol%)
THF, –45 ºC, 24 h;
then
cinnamaldehyde (1.0 equiv) 
141 (5.0 equiv) 
THF, 23 ºC, 24 h 258
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Table 4.1. Substrate scope for catalytic asymmetric synthesis of highly substituted 
pyrrolizidines: α-imino ester 
 
 
 In some cases, the pyrrolizidine products were obtained in lower ee using our 
standard reaction conditions (e.g. compounds 269c–e, 269q).15 It was determined that for 
these α-iminoesters, the first (1,3)-DCA proceeds slowly relative to the more electron-
poor substrates; we reasoned that the remaining imine reacts with lower 
enantioselectively upon warming, which ultimately results in the formation of the 
pyrrolizidine with reduced ee. We hypothesized that increasing the catalyst loading 
should ensure complete consumption of the α-imino ester prior to warming the reaction 
for the second (1,3)-DCA. This hypothesis proved to be true; using 6 mol % each of 
AgOAc and (S)-QUINAP, pyrrolizidines 269c–e and 269q were obtained in good yields 
and high ee (Table 4.1, Entries 3, 5, 11 and 17). Alternatively, the solubility of p-
AgOAc (3 mol%) 
(S)-QUINAP (3 mol%)
DIPEA (10 mol%)
THF, –45 ºC, 24 h;
then
cinnamaldehyde (1.0 equiv) 
141 (5.0 equiv) 






































































































a Isolated yield. b Determined by SFC using chiral stationary phase. c 6 mol % each AgOAc and (S)-QUINAP were employed.
d 6 mol % each AgOAc and (S)-QUINAP were employed at 0.1 M reaction concentration.
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methoxy and 2-naphthyl α-iminoesters 268k and 268p was poor under our standard 
conditions; for these substrates the best results were obtained by lowering the overall 
reaction concentration (to 0.1 M versus 0.3 M) and increasing the catalyst loading to 6 
mol %.  
  A variety of dipolarophiles can be used for the second (1,3)-DCA (Table 4.2). For 
example, use of E-1-nitro-2-phenylethylene as the second dipolarophile provides 
pyrrolizidine 270e in 89% yield and 90% ee. This compound contains six stereogenic 
centers and is isolated as a single diastereomer. Use of methyl methacrylate provides 
pyrrolizidine 270d, which contains an all-carbon quaternary center, in 91% yield and 
90% ee. 
Table 4.2. Substrate scope for catalytic asymmetric synthesis of highly substituted 
pyrrolizidines: second dipolarophile 
 
 
Interestingly, α,β-unsaturated aldehydes appear to be uniquely well suited for 





































92% yield, 90% ee




3:1 dr,b,c 90% ee
89% yield, 90% ee





AgOAc (3 mol%) 
(S)-QUINAP (3 mol%)
DIPEA (10 mol%)
THF, –45 ºC, 24 h;
then
cinnamaldehyde (1.0 equiv) 
dipolarophile (5.0 equiv) 
















a 10.0 equivs of dipolarophile were used. b For this reaction, crotonaldehyde was used instead of
cinnamaldehyde. c Refers to endo/exo selectivity of the second (1,3)-DCA reaction.
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to employ aryl aldehydes (e.g. benzaldehyde) or alkyl aldehydes (e.g. 2-
ethylbuytraldehyde) for the second (1,3)-DCA failed to provide the pyrrolizidine 
products in synthetically useful yields (see Experimental Section). We believe this unique 
reactivity of α,β-unsaturated aldehydes explains why standard catalytic, asymmetric 
(1,3)-DCAs are not plagued by unwanted pyrrolizidine formation, since α-imino esters 
derived from enals are rarely employed in methods development. 
Using benzaldehyde-derived α-imino ester 268a, the catalytic asymmetric (1,3)-
DCA cascade reaction has been conducted on gram-scale, providing pyrrolizidine ent-
269a16 in 89% yield and slightly diminished ee (87%).17 Importantly, this compound can 
be selectively modified to give several intermediates capable of further derivitazation 
(Scheme 4.4). For example, the more reactive and accessible methyl ester of ent-269a 
can be selectively saponified using LiOH or reduced using LiEt3BH to give carboxylic 
acid 271 or alcohol 272, respectively. Alternatively, the tert-butyl esters can be cleaved 
upon treatment with trifluoroacetic acid (TFA) to give dicarboxylic acid 273. Finally, the 
styrene of ent-269a can be ozonolytically cleaved and reduced in situ to provide amino 
alcohol 274 in 64% yield. Thus, each of the functional groups of ent-269a can be 
chemoselectively modified. 
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4.3 DIKETOPIPERAZINE OXIDATION AND STEREOCHEMISTRY 
During studies aimed at the preparation of diketopiperazine 194 for the synthesis 
of acetylaranotin (11), we observed the formation of tetraol 193 when dipeptide 192 was 
treated with TBAF•(t-BuOH)4 in MeCN at 70 °C under an air atmosphere (see Scheme 
4.5, also see Chapter 2).18 Furthermore, isolation of diketopiperazine 194 and resubjection 
to the above aerobic conditions provided the same oxidation product 193. Based on these 
results, we tentatively proposed the mechanistic hypothesis shown in Scheme 4.6. First, 
fluoride-promoted global desilylation of 192 provides deprotected dipeptide 195, which 
cyclizes to give the expected syn,syn,syn diketopiperazine 196. Subsequent epimerization 
to the anti,syn,anti configuration affords the observed diketopiperazine 194. Finally, 
stereoretentive aerobic oxidation of 194 then furnishes the tetraol 193. 
Scheme 4.5. Formation of dihydroxylated diketopiperazine 193 
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Such O2-mediated α-oxidations are typically carried out using very strong, ionic 
bases (e.g. KOt-Bu or NaHMDS),19,20,21 although a recent report from Buckley and 
coworkers supports the hypothesis that the fluoride ion may play some role in the 
oxidizing capability of our system. 22  Furthermore, the fact that no hydroperoxide 
intermediates or anti,anti,syn products are observed suggests that each oxygen atom on a 
single diketopiperazine ring may originate from a single molecule of O2, via a sequence 
involving initial intermolecular oxidation of the first C–H bond by O2 followed by 
intramolecular oxidation of the second C–H bond by the resulting peroxide radical. 
 In an effort to further elucidate the nature of this oxidation process and better-
understand its stereochemical outcome, control experiments were carried out using TBS-
protected syn,syn,syn diketopiperazine 190 (see Scheme 4.7). Diketopiperazine 190 could 
be epimerized with or without concomitant cleavage of the TBS ethers, by treatment with 
TBAF•(t-BuOH)4 in THF under an inert atmosphere at ambient temperature or Cs2CO3 in 
THF/MeOH at ambient temperature to furnish diketopiperazines 194 or 275, respectively. 
This suggests that for both the bis-TBS-protected and unprotected diketopiperazine, the 
thermodynamic preference is for the anti,syn,anti configuration. However, we were 
surprised to find that in the presence of ambient air atmosphere, diketopiperazine 190 
undergoes TBAF•(t-BuOH)4-promoted deprotection with concomitant stereoretentive C–
H oxidation to afford syn,syn,syn oxidation product 277! This suggests that the TBAF•(t-
BuOH)4-promoted oxidation is stereospecific, and unlikely to involve enol intermediates, 
given that no epimerization occurs prior to oxidation. Finally, it was observed that the 
unepimerized, unprotected diketopiperazine 276 could be obtained by subjection of 190 
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to HCO2H in THF/H2O, and future control experiments will seek to determine the 
stereochemical outcome of dihydroxylation or sulfenylation of this substrate.   
Scheme 4.7. Manipulation of diketopiperazine oxidation and stereochemistry 
 
 Taken together, the above observations suggest the mechanism for oxidation of 
diketopiperazine 194 could be as shown in Scheme 4.8. Intermolecular hydrogen radical 
abstraction from 194 occurs to afford radical species 278, which reacts with triplet O2 to 
provide peroxide radical 279. Subsequent intramolecular hydrogen radical abstraction 
affords diketopiperazine radical 280, which undergoes intramolecular SH2-type 
displacement to afford alkoxy radical 281. Final intermolecular hydrogen radical 
abstraction from another molecule of 194 or some propagating (or terminating) species 
R–H furnishes the oxidized product (193). Unfortunately, preliminary efforts aimed at 
applying these conditions to simpler diketopiperazines as a general method for C–H 








































































(92% yield) (77% yield)
194
(62% yield) (50% yield)
190 275
277276
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Scheme 4.8. Proposed mechanism for aerobic oxidation of diketopiperazine 194 
 
4.4 CONCLUDING REMARKS 
In conclusion, a catalytic asymmetric double (1,3)-dipolar cycloaddition reaction 
has been developed, as part of our efforts to further explore interesting side reactions 
observed during synthetic studies toward acetylaranotin (11). This reaction provides 
access to highly substituted, enantioenriched pyrrolidizines from inexpensive, 
commercially available starting materials. Depending on which of the second 
dipolarophiles are employed, pyrrolizidines containing as many as six stereogenic centers 
have been prepared with high levels of enantio- and diastereoselectivity. We expect that 
this reaction could be of use for the preparation of natural product analogues of new lead 
compounds for pharmaceutical studies. 
Likewise, a series of control experiments allowed us to probe the mechanism of 
the aerobic oxidation of diketopiperazine 194. Though we were unable to develop this 
transformation into a general reaction methodology, future studies of related complex 
diketopiperazines may allow for the identification of structural parameters required for 
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4.5 EXPERIMENTAL SECTION 
4.5.1 Materials and Methods 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 
acetonitrile (MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by 
passing through activated alumina columns. Triethylamine (Et3N) and N,N-
diisopropylethylamine (DIPEA) were distilled over calcium hydride prior to use. Unless 
otherwise stated, chemicals and reagents were used as received. All reactions were 
monitored by thin-layer chromatography using EMD/Merck silica gel 60 F254 pre-coated 
plates (0.25 mm) and were visualized by UV, p-anisaldehyde, or KMnO4 staining. Flash 
column chromatography was performed either as described by Still et al.23 using silica gel 
(particle size 0.032-0.063) purchased from Silicycle or using pre-packaged RediSep®Rf 
columns on a CombiFlash Rf system (Teledyne ISCO Inc.). Optical rotations were 
measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 nm. 1H 
and 13C NMR spectra were recorded on a Varian 400 MR (at 400 MHz and 101 MHz, 
respectively), a Varian Inova 500 (at 500 MHz and 126 MHz, respectively), or a Varian 
Inova 600 (at 600 MHz and 150 MHz, respectively), and are reported relative to internal 
CHCl3 (1H, δ = 7.26), MeCN-d2 (1H, δ = 1.94), or acetone-d5 (1H, δ = 2.05), and CDCl3 
(13C, δ = 77.0), CD3CN (13C, δ = 118.26), DMSO-d6 (13C, δ = 39.52). Data for 1H NMR 
spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant 
(Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR spectra were 
recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of 
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absorption (cm–1). HRMS were acquired using an Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI), or mixed (MM) ionization mode. Analytical SFC 
was performed with a Mettler SFC supercritical CO2 analytical chromatography system 
with Chiralcel AD-H, OD-H, AS-H, OB-H, and OJ-H columns (4.6 mm x 25 cm) with 
visualization at 254 nm. Analytical chiral HPLC was performed with an Agilent 1100 
Series HPLC utilizing a Chiralpak AD column (4.6 mm x 25 cm) obtained from Daicel 
Chemical Industries, Ltd. with visualization at 254 nm. Melting points were determined 
using a Büchi B-545 capillary melting point apparatus and the values reported are 
uncorrected. 
4.5.2 Preparative Procedures and Spectroscopic Data 
General procedure 1 for the synthesis of α-iminoesters 152, 268a-s 
 
 The α-iminoesters were prepared according to the procedure reported by 
Longmire et al.24 To a suspension of the glycine methyl (or ethyl) ester hydrochloride 
(1.1 equiv) and magnesium sulfate (2.0 equiv) in methylene chloride was added 
triethylamine (1.1 equiv). This solution was stirred at room temperature for 1 h before the 
aldehyde (1.0 equiv) was added. After stirring at room temperature overnight, magnesium 
sulfate was filtered off and washed with methylene chloride. The filtrate was washed with 
distilled water (5x) and then with brine, dried over magnesium sulfate, filtered, and 
concentrated to afford the α-iminoesters. The crude iminoesters could be used directly for 
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1.0–4.0 g of aldehydes at 0.5 M concentration. NOTE: Formation of α-iminoester 152 
was allowed to proceed for 1.5 h rather than overnight in order to avoid decomposition. 
General procedure 2 for the synthesis of pyrrolizidines 269a-s 
 
Silver(I) acetate (1.0 equiv) and (S)-QUINAP (1.0 equiv) were added to a vial. 
Tetrahydrofuran was then introduced, and this solution was stirred at room temperature 
for 1 h to make a stock solution of 0.009 M silver(I)/(S)-QUINAP catalyst. Silver(I) 
acetate/(S)-QUINAP catalyst solution (0.03 equiv) followed by the dipolarophile (t-Bu 
Acrylate; 1.5 equiv) and Hünig’s base (0.1 equiv) were added to the α-iminoester (1.0 
equiv) at -45 oC in the glovebox. The final concentration of the α-iminoester was 0.3 M. 
After stirring for 24 hours, the reaction was allowed to warm to room temperature and 
taken out of the glovebox. Dipolarophile (5 equiv) and then cinnamaldehyde (1 equiv) 
were added. After stirring for 24 hours, the reaction was quenched with a tetrahydrofuran 
solution of acetic acid (1.1 equiv) and concentrated directly. The reactions were 
performed on a scale of 20–80 mg of the iminoester. 
Gram-scale procedure for the preparation of pyrrolizidine ent-269a 
 
18.8 mg silver (I) acetate (0.113 mmol) and 49.4 mg (R)-QUINAP (0.112 mmol) 
were added to a vial. Tetrahydrofuran (12.5 mL) was then introduced, and this solution 
AgOAc (3 mol%) 
(S)-QUINAP (3 mol%)
DIPEA (10 mol%)
THF, –45 ºC, 24 h;
then
cinnamaldehyde (1.0 equiv) 
141 (5.0 equiv) 
















AgOAc (3 mol%) 
(R)-QUINAP (3 mol%)
DIPEA (10 mol%)
THF, –45 ºC, 24 h;
Ph
then
cinnamaldehyde (1.0 equiv) 
141 (5.0 equiv) 
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was stirred at room temperature for 1 h to make a stock solution of 0.009 M silver(I)/(R)-
QUINAP catalyst. Silver(I) acetate/(R)-QUINAP catalyst solution (10 mL, 0.09 mmol) 
followed by the 0.66 ml t-butyl acrylate (4.5 mmol) and 52 µl Hünig’s base (0.30 mmol) 
were added to 532 mg of α-iminoester 268a (3.00 mmol) at -45 oC. The final 
concentration of the α-iminoester was 0.3 M. After stirring for 24 hours, the reaction was 
allowed to warm to room temperature. 2.2 ml t-butyl acrylate (15 mmol) and then 380 µl 
cinnamaldehyde (3.0 mmol) were added. After stirring for 24 hours, the reaction was 
quenched with 2 mL of a tetrahydrofuran solution of acetic acid (10:1 v/v) and 
concentrated directly. The crude reaction mixture was purified by silica gel column 
chromatography (5→20% ethyl acetate in hexanes) to obtain 1.46 g pyrrolizidine 269a in 
89% yield and 87% ee. 
(2R,3R,5R,6R)-2,6-di-tert-butyl-7a-ethyl-3,5-di((E)-styryl)hexahydro-1H-pyrrolizine-
2,6,7a-tricarboxylate (258) 
According to the general procedure pyrrolizidine 258 was obtained 
as a light yellow foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 73% yield and 90% ee. The enantiomeric excess 
was determined by chiral SFC analysis (OJ-H, 2.5 mL/min, 4% IPA in CO2, λ = 254 nm): 
tR (major) = 5.2 min, tR (minor) = 6.6 min. [α]D25 = –109.5° (c = 1.01, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.40 – 7.36 (m, 2H), 7.35 – 7.23 (m, 7H), 7.19 – 7.15 (m, 1H), 6.63 
(d, J = 15.5 Hz, 1H), 6.53 (d, J = 15.5 Hz, 1H), 6.20 (dd, J = 15.6, 7.7 Hz, 1H), 6.06 (dd, 
J = 15.5, 10.6 Hz, 1H), 4.30 (dd, J = 10.6, 7.6 Hz, 1H), 4.27 – 4.16 (m, 3H), 3.45 (ddd, J 
= 13.3, 7.6, 6.0 Hz, 1H), 3.08 (dt, J = 10.3, 7.7 Hz, 1H), 2.78 (dd, J = 13.5, 10.3 Hz, 1H), 
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1.31 (t, J = 7.1 Hz, 3H), 1.30 (s, 9H), 1.28 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.2, 
170.5, 170.1, 137.1, 136.4, 136.2, 131.2, 128.6, 128.3, 128.2, 127.9, 127.1, 126.7, 126.4, 
125.2, 80.8, 80.8, 75.5, 67.1, 64.4, 61.2, 50.8, 49.6, 37.4, 36.6, 28.1, 28.0, 14.3; FTIR 
(NaCl, thin film) 2978, 2932, 1727, 1495, 1477, 1449, 1392, 1367, 1257, 1152, 1029, 
968, 848, 754 cm-1; HRMS (MM) calc’d for [M+H]+ 588.3320, found 588.3284. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-phenyl-5-((E)-styryl)hexahydro-1H-
pyrrolizine-2,6,7a-tricarboxylate (269a)  
According to the general procedure pyrrolizidine 269a was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 90% yield and 91% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OD, 2.5 mL/min, 10% IPA 
in CO2, λ = 254 nm): tR (major) = 6.1 min, tR (minor) = 7.2 min. [α]D25 = –103.3° (c = 
0.74, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.39 (d, J = 7.3 Hz, 2H), 7.30 – 7.24 (m, 
6H), 7.21-7.10 (m, 2H), 6.30 (d, J = 15.6 Hz, 1H), 6.02 (dd, J = 15.6, 10.3 Hz, 1H), 4.78 
(d, J = 8.3 Hz, 1H), 4.19 (dd, J = 10.3, 7.7 Hz, 1H), 3.79 (s, 3H), 3.61 (ddd, J = 12.1, 7.5, 
6.5 Hz, 1H), 3.39 (td, J = 7.9, 3.8 Hz, 1H), 2.99 (dd, J = 13.2, 3.8 Hz, 1H), 2.37 (dd, J = 
13.1, 6.5 Hz, 1H), 2.29 (dd, J = 19.1, 6.4 Hz, 1H), 2.12 (dd, J = 13.3, 7.7 Hz, 1H), 1.26 
(s, 9H), 0.96 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 177.1, 171.0, 170.9, 141.1, 136.4, 
135.3, 128.5, 127.9, 127.8, 127.7, 126.7, 126.5, 126.3, 80.7, 80.2, 76.8, 65.2, 65.0, 52.9, 
52.2, 51.3, 39.1, 39.0, 28.0, 27.4; FTIR (NaCl, thin film) 2977, 1726, 1493, 1453, 1391, 
1367, 1293, 1255, 1204, 1151, 1094, 968, 845, 746 cm-1; HRMS (MM) calc’d for 







Chapter 4 – Further Investigation of Side Reactions  340 
(2R,3R,5S,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-((E)-styryl)-5-(o-tolyl)hexahydro-1H-
pyrrolizine-2,6,7a-tricarboxylate (269b) 
According to the general procedure pyrrolizidine 269b was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 91% yield and 89% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OD, 2.5 mL/min, 7% IPA in 
CO2, λ = 254 nm): tR (major) = 10.0 min, tR (minor) = 11.5 min. [α]D25 = –84.443° (c = 
0.95, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.03 (d, J = 7.7 Hz, 1H), 7.32 – 7.15 (m, 
6H), 7.10 (t, J = 7.4 Hz, 1H), 7.01 (d, J = 7.4 Hz, 1H), 6.22 (d, J = 15.6 Hz, 1H), 5.99 
(dd, J = 15.6, 10.4 Hz, 1H), 4.93 (d, J = 8.2 Hz, 1H), 4.10 (dd, J = 10.2, 7.6 Hz, 1H), 3.82 
(s, 3H), 3.65 (ddd, J = 13.5, 7.4, 0.8 Hz, 1H), 3.50 (t, J = 8.0 Hz, 1H), 3.05 (d, J = 13.1 
Hz, 1H), 2.40 (dd, J = 13.5, 6.0 Hz, 1H), 2.35 (t, J = 12.8 Hz, 1H), 2.09 (dd, J = 13.1, 7.7 
Hz, 1H), 1.28 (s, 9H), 0.90 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 177.37, 171.20, 
170.72, 138.66, 136.50, 135.55, 135.03, 129.21, 128.41, 127.58, 126.78, 126.48, 126.35, 
125.89, 80.61, 79.95, 77.25, 77.00, 76.75, 76.22, 64.01, 61.95, 52.14, 51.32, 50.98, 39.80, 
39.23, 27.99, 27.47, 27.21, 19.14; FTIR (NaCl, thin film) 2976, 1727, 1479, 1458, 1392, 
1367, 1294, 1256, 1199, 1151, 1097, 1034, 967, 844, 749 cm-1; HRMS (MM) calc’d for 
[M+H]+ 562.3163, found 574.3159. 
(2R,3R,5S,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-((E)-styryl)-5-(m-tolyl)hexahydro-
1H-pyrrolizine-2,6,7a-tricarboxylate (269c) 
According to the general procedure using 6 mol% 
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after silica gel column chromatography (5→20% ethyl acetate in hexanes) in 76% yield 
and 88% ee. The enantiomeric excess was determined by chiral SFC analysis (OD, 2.5 
mL/min, 7% IPA in CO2, λ = 254 nm): tR (major) = 9.8 min, tR (minor) = 11.4 min. [α]D25 
= -236.413° (c = 0.93, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.34 – 7.09 (m, 7H), 6.98 
(d, J = 7.4 Hz, 2H), 6.35 (d, J = 15.6 Hz, 1H), 6.05 (dd, J = 15.6, 10.3 Hz, 1H), 4.76 (d, J 
= 8.3 Hz, 1H), 4.22 (dd, J = 10.3, 7.7 Hz, 1H), 3.81 (s, 3H), 3.61 (ddd, J = 12.2, 7.5, 6.5 
Hz, 1H), 3.38 (td, J = 7.9, 4.3 Hz, 1H), 3.00 (dd, J = 13.3, 4.3 Hz, 1H), 2.39 (dd, J = 13.1, 
6.4 Hz, 1H), 2.30 (s, 3H), 2.14 (dd, J = 13.3, 7.8 Hz, 1H), 1.29 (s, 9H), 0.99 (s, 9H); 13C 
NMR (CDCl3, 126 MHz) δ 177.1, 171.0, 170.9, 141.0, 137.0, 136.5, 135.3, 128.6, 128.5, 
127.8, 127.7, 127.4, 126.5, 126.3, 125.0, 80.7, 80.1, 76.6, 65.2, 65.2, 52.8, 52.2, 51.1, 
39.0, 38.9, 28.0, 27.4, 21.5; FTIR (NaCl, thin film) 2978, 2930, 1732, 1606, 1456, 1367, 




According to the general procedure using 6 mol% 
AgOAc/QUINAP, pyrrolizidine 269d was obtained as a white foam 
after silica gel column chromatography (5→20% ethyl acetate in 
hexanes) in 92% yield and 90% ee. The enantiomeric excess was determined by chiral 
SFC analysis (AD, 2.5 mL/min, 7% IPA in CO2, λ = 254 nm): tR (minor) = 10.2 min, tR 
(major) = 11.3 min. [α]D25 = -178.7° (c = 0.85, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 
7.34 – 7.19 (m, 7H), 7.05 (d, J = 7.8 Hz, 2H), 6.35 (d, J = 15.6 Hz, 1H), 6.04 (dd, J = 
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13.2, 6.9 Hz, 1H), 3.38 (td, J = 8.1, 4.0 Hz, 1H), 3.00 (dd, J = 13.3, 4.0 Hz, 1H), 2.38 (dd, 
J = 13.2, 6.4 Hz, 1H), 2.30 (s, 1H), 2.13 (dd, J = 13.3, 7.6 Hz, 1H), 1.28 (s, 1H), 1.00 (s, 
1H); 13C NMR (CDCl3, 126 MHz) δ 177.1, 171.0, 170.9, 138.0, 136.5, 136.1, 135.2, 
128.4, 128.4, 127.8, 127.7, 126.5, 126.4, 80.7, 80.1, 76.6, 65.1, 64.9, 52.9, 52.2, 51.2, 
39.0, 28.0, 27.4, 21.0; FTIR (NaCl, thin film) 2977, 1727, 1512, 1495, 1477, 1457, 1367, 
1151, 968, 848, 748 cm-1; HRMS (MM) calc’d for [M+H]+ 562.3163, found 562.3170. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(3,5-dimethylphenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269e) 
According to the general procedure using 6 mol% 
AgOAc/QUINAP, pyrrolizidine 269e was obtained as a white foam 
after silica gel column chromatography (5→20% ethyl acetate in 
hexanes) in 78% yield and 88% ee. The enantiomeric excess was determined by chiral 
SFC analysis (AD, 2.5 mL/min, 5% IPA in CO2, λ = 254 nm): tR (minor) = 9.0 min, tR 
(major) = 10.5 min. [α]D25 = -120.032° (c = 0.86, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 
7.33 – 7.22 (m, 6H), 6.97 (s, 1H), 6.80 (s, 1H), 6.38 (d, J = 15.6 Hz, 1H), 6.06 (dd, J = 
15.6, 10.3 Hz, 1H), 4.72 (d, J = 8.3 Hz, 1H), 4.22 (dd, J = 10.3, 7.7 Hz, 1H), 3.82 (s, 1H), 
3.61 (ddd, J = 12.3, 7.5, 6.5 Hz, 1H), 3.35 (td, J = 7.9, 4.8 Hz, 1H), 2.99 (dd, J = 13.3, 4.8 
Hz, 1H), 2.39 (dd, J = 13.1, 6.4 Hz, 1H), 2.33 – 2.26 (m, 1H), 2.26 (s, 1H), 2.13 (dd, J = 
13.3, 7.8 Hz, 1H), 1.29 (s, 9H), 1.00 (s, 9H).; 13C NMR (CDCl3, 126 MHz) δ 177.09, 
170.91, 170.86, 140.95, 136.89, 136.49, 135.28, 128.44, 128.29, 127.65, 126.53, 126.30, 
125.68, 80.68, 80.02, 76.62, 65.34, 65.28, 52.66, 52.16, 51.04, 38.98, 38.69, 28.03, 27.38, 
21.35; FTIR (NaCl, thin film) 2977, 1728, 1603, 1456, 1391, 1366, 1152, 968, 847, 747 
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(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(4-fluorophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269f) 
According to the general procedure pyrrolizidine 269f was obtained 
as a white foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 87% yield and 93% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 4% IPA in 
CO2, λ = 254 nm): tR (minor) = 7.8 min, tR (major) = 9.7 min. [α]D25 = -40.596° (c = 0.79, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.41 – 7.36 (m, 2H), 7.30 – 7.26 (m, 2H), 7.24 – 
7.20 (m, 3H), 6.93 (t, J = 8.8 Hz, 2H), 6.29 (d, J = 15.6 Hz, 1H), 6.00 (dd, J = 15.6, 10.4 
Hz, 1H), 4.76 (d, J = 8.2 Hz, 1H), 4.15 (dd, J = 10.3, 7.7 Hz, 1H), 3.79 (s, 3H), 3.59 (ddd, 
J = 12.2, 7.5, 6.5 Hz, 1H), 3.36 (td, J = 7.8, 3.4 Hz, 1H), 2.36 (dd, J = 13.1, 6.5 Hz, 1H), 
2.32 – 2.25 (m, 1H), 2.11 (dd, J = 13.3, 7.7 Hz, 1H), 1.27 (s, 9H), 0.99 (s, 9H); 13C NMR 
(CDCl3, 126 MHz) δ 177.0, 170.9, 170.8, 162.9, 160.9, 136.7, 136.7, 136.3, 135.3, 129.5, 
129.4, 128.5, 127.8, 126.5, 126.1, 114.6, 114.4, 80.7, 80.3, 76.6, 64.7, 64.4, 53.0, 52.2, 
51.3, 39.2, 39.0, 28.0, 27.5; FTIR (NaCl, thin film) 3435, 2978, 2931, 1726, 1603, 1507, 




According to the general procedure pyrrolizidine 269g was 
obtained as a yellow oil after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 91% yield and 95% ee. The 
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CO2, λ = 254 nm): tR (major) = 6.2 min, tR (minor) = 8.1 min. [α]D25 = -476.013° (c = 
0.98, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.39 (d, J = 8.4 Hz, 2H), 7.30 – 7.17 (m, 
7H), 6.30 (d, J = 15.6 Hz, 1H), 6.01 (dd, J = 15.6, 10.4 Hz, 1H), 4.77 (d, J = 8.2 Hz, 1H), 
4.16 (dd, J = 10.2, 7.7 Hz, 1H), 3.78 (s, 3H), 3.62 (dt, J = 12.3, 6.9 Hz, 1H), 3.38 (td, J = 
7.9, 2.9 Hz, 1H), 2.99 (dd, J = 13.2, 2.7 Hz, 1H), 2.40 – 2.26 (m, 1H), 2.12 (dd, J = 13.3, 
7.7 Hz, 1H), 1.27 (s, 9H), 1.00 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.8, 170.7, 
170.5, 139.5, 136.1, 135.2, 132.2, 129.2, 128.4, 127.7, 127.7, 126.3, 126.0, 80.6, 80.2, 
76.5, 64.5, 64.3, 52.9, 52.1, 51.2, 39.2, 38.9, 27.9, 27.3; FTIR (NaCl, thin film) 3431, 
2977, 2932, 1727, 1489, 1456, 1292, 1151, 1088, 1014, 847, 750 cm-1; HRMS (MM) 
calc’d for [M+H]+ 582.2617, found 582.2611. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(4-bromophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269h) 
According to the general procedure pyrrolizidine 269h was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 89% yield and 92% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 3% IPA in 
CO2, λ = 254 nm): tR (major) = 6.1 min, tR (minor) = 8.0 min. [α]D25 = -59.159° (c = 0.70, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.41 – 7.36 (m, 2H), 7.35 – 7.27 (m, 4H), 7.27 – 
7.22 (m, 3H), 6.31 (d, J = 15.6 Hz, 1H), 6.00 (dd, J = 15.6, 10.4 Hz, 1H), 4.75 (d, J = 8.2 
Hz, 1H), 4.16 (dd, J = 10.4, 7.6 Hz, 1H), 3.80 (s, 3H), 3.62 (ddd, J = 12.3, 7.4, 6.5 Hz, 
1H), 3.38 (td, J = 7.8, 3.1 Hz, 1H), 2.99 (dd, J = 13.2, 3.1 Hz, 1H), 2.38 (dd, J = 13.2, 6.4 
Hz, 1H), 2.35 – 2.25 (m, 1H), 2.11 (dd, J = 13.3, 7.7 Hz, 1H), 1.28 (s, 9H), 1.01 (s, 9H); 
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128.5, 127.8, 126.5, 126.1, 120.4, 80.8, 80.4, 76.6, 64.7, 64.5, 53.0, 52.2, 51.3, 39.4, 39.0, 
28.0, 27.4; FTIR (NaCl, thin film) 3447, 2978, 2932, 1728, 1586, 1456, 1393, 1368, 




According to the general procedure pyrrolizidine 269i was obtained 
as a yellow foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 70% yield and 96% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 2% IPA in 
CO2, λ = 254 nm): tR (major) = 3.8 min, tR (minor) = 5.2 min. [α]D25 = -101.586° (c = 
0.77, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.13 (d, J = 8.8 Hz, 2H), 7.66 (d, J = 8.6 Hz, 
2H), 7.31 – 7.19 (m, 5H), 6.27 (d, J = 15.6 Hz, 1H), 6.00 (dd, J = 15.6, 10.4 Hz, 1H), 
4.88 (d, J = 8.2 Hz, 1H), 4.16 (dd, J = 10.4, 7.6 Hz, 1H), 3.81 (s, 3H), 3.65 (ddd, J = 12.2, 
7.4, 6.8 Hz, 1H), 3.47 (td, J = 7.9, 2.6 Hz, 1H), 3.03 (dd, J = 13.2, 2.6 Hz, 1H), 2.38 (dd, 
J = 14.5, 8.0 Hz, 1H), 2.37 – 2.29 (m, 1H), 2.16 (dd, J = 13.3, 7.7 Hz, 1H), 1.28 (s, 9H), 
0.98 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.7, 170.5, 170.5, 149.2, 146.9, 135.9, 
135.7, 128.8, 128.5, 128.0, 126.4, 125.6, 123.0, 80.9, 80.7, 76.7, 64.6, 64.4, 53.1, 52.3, 
51.3, 39.6, 39.0, 28.0, 27.4; FTIR (NaCl, thin film) 2978, 1727, 1598, 1522, 1457, 1392, 
1367, 1346, 1294, 1249, 1199, 1151, 850, 745 cm-1; HRMS (MM) calc’d for [M+H]+ 
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(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(4-cyanophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269j) 
According to the general procedure pyrrolizidine 269j was obtained 
as a yellow foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 80% yield and 96% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 4% IPA in 
CO2, λ = 254 nm): tR (major) = 5.7 min, tR (minor) = 7.1 min. [α]D25 = –57.101° (c = 0.70, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.62 – 7.53 (m, 4H), 7.31 – 7.19 (m, 5H), 6.27 (d, 
J = 15.6 Hz, 1H), 5.99 (dd, J = 15.6, 10.4 Hz, 1H), 4.84 (d, J = 8.2 Hz, 1H), 4.14 (dt, J = 
7.1, 5.9 Hz, 1H), 3.79 (s, 3H), 3.67 – 3.57 (m, 1H), 3.44 (td, J = 7.9, 2.7 Hz, 1H), 3.01 
(dd, J = 13.2, 2.6 Hz, 1H), 2.38 (dd, J = 13.2, 6.6 Hz, 1H), 2.35 ? 2.28 (m, 1H), 2.14 (dd, 
J = 13.3, 7.8 Hz, 1H), 1.28 (s, 9H), 0.97 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.8, 
170.6, 170.6, 147.2, 136.0, 135.7, 131.7, 128.8, 128.6, 128.0, 126.5, 125.8, 119.2, 110.4, 
80.9, 80.9, 80.6, 76.8, 64.7, 64.6, 53.0, 52.3, 51.4, 39.6, 39.1, 28.0, 27.5; FTIR (NaCl, 
thin film) 3453, 2978, 2931, 1732, 1608, 1456, 1393, 1368, 1257, 1151, 844, 738 cm-1; 
HRMS (MM) calc’d for [M+H]+ 573.2959, found 573.2924. 
 (2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(4-methoxyphenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269k) 
According to the general procedure using 6 mol% 
AgOAc/QUINAP in 0.1M THF, pyrrolizidine 269k was obtained 
as a yellow foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 86% yield and 90% ee. The enantiomeric excess was 
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(minor) = 9.8 min, tR (major) = 10.5 min. [α]D25 = -201.710° (c = 0.94, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.36 – 7.20 (m, 7H), 6.80 (d, J = 8.7 Hz, 2H), 6.34 (d, J = 15.6 Hz, 
1H), 6.04 (dd, J = 15.6, 10.3 Hz, 1H), 4.75 (d, J = 8.3 Hz, 1H), 4.19 (dd, J = 10.3, 7.7 Hz, 
1H), 3.80 (s, 3H), 3.77 (s, 3H), 3.65 – 3.56 (m, 1H), 3.36 (td, J = 7.9, 4.0 Hz, 1H), 2.99 
(dd, J = 13.3, 4.0 Hz, 1H), 2.38 (dd, J = 13.1, 6.4 Hz, 1H), 2.34 – 2.26 (m, 1H), 2.13 (dd, 
J = 13.3, 7.8 Hz, 1H), 1.28 (s, 9H), 1.01 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 177.1, 
171.0, 170.9, 158.5, 136.4, 135.1, 133.2, 128.9, 128.4, 127.7, 126.5, 126.3, 113.2, 80.6, 
80.1, 76.5, 65.0, 64.6, 55.3, 52.9, 52.2, 51.2, 38.9, 38.9, 28.0, 27.5; FTIR (NaCl, thin 
film) 2977, 1726, 1603, 1511, 1367, 1248, 1151, 1034, 845, 752 cm-1; HRMS (MM) 
calc’d for [M+H]+ 578.3112, found 578.3119. 
(2R,3R,5S,6R,7aR)-2,6-di-tert-butyl-7a-methoxy-3-((E)-styryl)-5-(o-tolyl)hexahydro-
1H-pyrrolizine-2,6,7a-tricarboxylate (269l) 
According to the general procedure pyrrolizidine 269l was obtained 
as a white foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 72% yield and 90% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OD, 2.5 mL/min, 15% IPA 
in CO2, λ = 254 nm): tR (major) = 4.0 min, tR (minor) = 4.6 min. [α]D25 = –188.252° (c = 
1.0, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.89 (dd, J = 7.5, 1.2 Hz, 1H), 7.30 – 7.23 
(m, 3H), 7.23 – 7.12 (m, 3H), 6.95 (t, J = 7.3 Hz, 1H), 6.71 (d, J = 8.0 Hz, 1H), 6.23 (d, J 
= 15.6 Hz, 1H), 6.02 (dd, J = 15.6, 10.4 Hz, 1H), 5.01 (d, J = 7.8 Hz, 1H), 4.14 (dd, J = 
10.3, 7.6 Hz, 1H), 3.79 (s, 3H), 3.63 (s, 3H), 3.55 (td, J = 7.7, 1.5 Hz, 1H), 3.01 (d, J = 
12.8 Hz, 1H), 2.35 (dd, J = 9.4, 4.0 Hz, 2H), 2.10 (dd, J = 13.1, 7.7 Hz, 1H), 1.28 (s, 9H), 
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129.2, 129.0, 128.3, 127.4, 127.4, 127.0, 126.5, 120.3, 109.3, 80.6, 79.6, 76.2, 64.4, 59.6, 
55.0, 52.1, 51.5, 51.3, 39.7, 39.3, 36.6, 28.0, 27.3, 24.6;  FTIR (NaCl, thin film) 2977, 
2949, 1723, 1600, 1489, 1458, 1437, 1391, 1367, 1294, 1242, 1152, 1106, 1031, 968, 
848, 756 cm-1; HRMS (MM) calc’d for [M+H]+ 578.3112, found 578.3137. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(2-chlorophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269m) 
According to the general procedure pyrrolizidine 269m was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 87% yield and 94% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 2% IPA in 
CO2, λ = 254 nm): tR (minor) = 5.3 min, tR (minor) = 6.2 min. [α]D25 = -76.881° (c = 0.75, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.08 (dd, J = 7.7, 1.6 Hz, 1H), 7.29 – 7.18 (m, 
7H), 7.14 (td, J = 7.6, 1.7 Hz, 1H), 6.23 (d, J = 15.6 Hz, 1H), 5.99 (dd, J = 15.6, 10.4 Hz, 
1H), 5.11 (d, J = 8.1 Hz, 1H), 4.09 (dd, J = 10.6, 7.8 Hz, 1H), 3.80 (s, 3H), 3.67 (td, J = 
7.8, 1.5 Hz, 1H), 3.62 (dt, J = 11.8, 7.1 Hz, 1H), 3.04 (d, J = 13.0 Hz, 1H), 2.40 (dd, J = 
13.0, 6.7 Hz, 1H), 2.38 – 2.32 (m, 1H), 2.12 (dd, J = 13.2, 7.7 Hz, 1H), 1.29 (s, 9H), 0.94 
(s, 9H); 13C NMR (CDCl3, 126 MHz) 177.2, 171.2, 170.6, 138.4, 136.5, 135.4, 133.5, 
130.5, 128.4, 128.3, 127.9, 127.6, 126.6, 126.5, 126.2, 80.7, 80.0, 76.4, 64.1, 62.3, 52.2, 
51.4, 50.8, 39.7, 39.1, 28.0, 27.3; FTIR (NaCl, thin film) 3444, 2978, 1728, 1456, 1393, 
1367, 1256, 1205, 1152, 1034, 969, 844, 752 cm-1; HRMS (MM) calc’d for [M+H]+ 
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 (2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(2-bromophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269n) 
According to the general procedure pyrrolizidine 269n was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 89% yield and 93% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 3% IPA in 
CO2, λ = 254 nm): tR (minor) = 4.4 min, tR (major) = 5.0 min. [α]D25 = -85.978° (c = 0.88, 
CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.09 (dd, J = 7.7, 1.6 Hz, 1H), 7.41 (dd, J = 7.9, 
1.0 Hz, 1H), 7.35 – 7.15 (m, 6H), 7.07 (td, J = 7.6, 1.7 Hz, 1H), 6.23 (d, J = 15.6 Hz, 
1H), 5.98 (dd, J = 15.6, 10.4 Hz, 1H), 5.07 (d, J = 8.1 Hz, 1H), 4.08 (dd, J = 10.3, 7.5 Hz, 
1H), 3.81 (s, 3H), 3.70 (td, J = 7.9, 1.2 Hz, 1H), 3.61 (dt, J = 11.7, 7.2 Hz, 1H), 3.04 (d, J 
= 13.1 Hz, 1H), 2.42 – 2.32 (m, 2H), 2.12 (dd, J = 13.2, 7.7 Hz, 1H), 1.29 (s, 9H), 0.94 
(s, 9H); 13C NMR (CDCl3, 126 MHz) δ 177.2, 171.2, 170.6, 139.9, 136.5, 135.5, 131.7, 
130.9, 128.3, 128.3, 127.6, 127.3, 126.5, 126.2, 123.9, 80.7, 80.0, 76.5, 64.7, 64.0, 52.2, 
51.4, 50.7, 39.7, 39.2, 28.0, 27.3; FTIR (NaCl, thin film) 2977, 1727, 1457, 1392, 1367, 
1293, 1257, 1203, 1151, 1094, 1022, 968, 843, 751 cm-1; HRMS (MM) calc’d for 
[M+H]+ 626.2112, found 628.2134. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(3-bromophenyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269o) 
According to the general procedure pyrrolizidine 269o was 
obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 82% yield and 92% ee. The 
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CO2, λ = 254 nm): tR (minor) = 6.9 min, tR (major) = 8.0 min. [α]D25 = -102.419° (c = 
0.67, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.63 (s, 1H), 7.38 – 7.20 (m, 6H), 7.13 (t, J 
= 7.8 Hz, 2H), 6.33 (d, J = 15.6 Hz, 1H), 6.01 (dd, J = 15.6, 10.4 Hz, 1H), 4.77 (d, J = 8.3 
Hz, 1H), 4.18 (dd, J = 10.3, 7.7 Hz, 1H), 3.82 (s, 3H), 3.61 (ddd, J = 12.4, 7.4, 6.6 Hz, 
1H), 3.40 (td, J = 7.9, 3.3 Hz, 1H), 2.99 (dd, J = 13.2, 3.3 Hz, 1H), 2.40 (dd, J = 13.1, 6.4 
Hz, 1H), 2.31 (t, J = 12.8 Hz, 1H), 2.12 (dd, J = 13.3, 7.7 Hz, 1H), 1.29 (s, 9H), 1.02 (s, 
9H); 13C NMR (CDCl3, 126 MHz) δ 176.9, 170.7, 170.6, 143.8, 136.2, 135.5, 131.0, 
129.8, 129.5, 128.5, 127.8, 126.5, 125.9, 122.1, 80.8, 80.5, 76.7, 64.7, 64.5, 53.0, 52.2, 
51.2, 39.3, 39.0, 28.0, 27.4; FTIR (NaCl, thin film) 2978, 1728, 1594, 1569, 1456, 1393, 
1367, 1293, 1257, 1204, 1151, 969, 845, 746 cm-1; HRMS (MM) calc’d for [M+H]+ 
626.2112, found 626.2127. 
(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(naphthalen-2-yl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269p) 
According to the general procedure using 6 mol% 
AgOAc/QUINAP in 0.1M THF, pyrrolizidine 269p was obtained 
as a yellow foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 93% yield and 92% ee. The enantiomeric excess was 
determined by chiral SFC analysis (AD, 2.5 mL/min, 7% IPA in CO2, λ = 254 nm): tR 
(major) = 6.0 min, tR (minor) = 9.8 min. [α]D25 = -387.655° (c = 0.93, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.97 (s, 1H), 7.85 – 7.77 (m, 2H), 7.74 (d, J = 8.5 Hz, 1H), 7.52 (dd, 
J = 8.5, 1.6 Hz, 1H), 7.47 – 7.40 (m, 2H), 7.30 – 7.19 (m, 4H), 6.29 (d, J = 15.6 Hz, 1H), 
6.09 (dd, J = 15.6, 10.3 Hz, 1H), 4.99 (d, J = 8.2 Hz, 1H), 4.27 (dd, J = 10.3, 7.6 Hz, 1H), 
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Hz, 1H), 2.45 (dd, J = 13.1, 6.4 Hz, 1H), 2.38 (t, J = 12.7 Hz, 1H), 2.19 (dd, J = 13.2, 7.7 
Hz, 1H), 1.30 (s, 9H), 0.82 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 177.11, 170.96, 
170.71, 138.60, 136.30, 135.25, 133.30, 132.77, 128.40, 127.91, 127.66, 127.39, 127.18, 
126.46, 126.41, 126.25, 125.47, 125.11, 80.68, 80.12, 76.64, 65.26, 64.83, 53.11, 52.19, 
51.25, 39.26, 39.05, 27.99, 27.22; FTIR (NaCl, thin film) 2977, 1727, 1457, 1391, 1368, 




According to the general procedure using 6 mol% 
AgOAc/QUINAP, pyrrolizidine 269q was obtained as a white foam 
after silica gel column chromatography (5→20% ethyl acetate in 
hexanes) in 84% yield and 93% ee. The enantiomeric excess was determined by chiral 
SFC analysis (AD, 2.5 mL/min, 7% IPA in CO2, λ = 254 nm): tR (minor) = 8.4 min, tR 
(major) = 9.8 min. [α]D25 = -188.706° (c = 0.82, CHCl3); 1H NMR (CDCl3, 500 MHz) δ  
8.30 (d, J = 7.1 Hz, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.83 (dd, J = 8.1, 1.2 Hz, 1H), 7.72 (d, 
J = 8.1 Hz, 1H), 7.54 – 7.47 (m, 1H), 7.38 (dddd, J = 22.6, 8.2, 6.8, 1.3 Hz, 2H), 7.20 – 
7.13 (m, 3H), 7.01 –6.98 (m, 2H), 6.17 (d, J = 15.6 Hz, 1H), 6.00 (dd, J = 15.6, 10.3 Hz, 
1H), 5.56 (d, J = 8.4 Hz, 1H), 4.19 (dd, J = 10.2, 7.5 Hz, 1H), 3.84 (s, 3H), 3.77 (td, J = 
8.0, 1.8 Hz, 1H), 3.70 (dt, J = 11.2, 7.4 Hz, 1H), 3.11 (dd, J = 13.0, 1.5 Hz, 1H), 2.45 (dd, 
J = 9.3, 3.3 Hz, 2H), 2.19 (dd, J = 13.1, 7.7 Hz, 1H), 1.28 (s, 9H), 0.53 (s, 9H); 13C NMR 
(CDCl3, 126 MHz) δ 177.3, 171.1, 170.9, 136.4, 136.3, 135.3, 133.4, 131.7, 128.3, 128.3, 
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52.2, 51.5, 40.0, 39.2, 28.0, 26.9; FTIR (NaCl, thin film) 2977, 1727, 1596, 1457, 1391, 




According to the general procedure pyrrolizidine 269r was 
obtained as a yellow foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 90% yield and 90% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OJ, 2.5 mL/min, 20% IPA 
in CO2, λ = 254 nm): tR (major) = 2.7 min, tR (minor) = 3.7 min. [α]D25 = -218.400° (c = 
0.79, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 8.53 (s, 1H), 8.43 (d, J = 4.7 Hz, 1H), 7.92 
(d, J = 7.8 Hz, 1H), 7.32 – 7.18 (m, 6H), 6.31 (d, J = 15.6 Hz, 1H), 6.01 (dd, J = 15.6, 
10.4 Hz, 1H), 4.83 (d, J = 8.3 Hz, 1H), 4.15 (dd, J = 10.2, 7.7 Hz, 1H), 3.80 (s, 3H), 3.59 
(dt, J = 12.1, 7.0 Hz, 1H), 3.44 (td, J = 8.0, 3.4 Hz, 1H), 3.01 (dd, J = 13.2, 3.4 Hz, 1H), 
2.40 (dd, J = 13.2, 6.5 Hz, 1H), 2.31 (t, J = 12.7 Hz, 1H), 2.15 (dd, J = 13.3, 7.7 Hz, 1H), 
1.27 (s, 9H), 0.98 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.78, 170.62, 149.35, 147.87, 
136.89, 136.00, 135.63, 128.50, 127.89, 126.46, 125.69, 123.19, 80.83, 80.61, 76.63, 
64.78, 62.65, 52.75, 52.28, 51.26, 39.26, 38.90, 27.98, 27.40; FTIR (NaCl, thin film) 
2978, 1730, 1586, 1457, 1420, 1369, 1256, 1152, 1026, 844, 737 cm-1; HRMS (MM) 
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(2R,3S,5R,6R,7aR)-2,6-di-tert-butyl-7a-methyl-3-(pyridin-2-yl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (269s)  
According to the general procedure pyrrolizidine 269s was obtained 
as a white foam after silica gel column chromatography (5→20% 
ethyl acetate in hexanes) in 33% yield and 44% ee. The 
enantiomeric excess was determined by chiral SFC analysis (AD, 2.5 mL/min, 20% IPA 
in CO2, λ = 254 nm): tR (major) = 2.2 min, tR (minor) = 3.9 min. [α]D25 = –68.157° (c = 
0.92, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.41 (d, J = 4.1 Hz, 1H), 7.72 (d, J = 7.8 
Hz, 2H), 7.67 – 7.55 (m, 2H), 7.26 – 7.19 (m, 2H), 7.08 (dd, J = 6.5, 5.1 Hz, 2H), 6.45 
(dd, J = 22.7, 15.6 Hz, 1H), 6.04 (dt, J = 28.1, 14.0 Hz, 1H), 4.83 (d, J = 7.9 Hz, 1H), 
4.26 (dt, J = 22.8, 11.4 Hz, 1H), 3.75 (d, J = 8.7 Hz, 2H), 3.68 – 3.59 (m, 1H), 3.51 (td, J 
= 8.0, 5.5 Hz, 1H), 3.08 (dd, J = 13.3, 5.4 Hz, 1H), 2.38 – 2.35 (m, 1H), 2.34 (d, J = 3.1 
Hz, 1H), 2.22 (dt, J = 15.5, 7.8 Hz, 1H), 1.31 – 1.20 (m, 8H), 1.06 (s, 7H); 13C NMR (126 
MHz, CDCl3) δ 177.04, 170.94, 170.47, 161.47, 136.22, 135.97, 128.47, 127.85, 126.66, 
125.49, 122.60, 121.63, 80.80, 80.20, 76.64, 66.44, 66.06, 52.27, 52.18, 50.80, 39.08, 
38.87, 28.06, 27.54; FTIR (NaCl, thin film) 2976, 1726, 1589, 1457, 1434, 1366, 1256, 
1151, 968, 847, 751 cm-1; HRMS (MM) calc’d for [M+H]+ 549.2959, found 549.2908. 
 (2R,3S,5R,6R,7aR)-2-tert-butyl-6,7a-dimethyl-3-phenyl-5-((E)-styryl)hexahydro-1H-
pyrrolizine-2,6,7a-tricarboxylate (270a) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and methyl acrylate 
as the dipolarophile in the second (1,3)-dipolar cycloaddition, 
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(5→20% ethyl acetate in hexanes) in 92% yield and 90% ee. The enantiomeric excess 
was determined by chiral SFC analysis (AD, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): 
tR (major) = 7.6 min, tR (minor) = 9.4 min. [α]D25 = -96.513° (c = 0.94, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.42 – 7.38 (m, 2H), 7.32 – 7.21 (m, 6H), 7.19 – 7.15 (m, 2H), 6.34 
(d, J = 15.6 Hz, 1H), 6.03 (dd, J = 15.6, 10.3 Hz, 1H), 4.83 (d, J = 8.4 Hz, 1H), 4.28 (dd, 
J = 10.2, 7.8 Hz, 1H), 3.82 (s, 3H), 3.70 (ddd, J = 11.9, 7.7, 6.8 Hz, 1H), 3.56 (s, 3H), 
3.44 (td, J = 7.8, 4.5 Hz, 1H), 3.03 (dd, J = 13.3, 4.5 Hz, 1H), 2.45 (dd, J = 13.2, 6.6 Hz, 
1H), 2.37 (dd, J = 13.2, 11.9 Hz, 1H), 2.19 (dd, J = 13.3, 7.8 Hz, 1H), 0.98 (s, 9H); 13C 
NMR (CDCl3, 126 MHz) δ 176.8, 172.4, 170.8, 140.9, 136.4, 135.3, 128.5, 127.9, 127.8, 
127.8, 126.8, 126.6, 125.8, 80.3, 76.8, 65.3, 52.6, 52.3, 51.8, 50.5, 39.1, 38.7, 27.4; FTIR 
(NaCl, thin film) 3450, 2978, 1730, 1493, 1451, 1367, 1152, 970, 844, 747 cm-1; HRMS 
(MM) calc’d for [M+H]+ 506.2537, found 506.2523. 
 (2R,3S,5R,6R,7aS)-2-tert-butyl-7a-methyl-3-phenyl-6-(phenylsulfonyl)-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,7a-dicarboxylate (270b) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and vinyl sulphone as 
the dipolarophile in the second (1,3)-dipolar cycloaddition, 
pyrrolizidine 270b was obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 64% yield and 90% ee. The enantiomeric excess 
was determined by chiral SFC analysis (AD, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): 
tR (minor) = 3.9 min, tR (major) = 4.6 min; [α]D25 = -10.465° (c = 0.87, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.77 (dd, J = 8.3, 1.1 Hz, 2H), 7.55 (t, J = 7.5 Hz, 2H), 7.42 – 7.10 
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1H), 4.41 – 4.29 (m, 1H), 3.98 (dd, J = 10.5, 7.0 Hz, 1H), 3.80 (s, 3H), 3.43 (ddd, J = 
16.7, 10.2, 6.2 Hz, 1H), 3.07 (dd, J = 13.2, 3.8 Hz, 1H), 2.69 (dd, J = 13.0, 6.4 Hz, 1H), 
2.56 (t, J = 12.5 Hz, 1H), 2.14 (dd, J = 13.3, 7.8 Hz, 1H), 0.95 (s, 9H); 13C NMR (CDCl3, 
126 MHz) δ 175.8, 170.8, 140.4, 138.9, 136.1, 135.6, 133.6, 128.8, 128.4, 128.4, 127.8, 
127.8, 126.8, 126.7, 124.0, 80.3, 75.8, 68.0, 64.6, 64.0, 52.4, 52.1, 38.9, 36.9, 27.3, 27.3; 
FTIR (NaCl, thin film) 2979, 1726, 1446, 1367, 1305, 1248, 1148, 1085, 749, 722 cm-1; 
HRMS (MM) calc’d for [M+H]+ 588.2414, found 588.2407. 
(2R,3S,5R,6R,7S,7aS)-2-tert-butyl-7a-methyl-6-formyl-3,7-diphenyl-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,7a-dicarboxylate (270c) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and cinnamaldehyde 
as the dipolarophile in the second (1,3)-dipolar cycloaddition, 
pyrrolizidine 270c was obtained as a white foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 90% yield and 90% ee. The enantiomeric excess 
was determined by chiral SFC analysis (OB-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 
nm): tR (minor) = 3.7 min, tR (major) = 4.9 min; [α]D25 = -39.981° (c = 0.96, CHCl3); 1H 
NMR (CDCl3, 500 MHz) δ 9.64 (d, J = 1.8 Hz, 1H), 7.37 – 7.11 (m, 14H), 6.44 (d, J = 
15.5 Hz, 1H), 6.14 (dd, J = 15.5, 10.7 Hz, 1H), 4.87 (d, J = 7.9 Hz, 1H), 4.79 (dd, J = 
10.7, 8.1 Hz, 1H), 4.55 (ddd, J = 12.0, 8.1, 1.7 Hz, 1H), 3.86 (d, J = 12.1 Hz, 1H), 3.47 
(td, J = 7.9, 4.5 Hz, 1H), 3.30 (s, 3H), 3.04 (dd, J = 13.5, 4.6 Hz, 1H), 2.40 (dd, J = 13.6, 
7.9 Hz, 1H), 1.33 – 1.23 (m, 1H), 1.01 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 199.9, 
174.1, 170.5, 140.4, 136.1, 136.0, 135.9, 128.5, 128.5, 128.1, 127.9, 127.6, 127.4, 126.8, 
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film) 2978, 1728, 1495, 1452, 1391, 1367, 1204, 1152, 1073, 747 cm-1; HRMS (MM) 
calc’d for [M+H]+ 552.2744, found 552.2712. 
(2R,3R,5S,6R,7aS)-6-tert-butyl-2,7a-dimethyl-2-methyl-5-phenyl-3-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6,7a-tricarboxylate (270d) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and methyl 
methacrylate as the dipolarophile in the second (1,3)-dipolar 
cycloaddition, pyrrolizidine 270d was obtained as a white foam after silica gel column 
chromatography (5→20% ethyl acetate in hexanes) in 91% yield and 90% ee. The 
enantiomeric excess was determined by chiral SFC analysis (OB-H, 2.5 mL/min, 10% 
IPA in CO2, λ = 254 nm): tR (major) = 2.8 min, tR (minor) = 3.3 min; [α]D25 = -67.966° (c 
= 0.97, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.45 (dd, J = 8.1, 1.0 Hz, 1H), 7.26 – 7.17 
(m, 6H), 7.13 – 7.07 (m, 3H), 6.39 (d, J = 15.6 Hz, 1H), 5.99 (dd, J = 15.6, 9.7 Hz, 1H), 
5.02 (d, J = 9.0 Hz, 1H), 3.90 (d, J = 9.3 Hz, 1H), 3.84 (s, 3H), 3.64 (s, 3H), 3.56 (ddd, J 
= 9.0, 7.8, 6.3 Hz, 1H), 3.02 (dd, J = 13.2, 6.3 Hz, 1H), 2.78 (d, J = 13.8 Hz, 1H), 2.36 – 
2.28 (m, 2H), 1.38 (s, 3H), 0.99 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.8, 176.8, 
170.9, 142.1, 136.7, 134.6, 128.3, 128.2, 127.7, 127.5, 126.7, 126.4, 125.1, 80.2, 76.9, 
75.0, 65.4, 56.1, 56.1, 52.3, 51.9, 50.4, 48.0, 39.0, 27.4, 23.1; FTIR (NaCl, thin film) 
2950, 1727, 1493, 1433, 1450, 1367, 1253, 1152, 1121, 969, 746 cm-1; HRMS (MM) 
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(2R,3S,5R,6R,7R,7aS)-2-tert-butyl-7a-methyl-6-nitro-3,7-diphenyl-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,7a-dicarboxylate (270e) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and crotonaldehyde as 
the dipolarophile in the second (1,3)-dipolar cycloaddition, 
pyrrolizidine 270e was obtained as a yellow foam after silica gel column chromatography 
(5→20% ethyl acetate in hexanes) in 89% yield and 90% ee. The enantiomeric excess 
was determined by chiral SFC analysis (OJ, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): 
tR (minor) = 6.0 min, tR (major) = 7.4 min; [α]D25 = -27.059° (c = 0.98, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 7.40 – 7.15 (m, 15H), 6.48 (d, J = 15.5 Hz, 1H), 6.22 – 6.11 (m, 
1H), 5.05 (d, J = 8.1 Hz, 1H), 4.94 (dd, J = 10.1, 8.0 Hz, 1H), 4.23 (d, J = 11.1 Hz, 1H), 
3.59 (td, J = 7.9, 4.9 Hz, 1H), 3.38 (s, 3H), 3.12 (dd, J = 13.6, 4.9 Hz, 1H), 2.48 (dd, J = 
13.7, 7.9 Hz, 1H), 1.02 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 173.2, 170.2, 139.9, 
138.2, 135.6, 133.7, 128.8, 128.4, 128.3, 128.3, 127.9, 127.5, 127.1, 127.0, 126.8, 122.0, 
92.1, 80.6, 80.5, 65.3, 64.8, 57.2, 51.6, 51.5, 37.1, 27.4; FTIR (NaCl, thin film) 2949, 
1730, 1550, 1452, 1205, 1152, 1074, 911, 734 cm-1; HRMS (MM) calc’d for [M+H]+ 
569.2646, found 569.2632. 
 (2R,3S,5R,6R,7R,7aS)-2-tert-butyl-7a-methyl-6-formyl-7-methyl-3-phenyl-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,7a-dicarboxylate (270f) 
According to the general procedure using 1.1 equivalents of t-Bu 
acrylate in the first (1,3)-dipolar cycloaddition and crotonaldehyde as 
the dipolarophile in the second (1,3)-dipolar cycloaddition, 
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(5→20% ethyl acetate in hexanes) in 59% yield (3:1mixture of diastereomers) and 90% 
ee. The enantiomeric excess was determined by chiral SFC analysis (AD, 2.5 mL/min, 
5% IPA in CO2, λ = 254 nm): tR (major) = 5.9 min, tR (minor) = 6.7 min; [α]D25 = -
39.981° (c = 0.96, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 9.56 (d, J = 1.6 Hz, 1H), 7.30 – 
7.20 (m, 5H), 5.50 (dq, J = 14.8, 6.5 Hz, 1H), 5.27 (ddd, J = 15.0, 10.9, 1.6 Hz, 1H), 4.70 
(d, J = 7.9 Hz, 1H), 4.36 (dd, J = 10.8, 8.2 Hz, 1H), 3.78 (s, 3H), 3.48 (ddd, J = 11.7, 8.2, 
1.5 Hz, 1H), 3.33 – 3.26 (m, 1H), 3.00 (dd, J = 13.6, 5.3 Hz, 1H), 2.44 (tt, J = 13.6, 6.8 
Hz, 1H), 2.04 (dd, J = 13.6, 7.9 Hz, 1H), 1.61 (dd, J = 6.5, 1.5 Hz, 3H), 1.03 (s, 9H); 13C 
NMR (CDCl3, 126 MHz) δ 201.2, 175.3, 170.6, 141.0, 132.6, 128.3, 127.8, 127.8, 127.6, 
127.6, 127.4, 126.7, 80.3, 80.3, 77.3, 77.0, 76.8, 64.4, 63.3, 62.3, 52.6, 51.7, 43.3, 36.8, 
27.5, 17.7, 13.7; FTIR (NaCl, thin film) 2976, 2932, 1732, 1453, 1367, 1367, 974, 745 
cm-1; HRMS (MM) calc’d for [M+H]+ 428.2431, found 428.2431. 
(2S,3R,5S,6S,7aS)-2,6-bis(tert-butoxycarbonyl)-3-phenyl-5-((E)-styryl)hexahydro-1H-
pyrrolizine-7a-carboxylic acid (271) 
20 mg of pyrrolizidine ent-269a was dissolved in 0.4 ml THF. 4.4 
mg of LiOH was dissolved in 0.4 ml of H2O and then transferred to 
the organic solution. The reaction was allowed to stir for 14 h and 
then quenched with 1 ml of 10% NaH2PO4 and extracted with 1 ml DCM three times. The 
organic solution was then dried with MgSO4, filtered, and concentrated. The crude 
mixture was then purified (5→20% ethyl acetate in hexanes) to afford 14 mg of 271 in 
74% yield. 1H NMR (500 MHz, CDCl3) δ 1H NMR 7.32 – 7.22 (m, 6H), 7.12 (dd, J = 7.6, 
1.7 Hz, 4H), 6.32 (d, J = 15.5 Hz, 1H), 5.98 (dd, J = 15.5, 10.5 Hz, 1H), 4.87 (d, J = 7.7 
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13.9, 2.5 Hz, 1H), 2.74 (dd, J = 13.3, 6.5 Hz, 1H), 2.47 – 2.33 (m, 2H), 1.28 (s, 9H), 1.04 
(s, 9H); 13C NMR (126 MHz, CDCl3) δ 176.83, 171.33, 169.92, 138.32, 136.48, 135.82, 
128.54, 128.37, 128.18, 127.54, 127.21, 126.56, 123.56, 81.67, 81.41, 78.12, 77.28, 
77.02, 76.77, 66.20, 65.71, 53.40, 51.37, 38.80, 38.53, 27.99, 27.42; FTIR (NaCl, thin 
film) 2977, 2928,1725, 1495, 1454, 1367, 1250, 1151, 1030, 970, 845, 744 cm-1; HRMS 
(MM) calc’d for [M+H]+ 534.2832, found 534.285. 
(2R,3S,5R,6R,7aR)-di-tert-butyl-7a-(hydroxymethyl)-3-phenyl-5-((E)-
styryl)hexahydro-1H-pyrrolizine-2,6-dicarboxylate (272) 
20 mg of pyrrolizidine ent-269a was dissolved in 0.73 ml THF and 
put to 0 oC. 0.11 ml of 1 M LiEt3BH in THF was added drop-wise. 
The reaction was then quenched with 1 ml of saturated aqueous 
NH4Cl and extracted with 1 ml DCM three times. The organic solution was then dried 
with MgSO4, filtered, and concentrated. The crude mixture was then purified (5→20% 
ethyl acetate in hexanes) to afford 14 mg of 272 in 74% yield. 1H NMR (500 MHz, 
CDCl3) δ 7.26 (dd, J = 8.1, 1.0 Hz, 2H), 7.15 – 7.06 (m, 4H), 7.06 – 6.99 (m, 2H), 6.94 – 
6.91 (m, 2H), 6.29 (d, J = 15.6 Hz, 1H), 5.90 (dd, J = 15.6, 9.8 Hz, 1H), 4.89 (d, J = 9.4 
Hz, 1H), 4.15 – 4.05 (m, 1H), 3.48 (s, 2H), 3.47 – 3.42 (m, 1H), 3.18 (dd, J = 17.4, 8.7 
Hz, 1H), 2.62 (dd, J = 13.5, 6.5 Hz, 1H), 2.17 (dd, J = 13.4, 9.1 Hz, 1H), 2.03 (dd, J = 
13.5, 8.9 Hz, 1H), 1.95 (dd, J = 13.4, 8.4 Hz, 1H), 1.22 (s, 9H), 0.90 (s, 9H); 13C NMR 
(126 MHz, CDCl3) δ 173.15, 172.26, 141.97, 136.59, 134.14, 128.32, 128.23, 127.92, 
127.51, 126.87, 126.31, 126.09, 80.87, 80.41, 77.28, 77.02, 76.77, 75.48, 66.18, 65.77, 
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2928,1722, 1493, 1452, 1367, 1249, 1151, 1030, 970, 846, 743 cm-1; HRMS (MM) calc’d 
for [M+H]+ 520.3012, found 520.3012. 
(2S,3R,5S,6S,7aS)-2,6-dicarboxy-7a-(methoxycarbonyl)-3-phenyl-5-((E)-
styryl)octahydropyrrolizin-4-ium 2,2,2-trifluoroacetate (273) 
To a stirring solution of triester ent-269a (204 mg, 0.372 mmol) in 2.6 
mL of CH2Cl2 was added triethylsilane (0.29 mL, 1.8 mmol), followed 
by 1.0 mL of trifluoroacetic acid. The resulting solution was stirred for 
20 h, and subsequently concentrated in vacuo. The crude residue was 
dissolved in 4 mL of Et2O, and added dropwise to 30 mL of vigorously stirring hexanes, 
resulting in precipitation of a white solid (the reaction vessel was rinsed twice with 2 mL 
of Et2O, and the rinsates added to the hexanes mixture). The solids were isolated by 
filtration to afford 180 mg (88% yield) of trifluoroacetate salt 273 as a white amorphous 
solid. [α]D25 = +171.4° (c = 1.04, MeOH); 1H NMR (CDCl3, 500 MHz) δ 9.89 (s, 3H), 
7.36 – 7.26 (m, 10H), 6.52 (d, J = 15.5 Hz, 1H), 6.23 (dd, J = 15.5, 10.5 Hz, 1H), 5.16 (d, 
J = 7.4 Hz, 1H), 4.68 (dd, J = 10.5, 7.6 Hz, 1H), 3.84 (s, 3H), 3.67 – 3.60 (m, 1H), 2.97 
(dd, J = 13.9, 3.4 Hz, 1H), 2.69 – 2.55 (m, 3H); 13C NMR (CDCl3, 126 MHz) δ 173.8, 
173.6, 171.5, 160.7 (q, JC-F = 36.5 Hz), 140.9, 136.1, 134.8, 129.9, 129.7, 129.6, 129.5, 
128.4, 127.9, 120.0, 117.2 (q, JC-F = 290.8 Hz), 81.1, 69.5, 68.8, 54.5, 52.3, 50.3, 38.8, 
38.1; FTIR (NaCl, thin film) 2960, 2530, 1955, 1907, 1732, 1652, 1495, 1454, 1439, 
1409, 1318, 1263, 1193, 1141, 976, 797, 750 cm-1; HRMS (MM) calc’d for [M–C2F3O2]+ 
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(3aR,5R,6S,7aR,8aS)-7a-(methoxycarbonyl)-1-oxo-5-phenyloctahydro-1H-furo[3,4-
b]pyrrolizine-6-carboxylic acid (274) 
 A solution of styrene ent-269a (150 mg, 0.274 mmol) and p-
toluenesulfonic acid hydrate (261 mg, 1.37 mmol) in 2.8 mL of 
EtOAc was cooled to –78 °C with stirring. Ozone was bubbled 
through the solution until it became a pale blue suspension. The suspension was then 
sparged with oxygen (until the blue color no longer persisted), warmed to 0 °C in an ice 
bath, and diluted with 2.8 mL of saturated aqueous NaHCO3. Sodium borohydride (104 
mg, 2.75 mmol) was added portionwise, and the resulting mixture was stirred vigorously 
at 0 °C for 1 h. An additional portion of sodium borohydride (104 mg, 2.75 mmol) was 
added, and vigorous stirring continued at 0 °C for 1 h. A final portion of sodium 
borohydride (52 mg, 1.37 mmol) was added, and vigorous stirring continued at 0 °C for 1 
h.  The reaction mixture was then further diluted with saturated aqueous NaHCO3 and 
extracted with EtOAc (5 x 5 mL) (NOTE: effervescence was allowed to subside prior to 
extraction), and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated in vacuo. The resulting residue was subjected to silica gel column 
chromatography (50:1→10:1 CH2Cl2–Et2O), to afford 83 mg (64% yield) of 274 as a 
white foam. [α]D25 = +346.27 (c = 0.98, CHCl3); 1H NMR (CDCl3, 500 MHz) δ 7.48 – 
7.42 (m, 2H), 7.29 – 7.24 (m, 2H), 7.21 – 7.17 (m, 1H), 4.83 (d, J = 8.9 Hz, 1H), 3.79 (s, 
3H), 3.68 – 3.60 (m, 2H), 3.57 – 3.48 (m, 2H), 3.28 (dd, J = 16.7, 8.2 Hz, 1H), 2.95 (dd, J 
= 13.0, 5.8 Hz, 1H), 2.41 (dd, J = 13.1, 7.9 Hz, 1H), 2.32 – 2.23 (m, 2H), 2.20 (dd, J = 
8.7, 5.0 Hz, 1H), 1.49 (s, 9H), 0.96 (s, 9H); 13C NMR (CDCl3, 126 MHz) δ 176.56, 
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64.01, 60.67, 52.25, 51.25, 49.13, 39.75, 37.40, 27.98, 27.38; FTIR (NaCl, thin film) 
3502, 2977, 2929, 1729, 1478, 1456, 1392, 1367, 1303, 1252, 1209, 1152, 1094, 1042, 
919, 845, 735 cm-1; HRMS (MM) calc’d for [M+H]+ 476.2643, found 476.2644. 
(2R,3R,5R,6R)-2,6-dicarboxy-7a-(ethoxycarbonyl)-3,5-di((E)-
styryl)octahydropyrrolizin-4-ium 2,2,2-trifluoroacetate (260) 
 
To a stirring solution of triester 258 (racemic, 191 mg, 0.325 mmol) in 2.3 mL of CH2Cl2 
was added triethylsilane (0.26 mL, 1.6 mmol), followed by 0.93 mL of trifluoroacetic 
acid. The resulting solution was stirred for 24 h, and subsequently concentrated in vacuo. 
The crude residue was suspended in 3 mL of EtOAc, and added dropwise to 35 mL of 
vigorously stirring hexanes, resulting in precipitation of a white solid (the reaction vessel 
was rinsed twice with 2 mL of EtOAc, and the rinsates added to the hexanes mixture). 
The solids were isolated by filtration to afford 153 mg (80% yield) of trifluoroacetate salt 
260 as a white amorphous solid. Crystals suitable for X-ray diffraction analysis (XRD) 
were obtained by vapor diffusion of pentane into a saturated solution of 260 in acetone. 
1H NMR (acetone-d6, 500 MHz) δ 9.88 (s, 3H), 7.54 – 7.50 (m, 2H), 7.38 – 7.26 (m, 7H), 
7.25 – 7.20 (m, 1H), 6.85 (d, J = 15.5 Hz, 1H), 6.74 (dd, J = 15.7, 1.1 Hz, 1H), 6.50 (dd, 
J = 15.5, 10.6 Hz, 1H), 6.34 (dd, J = 15.7, 7.6 Hz, 1H), 4.72 (dd, J = 10.6, 7.5 Hz, 1H), 
4.63 (td, J = 7.4, 1.3 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 3.69 (ddd, J = 11.7, 7.6, 6.8 Hz, 









(trifluoroacetate counterion omitted for clarity)260
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2.49 (dd, J = 13.7, 7.7 Hz, 1H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (DMSO-d6, 126 MHz) 
δ 173.8 (br), 171.8, 171.2, 158.5 (q, JC-F = 36.1 Hz), 137.5 (br), 136.4, 135.9, 132.5 (br), 
128.7, 128.4, 127.9, 127.1, 126.4, 125.7 (br), 122.6 (br), 115.8 (q, JC-F = 291.8 Hz), 76.5, 
68.0, 64.8, 61.7, 49.3, 48.5, 36.8, 35.4, 14.0; FTIR (NaCl, thin film) 3029, 2528, 1718, 
1653, 1452, 1405, 1375, 1263, 1191, 1139, 971, 797, 749, 720 cm-1; HRMS (MM) calc’d 




3 mol % catalyst  solution in THF was pre-stirred for 30 minutes and then added to 52 mg 
of pyrrolidine 153. 15 µl of benzaldehyde was added followed by 11 µl  of t-Bu Acrylate 
and 3 µl of  DIPEA. After 24 h the reaction mixture was concentrated and purified by 
silica gel column chromatography (5→20% ethyl acetate in hexanes) to afford 282 in 
14% yield. The enantiomeric excess was determined by chiral SFC analysis (OD, 2.5 
mL/min, 7% IPA in CO2, λ = 254 nm): tR (major) = 10.6 min, tR (minor) = 11.5 min. 
[α]D25 = –66.858° (c = 0.95, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.23 (m, 5H), 
7.23 – 7.13 (m, 5H), 6.33 (dd, J = 15.7, 0.8 Hz, 1H), 6.07 (dd, J = 15.7, 7.1 Hz, 1H), 4.79 
(d, J = 9.0 Hz, 1H), 4.25 (tdd, J = 10.7, 7.1, 3.6 Hz, 2H), 3.84 – 3.73 (m, 1H), 3.69 (t, J = 
7.2 Hz, 1H), 3.11 (dd, J = 14.9, 8.0 Hz, 1H), 2.88 (dd, J = 13.4, 6.9 Hz, 1H), 2.51 (dd, J = 
13.1, 6.8 Hz, 1H), 2.37 (t, J = 13.2 Hz, 1H), 2.20 (dd, J = 13.4, 8.1 Hz, 1H), 1.33 (dd, J = 












AgOAc (3 mol %)
(S)-QUINAP (3 mol %)
DIPEA (10 mol %)
benzaldehyde (1 equiv)




Chapter 4 – Further Investigation of Side Reactions  364 
170.86, 170.59, 138.21, 137.26, 130.50, 129.44, 128.97, 128.32, 128.24, 127.95, 127.00, 
126.37, 80.56, 80.38, 76.04, 67.07, 63.22, 61.05, 51.89, 50.88, 39.01, 37.18, 28.07, 27.98, 
27.35, 14.35; FTIR (NaCl, thin film) 2977, 2930,1728, 1599, 1494, 1477, 1458, 1367, 





3 mol % catalyst  solution in THF was pre-stirred for 30 minutes and then added 
to 52 mg of pyrrolidine 153. 18 µl of 2-ethyl butyraldehyde was added followed by 11 µl 
of t-Bu Acrylate and 3 µl of  DIPEA. After 24 h the reaction mixture was concentrated 
and purified by silica gel column chromatography (5→20% ethyl acetate in hexanes) to 
afford 283 in 12% yield and 96% ee. The enantiomeric excess was determined by chiral 
SFC analysis (AD, 2.5 mL/min, 5% IPA in CO2, λ = 254 nm): tR (minor) = 3.4 min, tR 
(major) = 5.3 min. [α]D25 = –70.072° (c = 0.89, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.38 (s, 1H), 7.35 – 7.26 (m, 2H), 7.23 – 7.17 (m, 2H), 6.74 (d, J = 15.6 Hz, 1H), 6.16 
(dd, J = 15.7, 6.7 Hz, 1H), 4.46 – 4.38 (m, 1H), 4.26 – 4.14 (m, 2H), 3.60 (ddd, J = 13.0, 
8.8, 6.3 Hz, 1H), 3.35 (dd, J = 11.7, 6.7 Hz, 1H), 2.91 (ddd, J = 10.3, 6.8, 3.7 Hz, 1H), 
2.74 (dd, J = 14.3, 10.2 Hz, 1H), 2.66 (t, J = 13.0 Hz, 1H), 2.09 (dd, J = 12.8, 6.2 Hz, 
1H), 1.89 (dd, J = 14.3, 3.7 Hz, 1H), 1.54 (s, 9H), 1.38 (s, 9H), 1.32 (t, J = 7.1 Hz, 1H), 










AgOAc (3 mol %)
(S)-QUINAP (3 mol %)
DIPEA (10 mol %)
2-ethylbutyraldehyde (1 equiv)
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174.77, 170.79, 137.62, 131.09, 130.48, 128.37, 126.91, 126.46, 80.95, 80.55, 75.83, 
69.39, 60.89, 60.41, 48.34, 47.21, 41.04, 38.19, 35.98, 28.15, 28.15, 21.78, 20.75, 14.31, 
10.48, 7.55; FTIR (NaCl, thin film) 2974, 1718, 1559, 1457, 1366, 1247, 1146, 847 cm-1; 
HRMS (MM) calc’d for [M+H]+ 556.3638, found 556.3625. 





X, Y JXY (Hz) 




X, Y JXY (Hz) 




X, Y JXY (Hz) 





X, Y JXY (Hz) 
HA, HB 7.8 
HB, HC 13.2 










X, Y JXY (Hz) 
HA, HB 6.6, 7.0 
HB, HC 12.0, 12.1 










X, Y JXY (Hz) 
HA, HB 8.1 
HB, HC 12.0 
















X, Y JXY (Hz) 
HA, HB 8.0 




X, Y JXY (Hz) 
HA, HB 8.2 




































































































































HG–HH no HI–HB 
 
 
Oxidation of diketopiperazine 194 to tetraol 193 
 
Diketopiperazine 194 (2.0 mg, 5.6 µmol) and mesitylene (~1 µL) were dissolved 
in CD3CN (600 µL) and transferred to an NMR tube. An initial 1H NMR spectrum was 
acquired in order to determine the exact ratio of starting material to internal standard. The 
solution was then transferred to a 1-dram vial equipped with a stir bar, and TBAF(t-
BuOH)4 (43 mg, 77 µmol) was added. The vial (open to ambient air until now) was 
sealed with a Teflon screw cap and was then heated to 70 °C with vigorous stirring. After 
4 h, the orange-brown solution was cooled to room temperature and transferred to an 
NMR tube. A final 1H NMR spectrum was acquired, and it was determined that tetraol 
193 had been formed in 50% yield (based on the mesitylene internal standard) and was 
the predominant dihydrooxepine-containing species. 
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 A solution of bis(tert-butyldimethylsilyl) ether 190 (105 mg, 0.179 mmol) in 9 
mL THF and a separate solution of TBAF•(t-BuOH)4 (1.20 g, 2.15 mmol) in 9 mL THF 
were each sparged with N2 for 1 h. The solution of TBAF•(t-BuOH)4 was then added to 
the solution of 190, and the resulting mixture was stirred under N2 for 52 h. The reaction 
mixture was then diluted with sat. aq. Na2SO4 and extracted with EtOAc (3x). The 
combined organics were then washed with sat. aq. Na2SO4 and filtered through a plug of 
SiO2. The resulting aqueous wash was back-extracted with EtOAc, and the resulting 
organic layer again passed through the SiO2 plug, which was finally rinsed with excess 
EtOAc. The resulting filtrate was then concentrated in vacuo, and purification via flash 
chromatography (gradient elution, 1→5% MeOH in 1:1 CH2Cl2/EtOAc) to afford diol 
194 (59.2 mg, 92% yield) as an off-white amorphous solid. 
Preparation of tetraol 277 from bis(tert-butyldimethylsilyl) ether 190 
 
 A solution of bis(tert-butyldimethylsilyl) ether 190 (11 mg, 0.017 mmol) in 1.7 
mL of THF under an air atmosphere was treated with TBAF•(t-BuOH)4 (114 mg, 0.204 
mmol), and the resulting solution was stirred for 46 h. The mixture was then diluted with 
sat. aq. Na2SO4 and extracted with EtOAc (3x). The combined organics were then 
washed with sat. aq. Na2SO4 and filtered through a plug of SiO2. The resulting aqueous 
wash was back-extracted with EtOAc, and the resulting organic layer again passed 
through the SiO2 plug, which was finally rinsed with excess EtOAc. The resulting filtrate 
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elution, 1:1→1:2 hexanes–EtOAc followed by 100% EtOAc) to afford tetraol 277 (3.3 
mg, 50% yield) as a white amorphous solid. [α]
! 
D
25.0 = –188 ° (c = 0.17, CH2Cl2); 1H NMR 
(500 MHz, CD3CN) δ 6.65 – 6.62 (m, 2H), 6.32 (dd, J = 8.4, 1.9 Hz, 2H), 5.93 (d, J = 1.6 
Hz, 2H), 5.69 (d, J = 0.9 Hz, 2H), 4.79 (ddd, J = 8.1, 2.4, 2.4 Hz, 2H), 4.66 (dd, J = 8.4, 
1.8 Hz, 2H), 4.29 (dddd, J = 7.9, 1.7, 1.7, 1.7 Hz, 2H), 3.02 – 2.94 (m, 2H), 2.84 (ddd, J 
= 16.4, 1.1, 0.6 Hz, 2H); 13C NMR (126 MHz, CD3CN) δ 170.2, 140.9, 140.1, 115.6, 
109.5, 91.9, 69.1, 67.7, 38.5; IR (NaCl/thin film): 3305, 2922, 2851, 1672, 1400, 1323, 
1284, 1199, 1132, 1063, 1034, 978, 917, 869, 796, 767, 735 cm–1; LRMS (ESI/APCI) 
calc’d for C18H17N2O8 [M–H]– 389.1, found 389.1. 
Preparation of 275 from bis(tert-butyldimethylsilyl) ether 190 
 
 A solution of diketopiperazine 190 (10.0 mg, 0.0170 mmol) in 2.5 mL 
THF/MeOH (1:1) was treated with Cs2CO3 (222 mg, 0.680 mmol), and the resulting 
mixture was stirred under an air atmosphere overnight. The mixture was then diluted with 
H2O and extracted with CH2Cl2 (3x). The combined organic layers were then washed 
with sat. aq. NH4Cl, dried over Na2SO4, filtered, and concentrated in vacuo. Purification 
by flash chromatography (isocratic elution, 3:1 hexanes–EtOAc) afforded 
diketopiperazine 275 (7.7 mg, 77% yield) as a white, amorphous solid. [α]
! 
D
25.0 = –323 ° (c 
= 0.39, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.48 (ddd, J = 2.5, 2.5, 1.0 Hz, 2H), 6.14 
(dd, J = 8.2, 2.2 Hz, 2H), 5.09 (dddd, J = 8.0, 1.6, 1.6, 1.6 Hz, 2H), 4.75 (dd, J = 8.2, 1.8 
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14.7, 11.7, 2.1, 2.1 Hz, 2H), 0.90 (s, 18H), 0.08 (s, 6H), 0.03 (s, 6H); 13C NMR (126 
MHz, CDCl3) δ 163.4, 138.6, 137.0, 112.4, 110.1, 69.2, 62.8, 58.1, 35.4, 25.7, 18.0, -4.6, 
-4.7; IR (NaCl/thin film): 2948, 2924, 2884, 2853, 1670, 1418, 1335, 1288, 1282, 1257, 
1243, 1198, 1183, 1162, 1128, 1101, 1072, 1059, 1018, 996, 939, 904, 889, 871, 834, 
806, 774, 723 cm–1; HRMS (ESI) calc’d for C24H31N2O5Si [M–C6H15OSi]+ 455.1997, 
found 455.2008 (detected fragment has undergone loss of tert-butyldimethylsilanolate 
anion). 
Preparation of diol 276 from bis(tert-butyldimethylsilyl) ether 190 
 
 To a solution of bis(tert-butyldimethylsilyl) ether 190 (8.9 mg, 0.015 mmol) in 
1.05 mL THF/H2O (6:1) was added 0.45 mL HCO2H with stirring. After 2.5 h, the 
mixture was quenched with sat. aq. NaHCO3 and extracted with EtOAc (3x). The 
combined organics were then washed with sat. aq. NaHCO3 (back-extracting the aqueous 
with EtOAc), dried over Na2SO4, filtered, and concentrated in vacuo. Purification by 
flash chromatography (gradient elution, 1:1→2:3 hexanes–EtOAc) afforded diol 276 (3.4 
mg, 62% yield). [α]
! 
D
25.0 = –264 ° (c = 0.17, CHCl3); 1H NMR (500 MHz, CDCl3) δ 6.57 
(ddd, J = 2.1, 2.1, 2.1 Hz, 2H), 6.27 (dd, J = 8.3, 1.9 Hz, 2H), 6.12 (d, J = 2.2 Hz, 2H), 
4.78 (dd, J = 8.3, 1.8 Hz, 2H), 4.70 (ddd, J = 8.1, 2.2, 2.2 Hz, 2H), 4.44 (dd, J = 10.3, 8.0 
Hz, 2H), 4.30 (dddd, J = 8.0, 2.0, 2.0, 2.0 Hz, 2H), 2.98 – 2.86 (m, 4H); 13C NMR (101 
MHz, CDCl3) δ 170.3, 140.2, 139.1, 114.4, 108.7, 69.2, 66.9, 62.1, 29.5; IR (NaCl/thin 
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1035, 905, 884, 808, 750 cm–1; HRMS (ESI) calc’d for C18H15N2O4 [M–H2O–HO]+ 
323.1026, found 323.1050 (detected fragment has undergone loss of H2O and OH–). 
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X-Ray Crystallography Reports Relevant to Chapter 4: 
Further Investigation of Side Reactions† 
  
                                                
† The work disclosed in this appendix for the X-ray crystallographic analysis of 260 was 
completed entirely by Larry Henling and Dr. Michael Day in the Caltech X-ray 
crystallography lab. 
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A5.1. CRYSTAL STRUCTURE ANALYSIS OF PYRROLIZIDINE 260 
Figure A5.1. Pyrrolizidine 260 (trifluoroactetate counterion omitted). 
Crystallographic data have been deposited at the CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK and copies can be obtained on request, free of charge, by 
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Table A5.1.  Crystal data and structure refinement for pyrrolizidine 260 (CCDC 
831402). 
Empirical formula  [C28H30NO6]+ [C2F3O2]¯ 
Formula weight  589.55 
Crystallization Solvent  Acetone/pentanes 
Crystal Habit  Plate 
Crystal size 0.36 x 0.33 x 0.11 mm3 
Crystal color  Colorless  
 Data Collection  
Type of diffractometer  Bruker SMART 1000 
Wavelength  0.71073 Å MoKα  
Data Collection Temperature  100(2) K 
θ range for 9978 reflections used 
in lattice determination  2.39 to 27.12° 
Unit cell dimensions a = 16.1696(19) Å α= 90° 
 b = 9.6337(11) Å β= 106.742(2)° 
 c = 18.988(2) Å γ = 90° 
Volume 2832.4(6) Å3 
Z 4 
Crystal system  Monoclinic 
Space group  P 21/n 
Density (calculated) 1.383 Mg/m3 
F(000) 1232 
θ range for data collection 1.96 to 27.61° 
Completeness to θ = 27.61° 99.5 %  
Index ranges -20 ≤ h ≤ 20, -12 ≤ k ≤ 12, -24 ≤ l ≤ 24 
Data collection scan type  ω scans; 6 settings 
Reflections collected 42760 
Independent reflections 6554 [Rint= 0.0503] 
Absorption coefficient 0.113 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6474
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Table A5.1 (cont.) 
Structure Solution and Refinement  
Structure solution program  SHELXS-97 (Sheldrick, 2008) 
Primary solution method  Direct methods 
Secondary solution method  Difference Fourier map 
Hydrogen placement  Geometric positions 
Structure refinement program  SHELXL-97 (Sheldrick, 2008) 
Refinement method Full matrix least-squares on F2 
Data / restraints / parameters 6554 / 0 / 410 
Treatment of hydrogen atoms  Riding 
Goodness-of-fit on F2 2.325 
Final R indices [I>2σ(I),  4759 reflections] R1 = 0.0492, wR2 = 0.0710 
R indices (all data) R1 = 0.0733, wR2 = 0.0735 
Type of weighting scheme used Sigma 
Weighting scheme used w=1/σ2(Fo2) 
Max shift/error  0.013 
Average shift/error  0.001 
Largest diff. peak and hole 0.281 and -0.312 e.Å-3 
 Special Refinement Details  
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under 
a nitrogen stream at 100K. 
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are 
based on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold 
expression of F2 > 2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of 
reflections for refinement.  R-factors based on F2 are statistically about twice as large as those based on F, 
and R-factors based on ALL data will be even larger. 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix.  The cell esds are taken into account individually in the estimation of esds in distances, 
angles and torsion angles; correlations between esds in cell parameters are only used when they are defined 
by crystal symmetry.  An approximate (isotropic) treatment of cell esds is used for estimating esds 
involving l.s. planes. 
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Table A5.2.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for pyrrolizidine 260 (CCDC 831402).  U(eq) is defined as 
the trace of the orthogonalized Uij tensor.  
________________________________________________________________________________ 
 x y z Ueq Occ 
________________________________________________________________________________ 
N(1) 548(1) 1210(1) 1090(1) 16(1) 1 
O(1) -1579(1) 3781(1) 489(1) 25(1) 1 
O(2) -759(1) 2797(1) -147(1) 28(1) 1 
O(3) 670(1) 806(1) -294(1) 23(1) 1 
O(4) 1170(1) 2975(1) -361(1) 25(1) 1 
O(5) 1918(1) 2777(1) 2575(1) 25(1) 1 
O(6) 2539(1) 788(1) 3074(1) 26(1) 1 
C(1) 36(1) 2023(2) 1518(1) 17(1) 1 
C(2) -108(1) 3419(2) 1109(1) 18(1) 1 
C(3) 755(1) 3679(2) 952(1) 20(1) 1 
C(4) 1065(1) 2252(2) 780(1) 18(1) 1 
C(5) 2030(1) 1918(2) 1165(1) 21(1) 1 
C(6) 2048(1) 890(2) 1782(1) 20(1) 1 
C(7) 1179(1) 104(2) 1512(1) 19(1) 1 
C(8) -768(1) 1304(2) 1551(1) 18(1) 1 
C(9) -963(1) 1085(2) 2172(1) 22(1) 1 
C(10) -1790(1) 540(2) 2231(1) 24(1) 1 
C(11) -2548(1) 711(2) 1668(1) 36(1) 1 
C(12) -3319(1) 204(2) 1732(1) 44(1) 1 
C(13) -3350(1) -471(2) 2361(1) 42(1) 1 
C(14) -2610(1) -639(2) 2924(1) 44(1) 1 
C(15) -1831(1) -126(2) 2865(1) 35(1) 1 
C(16) -848(1) 3306(2) 410(1) 20(1) 1 
C(17) 911(1) 1927(2) -29(1) 20(1) 1 
C(18) 1308(1) 2725(2) -1082(1) 28(1) 1 
C(19) 2251(1) 2581(2) -975(1) 50(1) 1 
C(20) 2157(1) 1604(2) 2514(1) 21(1) 1 
C(21) 906(1) -619(2) 2099(1) 19(1) 1 
C(22) 837(1) -1988(2) 2127(1) 20(1) 1 
C(23) 717(1) -2773(2) 2753(1) 19(1) 1 
C(24) 790(1) -4211(2) 2759(1) 23(1) 1 
C(25) 753(1) -4984(2) 3366(1) 29(1) 1 
C(26) 644(1) -4326(2) 3973(1) 32(1) 1 
C(27) 553(1) -2897(2) 3971(1) 32(1) 1 
C(28) 588(1) -2134(2) 3370(1) 27(1) 1 
C(31) 1037(1) 1596(3) 4807(1) 40(1) 1 
C(32) 1369(1) 1469(2) 4134(1) 23(1) 1 
F(1) 1353(4) 2727(5) 5180(2) 88(2) 0.751(12) 
F(2) 205(3) 1790(11) 4627(3) 115(2) 0.751(12) 
F(3) 1266(4) 589(4) 5255(3) 93(2) 0.751(12) 
F(1B) 967(17) 2814(10) 5038(10) 101(6) 0.249(12) 
F(2B) 292(10) 975(19) 4709(9) 91(6) 0.249(12) 
F(3B) 1501(11) 980(30) 5382(9) 158(9) 0.249(12) 
O(7) 2184(1) 1448(1) 4281(1) 30(1) 1 
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O(8) 829(1) 1394(1) 3536(1) 27(1) 1 
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Table A5.3.   Bond lengths [Å] and angles [°] for pyrrolizidine 260 (CCDC 831402). 
N(1)-C(4)  1.5278(18) 
N(1)-C(7)  1.5317(17) 
N(1)-C(1)  1.5326(17) 
O(1)-C(16)  1.3149(17) 
O(2)-C(16)  1.2127(18) 
O(3)-C(17)  1.2078(17) 
O(4)-C(17)  1.3201(17) 
O(4)-C(18)  1.4692(17) 
O(5)-C(20)  1.2102(18) 
O(6)-C(20)  1.3228(17) 
C(1)-C(8)  1.4903(19) 
C(1)-C(2)  1.537(2) 
C(2)-C(16)  1.513(2) 
C(2)-C(3)  1.5296(19) 
C(3)-C(4)  1.530(2) 
C(4)-C(17)  1.518(2) 
C(4)-C(5)  1.554(2) 
C(5)-C(6)  1.529(2) 
C(6)-C(20)  1.516(2) 
C(6)-C(7)  1.548(2) 
C(7)-C(21)  1.484(2) 
C(8)-C(9)  1.323(2) 
C(9)-C(10)  1.471(2) 
C(10)-C(15)  1.382(2) 
C(10)-C(11)  1.385(2) 
C(11)-C(12)  1.377(2) 
C(12)-C(13)  1.373(2) 
C(13)-C(14)  1.366(2) 
C(14)-C(15)  1.387(2) 
C(18)-C(19)  1.487(2) 
C(21)-C(22)  1.326(2) 
C(22)-C(23)  1.468(2) 
C(23)-C(24)  1.390(2) 
C(23)-C(28)  1.392(2) 
C(24)-C(25)  1.387(2) 
C(25)-C(26)  1.371(2) 
C(26)-C(27)  1.384(2) 
C(27)-C(28)  1.371(2) 
C(31)-F(1B)  1.269(11) 
C(31)-F(3)  1.272(4) 
C(31)-F(3B)  1.280(13) 
C(31)-F(2)  1.303(4) 
C(31)-F(2B)  1.311(10) 
C(31)-F(1)  1.319(4) 
C(31)-C(32)  1.527(2) 
C(32)-O(8)  1.2193(17) 


















































































O(7)-C(32)-C(31)          114.23(15) 
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Table A5.4.   Anisotropic displacement parameters (Å2x 104) for pyrrolizidine 260 
(CCDC 831402).  The anisotropic displacement factor exponent takes the form: -
2p2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
N(1) 139(7)  204(8) 146(7)  2(6) 30(5)  -10(6) 
O(1) 174(6)  362(7) 190(6)  -20(6) -1(5)  51(6) 
O(2) 246(6)  397(8) 197(7)  -54(6) 45(5)  41(6) 
O(3) 244(6)  239(7) 217(6)  -34(5) 81(5)  -48(5) 
O(4) 306(7)  284(7) 190(6)  22(5) 99(5)  -62(5) 
O(5) 236(6)  257(7) 229(7)  -9(5) 40(5)  -12(5) 
O(6) 233(6)  350(7) 187(6)  16(6) 37(5)  45(5) 
C(1) 148(8)  228(9) 144(9)  -14(7) 43(7)  10(7) 
C(2) 185(8)  172(9) 184(9)  -26(7) 40(7)  -7(7) 
C(3) 211(9)  199(9) 183(9)  -10(7) 45(7)  -25(7) 
C(4) 160(8)  221(9) 171(9)  5(7) 48(7)  -42(7) 
C(5) 142(8)  303(10) 190(9)  -6(8) 36(7)  -30(7) 
C(6) 150(8)  266(10) 193(9)  22(7) 44(7)  16(7) 
C(7) 174(8)  200(9) 186(9)  9(7) 42(7)  33(7) 
C(8) 136(8)  187(9) 202(9)  -15(7) 26(7)  2(7) 
C(9) 177(9)  235(10) 226(10)  17(8) 34(7)  31(7) 
C(10) 210(9)  230(10) 291(10)  25(8) 114(8)  27(8) 
C(11) 255(10)  446(13) 398(12)  148(10) 121(9)  1(9) 
C(12) 215(10)  558(14) 557(14)  139(11) 102(10)  -18(10) 
C(13) 294(11)  388(12) 648(15)  47(11) 256(11)  -49(10) 
C(14) 458(13)  496(14) 461(13)  138(11) 288(11)  -27(11) 
C(15) 302(10)  456(12) 321(11)  95(9) 125(9)  16(9) 
C(16) 195(9)  182(9) 222(10)  37(8) 48(7)  -3(7) 
C(17) 145(8)  252(10) 204(9)  34(8) 57(7)  -4(7) 
C(18) 375(11)  319(11) 179(10)  26(8) 133(8)  -9(9) 
C(19) 403(12)  682(16) 480(14)  -132(11) 243(11)  -74(11) 
C(20) 112(8)  296(10) 213(9)  40(8) 27(7)  -35(8) 
C(21) 145(8)  231(10) 176(9)  -5(7) 33(7)  28(7) 
C(22) 147(8)  268(10) 181(9)  -22(8) 29(7)  11(7) 
C(23) 131(8)  206(9) 225(10)  17(8) 17(7)  -10(7) 
C(24) 174(9)  247(10) 261(10)  -22(8) 37(7)  -10(7) 
C(25) 238(10)  240(10) 392(12)  83(9) 79(9)  2(8) 
C(26) 310(10)  355(12) 337(11)  128(9) 138(9)  6(9) 
C(27) 353(11)  366(12) 303(11)  18(9) 184(9)  16(9) 
C(28) 309(10)  236(10) 308(11)  16(8) 143(8)  1(8) 
C(31) 250(11)  614(17) 306(13)  -81(12) 47(9)  18(11) 
C(32) 237(10)  207(9) 220(10)  -7(8) 40(8)  -13(8) 
F(1) 950(30)  1110(30) 551(17)  -580(20) 176(17)  22(18) 
F(2) 289(18)  2770(70) 387(15)  -300(30) 109(13)  250(30) 
F(3) 1370(50)  920(30) 700(30)  484(17) 620(30)  210(20) 
F(1B) 2050(170)  330(50) 1220(100)  370(60) 1380(110)  390(70) 
F(2B) 590(90)  1560(110) 740(80)  -540(80) 470(80)  -890(90) 
F(3B) 540(60)  4000(300) 320(50)  820(100) 330(50)  1040(100) 
O(7) 178(6)  507(8) 195(6)  -11(6) 15(5)  -11(6) 
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O(8) 228(6)  307(7) 224(7)  -24(5) 2(5)  -14(5) 
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Table A5.5.  Hydrogen bonds for pyrrolizidine 260 (CCDC 831402) [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(1)-H(1)...O(3)#1 0.93 2.02 2.8670(16) 149.8 
 O(1)-H(1A)...O(7)#2 0.84 1.74 2.5814(14) 176.1 
 O(6)-H(6)...O(7) 0.84 1.77 2.5979(15) 168.4 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y,-z     
#2 x-1/2,-y+1/2,z-1/2      
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